id	sid	tid	token	lemma	pos
ajb-7	1	1	kbm	kbm	PROPN
ajb-7	1	2	journal	journal	PROPN
ajb-7	1	3	of	of	ADP
ajb-7	1	4	biology	biology	NOUN
ajb-7	1	5	(	(	PUNCT
ajb-7	1	6	2010	2010	NUM
ajb-7	1	7	)	)	PUNCT
ajb-7	1	8	1	1	NUM
ajb-7	1	9	(	(	PUNCT
ajb-7	1	10	2	2	NUM
ajb-7	1	11	):	):	PUNCT
ajb-7	1	12	34	34	NUM
ajb-7	1	13	-	-	SYM
ajb-7	1	14	40	40	NUM
ajb-7	1	15	doi	doi	NOUN
ajb-7	1	16	:	:	PUNCT
ajb-7	1	17	10.5147	10.5147	NUM
ajb-7	1	18	/	/	SYM
ajb-7	1	19	kbmjb.2010.0018	kbmjb.2010.0018	PROPN
ajb-7	1	20	kb	kb	PROPN
ajb-7	1	21	m	m	PROPN
ajb-7	1	22	j	j	PROPN
ajb-7	1	23	ou	ou	PROPN
ajb-7	1	24	rn	rn	PROPN
ajb-7	1	25	al	al	PROPN
ajb-7	1	26	o	o	PROPN
ajb-7	2	1	f	f	PROPN
ajb-7	2	2	bi	bi	NOUN
ajb-7	2	3	ol	ol	PROPN
ajb-7	2	4	og	og	PROPN
ajb-7	2	5	y	y	PROPN
ajb-7	2	6	is	be	AUX
ajb-7	2	7	sn	sn	PROPN
ajb-7	2	8	1	1	NUM
ajb-7	2	9	94	94	NUM
ajb-7	2	10	858	858	NUM
ajb-7	2	11	83	83	NUM
ajb-7	2	12	.	.	PUNCT
ajb-7	3	1	p	p	X
ajb-7	3	2	ub	ub	ADJ
ajb-7	3	3	lis	li	NOUN
ajb-7	3	4	he	he	PRON
ajb-7	3	5	d	d	NOUN
ajb-7	3	6	by	by	ADP
ajb-7	3	7	k	k	PROPN
ajb-7	3	8	bm	bm	PROPN
ajb-7	3	9	s	s	PROPN
ajb-7	3	10	ci	ci	PROPN
ajb-7	3	11	en	en	ADP
ajb-7	3	12	tifi	tifi	PROPN
ajb-7	3	13	c	c	AUX
ajb-7	3	14	pu	pu	PROPN
ajb-7	3	15	bl	bl	AUX
ajb-7	3	16	ish	ish	VERB
ajb-7	3	17	in	in	ADP
ajb-7	3	18	g	g	PROPN
ajb-7	3	19	,	,	PUNCT
ajb-7	4	1	l	l	NOUN
ajb-7	4	2	p	p	X
ajb-7	5	1	(	(	PUNCT
ajb-7	5	2	w	w	PROPN
ajb-7	5	3	w	w	PROPN
ajb-7	5	4	w	w	PROPN
ajb-7	5	5	.k	.k	PROPN
ajb-7	5	6	bm	bm	PROPN
ajb-7	6	1	-s	-s	X
ajb-7	6	2	ci	ci	PROPN
ajb-7	6	3	en	en	INTJ
ajb-7	6	4	tifi	tifi	PROPN
ajb-7	6	5	cpu	cpu	NOUN
ajb-7	6	6	bl	bl	AUX
ajb-7	6	7	ish	ish	VERB
ajb-7	6	8	in	in	ADP
ajb-7	6	9	g.	g.	PROPN
ajb-7	6	10	or	or	CCONJ
ajb-7	6	11	g	g	NOUN
ajb-7	6	12	)	)	PUNCT
ajb-7	6	13	risk	risk	NOUN
ajb-7	6	14	factors	factor	NOUN
ajb-7	6	15	affecting	affect	VERB
ajb-7	6	16	the	the	DET
ajb-7	6	17	phenotypic	phenotypic	ADJ
ajb-7	6	18	expression	expression	NOUN
ajb-7	6	19	of	of	ADP
ajb-7	6	20	heterozygous	heterozygous	ADJ
ajb-7	6	21	familial	familial	ADJ
ajb-7	6	22	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	6	23	in	in	ADP
ajb-7	6	24	pakistani	pakistani	ADJ
ajb-7	6	25	population	population	NOUN
ajb-7	6	26	fauzia	fauzia	PROPN
ajb-7	6	27	imtiaz1	imtiaz1	PROPN
ajb-7	6	28	,	,	PUNCT
ajb-7	6	29	wajahatullah	wajahatullah	ADJ
ajb-7	6	30	khan2	khan2	NOUN
ajb-7	6	31	*	*	NOUN
ajb-7	6	32	,	,	PUNCT
ajb-7	6	33	and	and	CCONJ
ajb-7	6	34	ahsan	ahsan	PROPN
ajb-7	6	35	a.	a.	PROPN
ajb-7	6	36	vahidy3	vahidy3	PROPN
ajb-7	6	37	1	1	NUM
ajb-7	6	38	department	department	NOUN
ajb-7	6	39	of	of	ADP
ajb-7	6	40	biochemistry	biochemistry	NOUN
ajb-7	6	41	,	,	PUNCT
ajb-7	6	42	dow	dow	PROPN
ajb-7	6	43	international	international	PROPN
ajb-7	6	44	medical	medical	PROPN
ajb-7	6	45	college	college	PROPN
ajb-7	6	46	,	,	PUNCT
ajb-7	6	47	dow	dow	PROPN
ajb-7	6	48	university	university	PROPN
ajb-7	6	49	of	of	ADP
ajb-7	6	50	health	health	PROPN
ajb-7	6	51	sciences	sciences	PROPN
ajb-7	6	52	,	,	PUNCT
ajb-7	6	53	baba	baba	PROPN
ajb-7	6	54	-	-	PUNCT
ajb-7	6	55	eurdu	eurdu	PROPN
ajb-7	6	56	road	road	NOUN
ajb-7	6	57	,	,	PUNCT
ajb-7	6	58	po	po	PROPN
ajb-7	6	59	box	box	PROPN
ajb-7	6	60	942,943	942,943	NUM
ajb-7	6	61	,	,	PUNCT
ajb-7	6	62	karachi	karachi	PROPN
ajb-7	6	63	74200	74200	NUM
ajb-7	6	64	,	,	PUNCT
ajb-7	6	65	pakistan	pakistan	PROPN
ajb-7	6	66	.	.	PUNCT
ajb-7	7	1	2	2	NUM
ajb-7	7	2	biochemistry	biochemistry	NOUN
ajb-7	7	3	department	department	NOUN
ajb-7	7	4	,	,	PUNCT
ajb-7	7	5	king	king	PROPN
ajb-7	7	6	saud	saud	PROPN
ajb-7	7	7	university	university	PROPN
ajb-7	7	8	,	,	PUNCT
ajb-7	7	9	po	po	PROPN
ajb-7	7	10	box	box	PROPN
ajb-7	7	11	2455	2455	NUM
ajb-7	7	12	,	,	PUNCT
ajb-7	7	13	riyadh	riyadh	PROPN
ajb-7	7	14	11451	11451	NUM
ajb-7	7	15	,	,	PUNCT
ajb-7	7	16	saudi	saudi	PROPN
ajb-7	7	17	arabia	arabia	PROPN
ajb-7	7	18	.	.	PUNCT
ajb-7	8	1	3	3	NUM
ajb-7	8	2	department	department	NOUN
ajb-7	8	3	of	of	ADP
ajb-7	8	4	genetics	genetic	NOUN
ajb-7	8	5	,	,	PUNCT
ajb-7	8	6	university	university	PROPN
ajb-7	8	7	of	of	ADP
ajb-7	8	8	karachi	karachi	PROPN
ajb-7	8	9	,	,	PUNCT
ajb-7	8	10	karachi	karachi	PROPN
ajb-7	8	11	pakistan	pakistan	PROPN
ajb-7	8	12	.	.	PUNCT
ajb-7	8	13	received	receive	VERB
ajb-7	8	14	:	:	PUNCT
ajb-7	8	15	february	february	PROPN
ajb-7	8	16	16	16	NUM
ajb-7	8	17	,	,	PUNCT
ajb-7	8	18	2010	2010	NUM
ajb-7	8	19	/	/	PUNCT
ajb-7	8	20	accepted	accept	VERB
ajb-7	8	21	:	:	PUNCT
ajb-7	8	22	may	may	AUX
ajb-7	8	23	27	27	NUM
ajb-7	8	24	,	,	PUNCT
ajb-7	8	25	2010	2010	NUM
ajb-7	8	26	abstract	abstract	ADJ
ajb-7	8	27	familial	familial	ADJ
ajb-7	8	28	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	8	29	(	(	PUNCT
ajb-7	8	30	fh	fh	PROPN
ajb-7	8	31	)	)	PUNCT
ajb-7	8	32	is	be	AUX
ajb-7	8	33	a	a	DET
ajb-7	8	34	genetic	genetic	ADJ
ajb-7	8	35	disorder	disorder	NOUN
ajb-7	8	36	of	of	ADP
ajb-7	8	37	lipoprotein	lipoprotein	ADJ
ajb-7	8	38	metabolism	metabolism	NOUN
ajb-7	8	39	recognized	recognize	VERB
ajb-7	8	40	by	by	ADP
ajb-7	8	41	high	high	ADJ
ajb-7	8	42	plasma	plasma	NOUN
ajb-7	8	43	concentrations	concentration	NOUN
ajb-7	8	44	of	of	ADP
ajb-7	8	45	low	low	ADJ
ajb-7	8	46	-	-	PUNCT
ajb-7	8	47	density	density	NOUN
ajb-7	8	48	lipoprotein	lipoprotein	ADJ
ajb-7	8	49	cholesterol	cholesterol	NOUN
ajb-7	8	50	(	(	PUNCT
ajb-7	8	51	ldlc	ldlc	NOUN
ajb-7	8	52	)	)	PUNCT
ajb-7	8	53	,	,	PUNCT
ajb-7	8	54	tendon	tendon	PROPN
ajb-7	8	55	xanthomas	xanthomas	PROPN
ajb-7	8	56	,	,	PUNCT
ajb-7	8	57	and	and	CCONJ
ajb-7	8	58	high	high	ADJ
ajb-7	8	59	risk	risk	NOUN
ajb-7	8	60	of	of	ADP
ajb-7	8	61	early	early	ADJ
ajb-7	8	62	coronary	coronary	ADJ
ajb-7	8	63	heart	heart	NOUN
ajb-7	8	64	disease	disease	NOUN
ajb-7	8	65	.	.	PUNCT
ajb-7	9	1	the	the	DET
ajb-7	9	2	phenotypic	phenotypic	ADJ
ajb-7	9	3	expression	expression	NOUN
ajb-7	9	4	of	of	ADP
ajb-7	9	5	fh	fh	PROPN
ajb-7	9	6	is	be	AUX
ajb-7	9	7	variable	variable	ADJ
ajb-7	9	8	and	and	CCONJ
ajb-7	9	9	several	several	ADJ
ajb-7	9	10	genetic	genetic	ADJ
ajb-7	9	11	and	and	CCONJ
ajb-7	9	12	other	other	ADJ
ajb-7	9	13	risk	risk	NOUN
ajb-7	9	14	factors	factor	NOUN
ajb-7	9	15	contribute	contribute	VERB
ajb-7	9	16	to	to	ADP
ajb-7	9	17	such	such	ADJ
ajb-7	9	18	variability	variability	NOUN
ajb-7	9	19	in	in	ADP
ajb-7	9	20	clinical	clinical	ADJ
ajb-7	9	21	expression	expression	NOUN
ajb-7	9	22	of	of	ADP
ajb-7	9	23	the	the	DET
ajb-7	9	24	disease	disease	NOUN
ajb-7	9	25	.	.	PUNCT
ajb-7	10	1	fh	fh	PROPN
ajb-7	10	2	is	be	AUX
ajb-7	10	3	an	an	DET
ajb-7	10	4	autosomal	autosomal	ADJ
ajb-7	10	5	disorder	disorder	NOUN
ajb-7	10	6	characterized	characterize	VERB
ajb-7	10	7	by	by	ADP
ajb-7	10	8	increased	increase	VERB
ajb-7	10	9	levels	level	NOUN
ajb-7	10	10	of	of	ADP
ajb-7	10	11	total	total	ADJ
ajb-7	10	12	cholesterol	cholesterol	NOUN
ajb-7	10	13	(	(	PUNCT
ajb-7	10	14	tc	tc	NOUN
ajb-7	10	15	)	)	PUNCT
ajb-7	10	16	,	,	PUNCT
ajb-7	10	17	low	low	ADJ
ajb-7	10	18	density	density	NOUN
ajb-7	10	19	lipoprotein	lipoprotein	ADJ
ajb-7	10	20	cholesterol	cholesterol	NOUN
ajb-7	10	21	(	(	PUNCT
ajb-7	10	22	ldl	ldl	NOUN
ajb-7	10	23	-	-	PUNCT
ajb-7	10	24	c	c	NOUN
ajb-7	10	25	)	)	PUNCT
ajb-7	10	26	and	and	CCONJ
ajb-7	10	27	tendinous	tendinous	ADJ
ajb-7	10	28	xanthmata	xanthmata	PROPN
ajb-7	10	29	(	(	PUNCT
ajb-7	10	30	tx	tx	PROPN
ajb-7	10	31	)	)	PUNCT
ajb-7	10	32	.	.	PUNCT
ajb-7	11	1	clinical	clinical	ADJ
ajb-7	11	2	phenotype	phenotype	NOUN
ajb-7	11	3	of	of	ADP
ajb-7	11	4	fh	fh	PROPN
ajb-7	11	5	has	have	AUX
ajb-7	11	6	previously	previously	ADV
ajb-7	11	7	been	be	AUX
ajb-7	11	8	shown	show	VERB
ajb-7	11	9	to	to	PART
ajb-7	11	10	be	be	AUX
ajb-7	11	11	associated	associate	VERB
ajb-7	11	12	with	with	ADP
ajb-7	11	13	increased	increase	VERB
ajb-7	11	14	coronary	coronary	ADJ
ajb-7	11	15	heart	heart	NOUN
ajb-7	11	16	disease	disease	NOUN
ajb-7	11	17	(	(	PUNCT
ajb-7	11	18	chd	chd	NOUN
ajb-7	11	19	)	)	PUNCT
ajb-7	11	20	and	and	CCONJ
ajb-7	11	21	premature	premature	ADJ
ajb-7	11	22	death	death	NOUN
ajb-7	11	23	.	.	PUNCT
ajb-7	12	1	the	the	DET
ajb-7	12	2	present	present	ADJ
ajb-7	12	3	study	study	NOUN
ajb-7	12	4	was	be	AUX
ajb-7	12	5	carried	carry	VERB
ajb-7	12	6	out	out	ADP
ajb-7	12	7	in	in	ADP
ajb-7	12	8	a	a	DET
ajb-7	12	9	pakistani	pakistani	ADJ
ajb-7	12	10	population	population	NOUN
ajb-7	12	11	to	to	PART
ajb-7	12	12	examine	examine	VERB
ajb-7	12	13	the	the	DET
ajb-7	12	14	contribution	contribution	NOUN
ajb-7	12	15	of	of	ADP
ajb-7	12	16	environmental	environmental	ADJ
ajb-7	12	17	factors	factor	NOUN
ajb-7	12	18	on	on	ADP
ajb-7	12	19	the	the	DET
ajb-7	12	20	expression	expression	NOUN
ajb-7	12	21	of	of	ADP
ajb-7	12	22	this	this	DET
ajb-7	12	23	disease	disease	NOUN
ajb-7	12	24	.	.	PUNCT
ajb-7	13	1	a	a	DET
ajb-7	13	2	detailed	detailed	ADJ
ajb-7	13	3	examination	examination	NOUN
ajb-7	13	4	of	of	ADP
ajb-7	13	5	the	the	DET
ajb-7	13	6	physical	physical	ADJ
ajb-7	13	7	and	and	CCONJ
ajb-7	13	8	biochemical	biochemical	ADJ
ajb-7	13	9	features	feature	NOUN
ajb-7	13	10	of	of	ADP
ajb-7	13	11	the	the	DET
ajb-7	13	12	fh	fh	PROPN
ajb-7	13	13	was	be	AUX
ajb-7	13	14	performed	perform	VERB
ajb-7	13	15	in	in	ADP
ajb-7	13	16	a	a	DET
ajb-7	13	17	cohort	cohort	NOUN
ajb-7	13	18	of	of	ADP
ajb-7	13	19	335	335	NUM
ajb-7	13	20	individuals	individual	NOUN
ajb-7	13	21	(	(	PUNCT
ajb-7	13	22	202	202	NUM
ajb-7	13	23	males	male	NOUN
ajb-7	13	24	,	,	PUNCT
ajb-7	13	25	133	133	NUM
ajb-7	13	26	females	female	NOUN
ajb-7	13	27	)	)	PUNCT
ajb-7	13	28	from	from	ADP
ajb-7	13	29	pakistan	pakistan	PROPN
ajb-7	13	30	.	.	PUNCT
ajb-7	14	1	our	our	PRON
ajb-7	14	2	results	result	NOUN
ajb-7	14	3	indicate	indicate	VERB
ajb-7	14	4	that	that	SCONJ
ajb-7	14	5	pakistani	pakistani	ADJ
ajb-7	14	6	females	female	NOUN
ajb-7	14	7	with	with	ADP
ajb-7	14	8	fh	fh	PROPN
ajb-7	14	9	had	have	VERB
ajb-7	14	10	high	high	ADJ
ajb-7	14	11	levels	level	NOUN
ajb-7	14	12	of	of	ADP
ajb-7	14	13	tc	tc	NOUN
ajb-7	14	14	and	and	CCONJ
ajb-7	14	15	ldl	ldl	NOUN
ajb-7	14	16	-	-	PUNCT
ajb-7	14	17	c	c	NOUN
ajb-7	14	18	as	as	SCONJ
ajb-7	14	19	compared	compare	VERB
ajb-7	14	20	to	to	ADP
ajb-7	14	21	pakistani	pakistani	ADJ
ajb-7	14	22	males	male	NOUN
ajb-7	14	23	.	.	PUNCT
ajb-7	15	1	overall	overall	ADJ
ajb-7	15	2	the	the	DET
ajb-7	15	3	concentrations	concentration	NOUN
ajb-7	15	4	of	of	ADP
ajb-7	15	5	high	high	ADJ
ajb-7	15	6	density	density	NOUN
ajb-7	15	7	lipoprotein	lipoprotein	ADJ
ajb-7	15	8	cholesterol	cholesterol	NOUN
ajb-7	15	9	(	(	PUNCT
ajb-7	15	10	hdl	hdl	NOUN
ajb-7	15	11	-	-	PUNCT
ajb-7	15	12	c	c	NOUN
ajb-7	15	13	)	)	PUNCT
ajb-7	15	14	were	be	AUX
ajb-7	15	15	significantly	significantly	ADV
ajb-7	15	16	lower	low	ADJ
ajb-7	15	17	for	for	ADP
ajb-7	15	18	both	both	DET
ajb-7	15	19	sexes	sex	NOUN
ajb-7	15	20	as	as	SCONJ
ajb-7	15	21	compared	compare	VERB
ajb-7	15	22	to	to	ADP
ajb-7	15	23	the	the	DET
ajb-7	15	24	controls	control	NOUN
ajb-7	15	25	(	(	PUNCT
ajb-7	15	26	normal	normal	ADJ
ajb-7	15	27	)	)	PUNCT
ajb-7	15	28	.	.	PUNCT
ajb-7	16	1	we	we	PRON
ajb-7	16	2	have	have	AUX
ajb-7	16	3	also	also	ADV
ajb-7	16	4	found	find	VERB
ajb-7	16	5	that	that	SCONJ
ajb-7	16	6	high	high	ADJ
ajb-7	16	7	cholesterol	cholesterol	NOUN
ajb-7	16	8	levels	level	NOUN
ajb-7	16	9	were	be	AUX
ajb-7	16	10	associated	associate	VERB
ajb-7	16	11	with	with	ADP
ajb-7	16	12	increased	increase	VERB
ajb-7	16	13	incidence	incidence	NOUN
ajb-7	16	14	of	of	ADP
ajb-7	16	15	chd	chd	PROPN
ajb-7	16	16	in	in	ADP
ajb-7	16	17	fh	fh	PROPN
ajb-7	16	18	pakistani	pakistani	ADJ
ajb-7	16	19	population	population	NOUN
ajb-7	16	20	where	where	SCONJ
ajb-7	16	21	both	both	CCONJ
ajb-7	16	22	male	male	ADJ
ajb-7	16	23	and	and	CCONJ
ajb-7	16	24	female	female	ADJ
ajb-7	16	25	individuals	individual	NOUN
ajb-7	16	26	showed	show	VERB
ajb-7	16	27	69	69	NUM
ajb-7	16	28	%	%	NOUN
ajb-7	16	29	and	and	CCONJ
ajb-7	16	30	31	31	NUM
ajb-7	16	31	%	%	NOUN
ajb-7	16	32	chd	chd	NOUN
ajb-7	16	33	,	,	PUNCT
ajb-7	16	34	respectively	respectively	ADV
ajb-7	16	35	.	.	PUNCT
ajb-7	17	1	the	the	DET
ajb-7	17	2	mean	mean	ADJ
ajb-7	17	3	onset	onset	VERB
ajb-7	17	4	age	age	NOUN
ajb-7	17	5	for	for	ADP
ajb-7	17	6	coronary	coronary	ADJ
ajb-7	17	7	symptoms	symptom	NOUN
ajb-7	17	8	was	be	AUX
ajb-7	17	9	about	about	ADV
ajb-7	17	10	38	38	NUM
ajb-7	17	11	years	year	NOUN
ajb-7	17	12	in	in	ADP
ajb-7	17	13	males	male	NOUN
ajb-7	17	14	as	as	ADP
ajb-7	17	15	compared	compare	VERB
ajb-7	17	16	to	to	ADP
ajb-7	17	17	45	45	NUM
ajb-7	17	18	years	year	NOUN
ajb-7	17	19	in	in	ADP
ajb-7	17	20	females	female	NOUN
ajb-7	17	21	.	.	PUNCT
ajb-7	18	1	a	a	DET
ajb-7	18	2	greater	great	ADJ
ajb-7	18	3	risk	risk	NOUN
ajb-7	18	4	of	of	ADP
ajb-7	18	5	developing	develop	VERB
ajb-7	18	6	chd	chd	NOUN
ajb-7	18	7	has	have	AUX
ajb-7	18	8	been	be	AUX
ajb-7	18	9	linked	link	VERB
ajb-7	18	10	with	with	ADP
ajb-7	18	11	levels	level	NOUN
ajb-7	18	12	of	of	ADP
ajb-7	18	13	tc	tc	NOUN
ajb-7	18	14	along	along	ADP
ajb-7	18	15	with	with	ADP
ajb-7	18	16	a	a	DET
ajb-7	18	17	history	history	NOUN
ajb-7	18	18	of	of	ADP
ajb-7	18	19	smoking	smoking	NOUN
ajb-7	18	20	in	in	ADP
ajb-7	18	21	males	male	NOUN
ajb-7	18	22	and	and	CCONJ
ajb-7	18	23	presence	presence	NOUN
ajb-7	18	24	of	of	ADP
ajb-7	18	25	hypertension	hypertension	NOUN
ajb-7	18	26	(	(	PUNCT
ajb-7	18	27	htn	htn	PROPN
ajb-7	18	28	)	)	PUNCT
ajb-7	18	29	in	in	ADP
ajb-7	18	30	females	female	NOUN
ajb-7	18	31	.	.	PUNCT
ajb-7	19	1	our	our	PRON
ajb-7	19	2	results	result	NOUN
ajb-7	19	3	indicate	indicate	VERB
ajb-7	19	4	that	that	SCONJ
ajb-7	19	5	these	these	DET
ajb-7	19	6	risk	risk	NOUN
ajb-7	19	7	factors	factor	NOUN
ajb-7	19	8	possibly	possibly	ADV
ajb-7	19	9	affect	affect	VERB
ajb-7	19	10	and	and	CCONJ
ajb-7	19	11	contribute	contribute	VERB
ajb-7	19	12	in	in	ADP
ajb-7	19	13	the	the	DET
ajb-7	19	14	phenotypic	phenotypic	ADJ
ajb-7	19	15	expression	expression	NOUN
ajb-7	19	16	of	of	ADP
ajb-7	19	17	fh	fh	PROPN
ajb-7	19	18	in	in	ADP
ajb-7	19	19	pakistani	pakistani	ADJ
ajb-7	19	20	population	population	NOUN
ajb-7	19	21	.	.	PUNCT
ajb-7	20	1	_	_	PUNCT
ajb-7	21	1	_	_	PUNCT
ajb-7	22	1	_	_	PUNCT
ajb-7	23	1	_	_	PUNCT
ajb-7	24	1	_	_	PUNCT
ajb-7	25	1	_	_	PUNCT
ajb-7	26	1	_	_	PUNCT
ajb-7	27	1	_	_	PUNCT
ajb-7	28	1	_	_	PUNCT
ajb-7	29	1	_	_	PUNCT
ajb-7	30	1	_	_	PUNCT
ajb-7	31	1	_	_	PUNCT
ajb-7	32	1	_	_	PUNCT
ajb-7	33	1	_	_	PUNCT
ajb-7	34	1	_	_	PUNCT
ajb-7	35	1	_	_	PUNCT
ajb-7	36	1	_	_	PUNCT
ajb-7	37	1	_	_	PUNCT
ajb-7	38	1	_	_	PUNCT
ajb-7	39	1	_	_	PUNCT
ajb-7	40	1	_	_	PUNCT
ajb-7	41	1	_	_	PUNCT
ajb-7	42	1	_	_	PUNCT
ajb-7	43	1	_	_	PUNCT
ajb-7	44	1	_	_	PUNCT
ajb-7	45	1	_	_	PUNCT
ajb-7	46	1	_	_	PUNCT
ajb-7	47	1	_	_	PUNCT
ajb-7	48	1	_	_	PUNCT
ajb-7	49	1	_	_	PUNCT
ajb-7	50	1	_	_	PUNCT
ajb-7	51	1	_	_	PUNCT
ajb-7	52	1	_	_	PUNCT
ajb-7	53	1	_	_	PUNCT
ajb-7	54	1	_	_	PUNCT
ajb-7	55	1	_	_	PUNCT
ajb-7	56	1	_	_	PUNCT
ajb-7	57	1	_	_	PUNCT
ajb-7	58	1	_	_	PUNCT
ajb-7	59	1	_	_	PUNCT
ajb-7	60	1	_	_	PUNCT
ajb-7	61	1	_	_	PUNCT
ajb-7	62	1	_	_	PUNCT
ajb-7	63	1	_	_	PUNCT
ajb-7	64	1	_	_	PUNCT
ajb-7	65	1	_	_	PUNCT
ajb-7	66	1	_	_	PUNCT
ajb-7	67	1	_	_	PUNCT
ajb-7	68	1	_	_	PUNCT
ajb-7	69	1	_	_	PUNCT
ajb-7	70	1	*	*	PUNCT
ajb-7	70	2	corresponding	correspond	VERB
ajb-7	70	3	author	author	NOUN
ajb-7	70	4	:	:	PUNCT
ajb-7	70	5	wkhan@ksu.edu.sa	wkhan@ksu.edu.sa	NOUN
ajb-7	70	6	keywords	keyword	NOUN
ajb-7	70	7	:	:	PUNCT
ajb-7	70	8	phenotypic	phenotypic	ADJ
ajb-7	70	9	expression	expression	NOUN
ajb-7	70	10	,	,	PUNCT
ajb-7	70	11	familial	familial	ADJ
ajb-7	70	12	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	70	13	,	,	PUNCT
ajb-7	70	14	risk	risk	NOUN
ajb-7	70	15	factors	factor	NOUN
ajb-7	70	16	,	,	PUNCT
ajb-7	70	17	coronary	coronary	ADJ
ajb-7	70	18	heart	heart	NOUN
ajb-7	70	19	disease	disease	NOUN
ajb-7	70	20	,	,	PUNCT
ajb-7	70	21	smoking	smoking	NOUN
ajb-7	70	22	,	,	PUNCT
ajb-7	70	23	hypertension	hypertension	NOUN
ajb-7	70	24	,	,	PUNCT
ajb-7	70	25	total	total	ADJ
ajb-7	70	26	cholesterol	cholesterol	NOUN
ajb-7	70	27	,	,	PUNCT
ajb-7	70	28	ldl	ldl	NOUN
ajb-7	70	29	-	-	PUNCT
ajb-7	70	30	c	c	NOUN
ajb-7	70	31	introduction	introduction	NOUN
ajb-7	70	32	familial	familial	ADJ
ajb-7	70	33	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	70	34	(	(	PUNCT
ajb-7	70	35	fh	fh	PROPN
ajb-7	70	36	)	)	PUNCT
ajb-7	70	37	is	be	AUX
ajb-7	70	38	a	a	DET
ajb-7	70	39	genetic	genetic	ADJ
ajb-7	70	40	disorder	disorder	NOUN
ajb-7	70	41	associated	associate	VERB
ajb-7	70	42	with	with	ADP
ajb-7	70	43	lipoprotein	lipoprotein	ADJ
ajb-7	70	44	metabolism	metabolism	NOUN
ajb-7	70	45	,	,	PUNCT
ajb-7	70	46	where	where	SCONJ
ajb-7	70	47	elevated	elevated	ADJ
ajb-7	70	48	levels	level	NOUN
ajb-7	70	49	of	of	ADP
ajb-7	70	50	low	low	ADJ
ajb-7	70	51	-	-	PUNCT
ajb-7	70	52	density	density	NOUN
ajb-7	70	53	lipoprotein	lipoprotein	ADJ
ajb-7	70	54	cholesterol	cholesterol	NOUN
ajb-7	70	55	(	(	PUNCT
ajb-7	70	56	ldl	ldl	NOUN
ajb-7	70	57	-	-	PUNCT
ajb-7	70	58	c	c	NOUN
ajb-7	70	59	)	)	PUNCT
ajb-7	70	60	occur	occur	VERB
ajb-7	70	61	due	due	ADP
ajb-7	70	62	to	to	ADP
ajb-7	70	63	a	a	DET
ajb-7	70	64	mutation	mutation	NOUN
ajb-7	70	65	in	in	ADP
ajb-7	70	66	the	the	DET
ajb-7	70	67	ldl	ldl	NOUN
ajb-7	70	68	receptor	receptor	NOUN
ajb-7	70	69	gene	gene	NOUN
ajb-7	70	70	(	(	PUNCT
ajb-7	70	71	austin	austin	PROPN
ajb-7	70	72	et	et	PROPN
ajb-7	70	73	al	al	PROPN
ajb-7	70	74	.	.	PROPN
ajb-7	70	75	,	,	PUNCT
ajb-7	70	76	2004	2004	NUM
ajb-7	70	77	;	;	PUNCT
ajb-7	70	78	kwiterovich	kwiterovich	NOUN
ajb-7	70	79	,	,	PUNCT
ajb-7	70	80	2008	2008	NUM
ajb-7	70	81	)	)	PUNCT
ajb-7	70	82	to	to	PART
ajb-7	70	83	which	which	PRON
ajb-7	70	84	ldl	ldl	NOUN
ajb-7	70	85	-	-	PUNCT
ajb-7	70	86	c	c	NOUN
ajb-7	70	87	bind	bind	NOUN
ajb-7	70	88	and	and	CCONJ
ajb-7	70	89	remove	remove	VERB
ajb-7	70	90	it	it	PRON
ajb-7	70	91	from	from	ADP
ajb-7	70	92	the	the	DET
ajb-7	70	93	bloodstream	bloodstream	NOUN
ajb-7	70	94	.	.	PUNCT
ajb-7	71	1	however	however	ADV
ajb-7	71	2	,	,	PUNCT
ajb-7	71	3	people	people	NOUN
ajb-7	71	4	with	with	ADP
ajb-7	71	5	fh	fh	PROPN
ajb-7	71	6	have	have	VERB
ajb-7	71	7	less	less	ADJ
ajb-7	71	8	ldl	ldl	NOUN
ajb-7	71	9	receptors	receptor	NOUN
ajb-7	71	10	which	which	PRON
ajb-7	71	11	result	result	VERB
ajb-7	71	12	in	in	ADP
ajb-7	71	13	increased	increase	VERB
ajb-7	71	14	than	than	ADP
ajb-7	71	15	normal	normal	ADJ
ajb-7	71	16	levels	level	NOUN
ajb-7	71	17	of	of	ADP
ajb-7	71	18	ldl	ldl	NOUN
ajb-7	71	19	-	-	PUNCT
ajb-7	71	20	c	c	NOUN
ajb-7	71	21	in	in	ADP
ajb-7	71	22	the	the	DET
ajb-7	71	23	blood	blood	NOUN
ajb-7	71	24	.	.	PUNCT
ajb-7	72	1	transmitted	transmit	VERB
ajb-7	72	2	in	in	ADP
ajb-7	72	3	an	an	DET
ajb-7	72	4	autosomal	autosomal	ADJ
ajb-7	72	5	dominant	dominant	ADJ
ajb-7	72	6	fashion	fashion	NOUN
ajb-7	72	7	,	,	PUNCT
ajb-7	72	8	fh	fh	PROPN
ajb-7	72	9	is	be	AUX
ajb-7	72	10	also	also	ADV
ajb-7	72	11	characterized	characterize	VERB
ajb-7	72	12	by	by	ADP
ajb-7	72	13	the	the	DET
ajb-7	72	14	presence	presence	NOUN
ajb-7	72	15	of	of	ADP
ajb-7	72	16	tendinous	tendinous	ADJ
ajb-7	72	17	xanthomas	xanthomas	PROPN
ajb-7	72	18	(	(	PUNCT
ajb-7	72	19	tx	tx	PROPN
ajb-7	72	20	)	)	PUNCT
ajb-7	72	21	and	and	CCONJ
ajb-7	72	22	premature	premature	ADJ
ajb-7	72	23	atherosclerosis	atherosclerosis	NOUN
ajb-7	72	24	.	.	PUNCT
ajb-7	73	1	(	(	PUNCT
ajb-7	73	2	alonso	alonso	NOUN
ajb-7	73	3	et	et	NOUN
ajb-7	73	4	al	al	PROPN
ajb-7	73	5	.	.	PROPN
ajb-7	73	6	,	,	PUNCT
ajb-7	73	7	2009	2009	NUM
ajb-7	73	8	)	)	PUNCT
ajb-7	73	9	.	.	PUNCT
ajb-7	74	1	fh	fh	PROPN
ajb-7	74	2	is	be	AUX
ajb-7	74	3	also	also	ADV
ajb-7	74	4	one	one	NUM
ajb-7	74	5	of	of	ADP
ajb-7	74	6	the	the	DET
ajb-7	74	7	most	most	ADV
ajb-7	74	8	common	common	ADJ
ajb-7	74	9	inherited	inherit	VERB
ajb-7	74	10	diseases	disease	NOUN
ajb-7	74	11	in	in	ADP
ajb-7	74	12	the	the	DET
ajb-7	74	13	world	world	NOUN
ajb-7	74	14	,	,	PUNCT
ajb-7	74	15	with	with	ADP
ajb-7	74	16	a	a	DET
ajb-7	74	17	worldwide	worldwide	ADJ
ajb-7	74	18	frequency	frequency	NOUN
ajb-7	74	19	of	of	ADP
ajb-7	74	20	1	1	NUM
ajb-7	74	21	in	in	ADP
ajb-7	74	22	500	500	NUM
ajb-7	74	23	for	for	ADP
ajb-7	74	24	heterozygotes	heterozygote	NOUN
ajb-7	74	25	and	and	CCONJ
ajb-7	74	26	1	1	NUM
ajb-7	74	27	per	per	ADP
ajb-7	74	28	million	million	NUM
ajb-7	74	29	for	for	ADP
ajb-7	74	30	homozygotes	homozygote	NOUN
ajb-7	74	31	or	or	CCONJ
ajb-7	74	32	compound	compound	NOUN
ajb-7	74	33	heterozygotes	heterozygote	NOUN
ajb-7	74	34	(	(	PUNCT
ajb-7	74	35	goldstein	goldstein	PROPN
ajb-7	74	36	et	et	PROPN
ajb-7	74	37	al	al	PROPN
ajb-7	74	38	.	.	PROPN
ajb-7	74	39	,	,	PUNCT
ajb-7	74	40	2001	2001	NUM
ajb-7	74	41	)	)	PUNCT
ajb-7	74	42	.	.	PUNCT
ajb-7	75	1	however	however	ADV
ajb-7	75	2	,	,	PUNCT
ajb-7	75	3	a	a	DET
ajb-7	75	4	higher	high	ADJ
ajb-7	75	5	incidence	incidence	NOUN
ajb-7	75	6	rate	rate	NOUN
ajb-7	75	7	can	can	AUX
ajb-7	75	8	be	be	AUX
ajb-7	75	9	found	find	VERB
ajb-7	75	10	in	in	ADP
ajb-7	75	11	certain	certain	ADJ
ajb-7	75	12	populations	population	NOUN
ajb-7	75	13	,	,	PUNCT
ajb-7	75	14	for	for	ADP
ajb-7	75	15	example	example	NOUN
ajb-7	75	16	the	the	DET
ajb-7	75	17	afrikaners	afrikaner	NOUN
ajb-7	75	18	,	,	PUNCT
ajb-7	75	19	christian	christian	PROPN
ajb-7	75	20	lebanese	lebanese	PROPN
ajb-7	75	21	,	,	PUNCT
ajb-7	75	22	finns	finn	NOUN
ajb-7	75	23	,	,	PUNCT
ajb-7	75	24	and	and	CCONJ
ajb-7	75	25	french	french	ADJ
ajb-7	75	26	-	-	PUNCT
ajb-7	75	27	canadians	canadian	NOUN
ajb-7	75	28	,	,	PUNCT
ajb-7	75	29	because	because	SCONJ
ajb-7	75	30	of	of	ADP
ajb-7	75	31	the	the	DET
ajb-7	75	32	founder	founder	NOUN
ajb-7	75	33	effects	effect	NOUN
ajb-7	75	34	(	(	PUNCT
ajb-7	75	35	goldstein	goldstein	PROPN
ajb-7	75	36	et	et	PROPN
ajb-7	75	37	al	al	PROPN
ajb-7	75	38	.	.	PROPN
ajb-7	75	39	,	,	PUNCT
ajb-7	75	40	2001	2001	NUM
ajb-7	75	41	)	)	PUNCT
ajb-7	75	42	.	.	PUNCT
ajb-7	76	1	patients	patient	NOUN
ajb-7	76	2	with	with	ADP
ajb-7	76	3	heterozygous	heterozygous	ADJ
ajb-7	76	4	fh	fh	PROPN
ajb-7	76	5	express	express	VERB
ajb-7	76	6	high	high	ADJ
ajb-7	76	7	levels	level	NOUN
ajb-7	76	8	of	of	ADP
ajb-7	76	9	plasma	plasma	NOUN
ajb-7	76	10	ldl	ldl	NOUN
ajb-7	76	11	-	-	PUNCT
ajb-7	76	12	c	c	NOUN
ajb-7	76	13	at	at	ADP
ajb-7	76	14	a	a	DET
ajb-7	76	15	young	young	ADJ
ajb-7	76	16	age	age	NOUN
ajb-7	76	17	,	,	PUNCT
ajb-7	76	18	causing	cause	VERB
ajb-7	76	19	atherosclerosis	atherosclerosis	NOUN
ajb-7	76	20	and	and	CCONJ
ajb-7	76	21	an	an	DET
ajb-7	76	22	increased	increase	VERB
ajb-7	76	23	risk	risk	NOUN
ajb-7	76	24	of	of	ADP
ajb-7	76	25	cardiovascular	cardiovascular	ADJ
ajb-7	76	26	diseases	disease	NOUN
ajb-7	76	27	(	(	PUNCT
ajb-7	76	28	austin	austin	PROPN
ajb-7	76	29	et	et	PROPN
ajb-7	76	30	al	al	PROPN
ajb-7	76	31	.	.	PROPN
ajb-7	76	32	,	,	PUNCT
ajb-7	76	33	2004	2004	NUM
ajb-7	76	34	)	)	PUNCT
ajb-7	76	35	.	.	PUNCT
ajb-7	77	1	heterozygous	heterozygous	ADJ
ajb-7	77	2	fh	fh	PROPN
ajb-7	77	3	patients	patient	NOUN
ajb-7	77	4	show	show	VERB
ajb-7	77	5	about	about	ADP
ajb-7	77	6	twoto	twoto	DET
ajb-7	77	7	three	three	NUM
ajb-7	77	8	-	-	ADJ
ajb-7	77	9	fold	fold	ADJ
ajb-7	77	10	increase	increase	NOUN
ajb-7	77	11	in	in	ADP
ajb-7	77	12	ldl	ldl	NOUN
ajb-7	77	13	-	-	PUNCT
ajb-7	77	14	c	c	NOUN
ajb-7	77	15	concentrations	concentration	NOUN
ajb-7	77	16	with	with	ADP
ajb-7	77	17	a	a	DET
ajb-7	77	18	decrease	decrease	NOUN
ajb-7	77	19	in	in	ADP
ajb-7	77	20	high	high	ADJ
ajb-7	77	21	-	-	PUNCT
ajb-7	77	22	density	density	NOUN
ajb-7	77	23	lipoprotein	lipoprotein	ADJ
ajb-7	77	24	(	(	PUNCT
ajb-7	77	25	hdl	hdl	NOUN
ajb-7	77	26	-	-	PUNCT
ajb-7	77	27	c	c	NOUN
ajb-7	77	28	)	)	PUNCT
ajb-7	77	29	levels	level	NOUN
ajb-7	77	30	,	,	PUNCT
ajb-7	77	31	along	along	ADP
ajb-7	77	32	with	with	ADP
ajb-7	77	33	tendinous	tendinous	ADJ
ajb-7	77	34	xanthomatosis	xanthomatosis	ADJ
ajb-7	77	35	and	and	CCONJ
ajb-7	77	36	premature	premature	ADJ
ajb-7	77	37	heart	heart	NOUN
ajb-7	77	38	disease	disease	NOUN
ajb-7	77	39	(	(	PUNCT
ajb-7	77	40	chd	chd	NOUN
ajb-7	77	41	)	)	PUNCT
ajb-7	77	42	between	between	ADP
ajb-7	77	43	the	the	DET
ajb-7	77	44	age	age	NOUN
ajb-7	77	45	of	of	ADP
ajb-7	77	46	35	35	NUM
ajb-7	77	47	and	and	CCONJ
ajb-7	77	48	55	55	NUM
ajb-7	77	49	years	year	NOUN
ajb-7	77	50	(	(	PUNCT
ajb-7	77	51	gagné	gagné	X
ajb-7	77	52	et	et	PROPN
ajb-7	77	53	al	al	PROPN
ajb-7	77	54	.	.	PROPN
ajb-7	77	55	,	,	PUNCT
ajb-7	77	56	1979	1979	NUM
ajb-7	77	57	;	;	PUNCT
ajb-7	77	58	civeira	civeira	PROPN
ajb-7	77	59	,	,	PUNCT
ajb-7	77	60	2004	2004	NUM
ajb-7	77	61	)	)	PUNCT
ajb-7	77	62	.	.	PUNCT
ajb-7	78	1	about	about	ADV
ajb-7	78	2	half	half	NOUN
ajb-7	78	3	of	of	ADP
ajb-7	78	4	the	the	DET
ajb-7	78	5	offspring	offspring	NOUN
ajb-7	78	6	of	of	ADP
ajb-7	78	7	an	an	DET
ajb-7	78	8	affected	affected	ADJ
ajb-7	78	9	parent	parent	NOUN
ajb-7	78	10	will	will	AUX
ajb-7	78	11	have	have	VERB
ajb-7	78	12	an	an	DET
ajb-7	78	13	increased	increase	VERB
ajb-7	78	14	level	level	NOUN
ajb-7	78	15	of	of	ADP
ajb-7	78	16	cholesterol	cholesterol	NOUN
ajb-7	78	17	in	in	ADP
ajb-7	78	18	the	the	DET
ajb-7	78	19	plasma	plasma	NOUN
ajb-7	78	20	and	and	CCONJ
ajb-7	78	21	both	both	DET
ajb-7	78	22	genders	gender	NOUN
ajb-7	78	23	are	be	AUX
ajb-7	78	24	equally	equally	ADV
ajb-7	78	25	34	34	NUM
ajb-7	78	26	35	35	NUM
ajb-7	78	27	affected	affect	VERB
ajb-7	78	28	.	.	PUNCT
ajb-7	79	1	although	although	SCONJ
ajb-7	79	2	,	,	PUNCT
ajb-7	79	3	a	a	DET
ajb-7	79	4	large	large	ADJ
ajb-7	79	5	number	number	NOUN
ajb-7	79	6	of	of	ADP
ajb-7	79	7	fh	fh	PROPN
ajb-7	79	8	cases	case	NOUN
ajb-7	79	9	are	be	AUX
ajb-7	79	10	due	due	ADJ
ajb-7	79	11	to	to	ADP
ajb-7	79	12	the	the	DET
ajb-7	79	13	mutations	mutation	NOUN
ajb-7	79	14	in	in	ADP
ajb-7	79	15	the	the	DET
ajb-7	79	16	ldl	ldl	NOUN
ajb-7	79	17	receptor	receptor	NOUN
ajb-7	79	18	gene	gene	NOUN
ajb-7	79	19	(	(	PUNCT
ajb-7	79	20	ldlr	ldlr	PROPN
ajb-7	79	21	)	)	PUNCT
ajb-7	79	22	,	,	PUNCT
ajb-7	79	23	additional	additional	ADJ
ajb-7	79	24	contributory	contributory	NOUN
ajb-7	79	25	genes	gene	NOUN
ajb-7	79	26	have	have	AUX
ajb-7	79	27	also	also	ADV
ajb-7	79	28	recently	recently	ADV
ajb-7	79	29	been	be	AUX
ajb-7	79	30	reported	report	VERB
ajb-7	79	31	for	for	ADP
ajb-7	79	32	fh	fh	PROPN
ajb-7	79	33	.	.	PUNCT
ajb-7	80	1	nevertheless	nevertheless	ADV
ajb-7	80	2	,	,	PUNCT
ajb-7	80	3	the	the	DET
ajb-7	80	4	mutations	mutation	NOUN
ajb-7	80	5	in	in	ADP
ajb-7	80	6	these	these	DET
ajb-7	80	7	genes	gene	NOUN
ajb-7	80	8	appear	appear	VERB
ajb-7	80	9	to	to	PART
ajb-7	80	10	be	be	AUX
ajb-7	80	11	rare	rare	ADJ
ajb-7	80	12	in	in	ADP
ajb-7	80	13	the	the	DET
ajb-7	80	14	populations	population	NOUN
ajb-7	80	15	that	that	PRON
ajb-7	80	16	have	have	AUX
ajb-7	80	17	so	so	ADV
ajb-7	80	18	far	far	ADV
ajb-7	80	19	been	be	AUX
ajb-7	80	20	investigated	investigate	VERB
ajb-7	80	21	(	(	PUNCT
ajb-7	80	22	abifadel	abifadel	PROPN
ajb-7	80	23	et	et	PROPN
ajb-7	80	24	al	al	PROPN
ajb-7	80	25	.	.	PROPN
ajb-7	80	26	,	,	PUNCT
ajb-7	80	27	2003	2003	NUM
ajb-7	80	28	;	;	PUNCT
ajb-7	80	29	rader	rader	PROPN
ajb-7	80	30	et	et	PROPN
ajb-7	80	31	al	al	PROPN
ajb-7	80	32	.	.	PROPN
ajb-7	80	33	,	,	PUNCT
ajb-7	80	34	2003	2003	NUM
ajb-7	80	35	;	;	PUNCT
ajb-7	80	36	damgaard	damgaard	PROPN
ajb-7	80	37	et	et	PROPN
ajb-7	80	38	al	al	PROPN
ajb-7	80	39	.	.	PROPN
ajb-7	80	40	,	,	PUNCT
ajb-7	80	41	2004	2004	NUM
ajb-7	80	42	;	;	PUNCT
ajb-7	80	43	graham	graham	PROPN
ajb-7	80	44	et	et	PROPN
ajb-7	80	45	al	al	PROPN
ajb-7	80	46	.	.	PROPN
ajb-7	80	47	,	,	PUNCT
ajb-7	80	48	2005	2005	NUM
ajb-7	80	49	)	)	PUNCT
ajb-7	80	50	.	.	PUNCT
ajb-7	81	1	advancing	advance	VERB
ajb-7	81	2	age	age	NOUN
ajb-7	81	3	and	and	CCONJ
ajb-7	81	4	male	male	ADJ
ajb-7	81	5	gender	gender	NOUN
ajb-7	81	6	are	be	AUX
ajb-7	81	7	strongly	strongly	ADV
ajb-7	81	8	associated	associate	VERB
ajb-7	81	9	with	with	ADP
ajb-7	81	10	chd	chd	NOUN
ajb-7	81	11	risk	risk	NOUN
ajb-7	81	12	,	,	PUNCT
ajb-7	81	13	with	with	ADP
ajb-7	81	14	men	man	NOUN
ajb-7	81	15	typically	typically	ADV
ajb-7	81	16	developing	develop	VERB
ajb-7	81	17	disease	disease	NOUN
ajb-7	81	18	symptoms	symptom	NOUN
ajb-7	81	19	10–15	10–15	NUM
ajb-7	81	20	years	year	NOUN
ajb-7	81	21	earlier	early	ADV
ajb-7	81	22	than	than	ADP
ajb-7	81	23	women	woman	NOUN
ajb-7	81	24	who	who	PRON
ajb-7	81	25	generally	generally	ADV
ajb-7	81	26	do	do	AUX
ajb-7	81	27	not	not	PART
ajb-7	81	28	show	show	VERB
ajb-7	81	29	such	such	ADJ
ajb-7	81	30	symptoms	symptom	NOUN
ajb-7	81	31	until	until	ADP
ajb-7	81	32	after	after	ADP
ajb-7	81	33	menopause	menopause	NOUN
ajb-7	81	34	(	(	PUNCT
ajb-7	81	35	aha	aha	INTJ
ajb-7	81	36	,	,	PUNCT
ajb-7	81	37	2001	2001	NUM
ajb-7	81	38	)	)	PUNCT
ajb-7	81	39	.	.	PUNCT
ajb-7	82	1	however	however	ADV
ajb-7	82	2	,	,	PUNCT
ajb-7	82	3	the	the	DET
ajb-7	82	4	course	course	NOUN
ajb-7	82	5	of	of	ADP
ajb-7	82	6	chd	chd	NOUN
ajb-7	82	7	symptom	symptom	NOUN
ajb-7	82	8	in	in	ADP
ajb-7	82	9	fh	fh	PROPN
ajb-7	82	10	is	be	AUX
ajb-7	82	11	different	different	ADJ
ajb-7	82	12	,	,	PUNCT
ajb-7	82	13	with	with	ADP
ajb-7	82	14	some	some	DET
ajb-7	82	15	patients	patient	NOUN
ajb-7	82	16	expressing	express	VERB
ajb-7	82	17	events	event	NOUN
ajb-7	82	18	earlier	early	ADV
ajb-7	82	19	than	than	ADP
ajb-7	82	20	others	other	NOUN
ajb-7	82	21	inspite	inspite	ADJ
ajb-7	82	22	of	of	ADP
ajb-7	82	23	similar	similar	ADJ
ajb-7	82	24	increased	increase	VERB
ajb-7	82	25	ldl	ldl	NOUN
ajb-7	82	26	-	-	PUNCT
ajb-7	82	27	c	c	NOUN
ajb-7	82	28	levels	level	NOUN
ajb-7	82	29	.	.	PUNCT
ajb-7	83	1	hence	hence	ADV
ajb-7	83	2	other	other	ADJ
ajb-7	83	3	factors	factor	NOUN
ajb-7	83	4	may	may	AUX
ajb-7	83	5	play	play	VERB
ajb-7	83	6	a	a	DET
ajb-7	83	7	part	part	NOUN
ajb-7	83	8	in	in	ADP
ajb-7	83	9	chd	chd	NOUN
ajb-7	83	10	risk	risk	NOUN
ajb-7	83	11	in	in	ADP
ajb-7	83	12	these	these	DET
ajb-7	83	13	individuals	individual	NOUN
ajb-7	83	14	.	.	PUNCT
ajb-7	84	1	earlier	early	ADJ
ajb-7	84	2	studies	study	NOUN
ajb-7	84	3	in	in	ADP
ajb-7	84	4	european	european	ADJ
ajb-7	84	5	and	and	CCONJ
ajb-7	84	6	north	north	NOUN
ajb-7	84	7	-	-	PUNCT
ajb-7	84	8	american	american	ADJ
ajb-7	84	9	populations	population	NOUN
ajb-7	84	10	have	have	AUX
ajb-7	84	11	established	establish	VERB
ajb-7	84	12	the	the	DET
ajb-7	84	13	influence	influence	NOUN
ajb-7	84	14	of	of	ADP
ajb-7	84	15	risk	risk	NOUN
ajb-7	84	16	factors	factor	NOUN
ajb-7	84	17	like	like	ADP
ajb-7	84	18	age	age	NOUN
ajb-7	84	19	,	,	PUNCT
ajb-7	84	20	smoking	smoking	NOUN
ajb-7	84	21	and	and	CCONJ
ajb-7	84	22	hypertension	hypertension	NOUN
ajb-7	84	23	(	(	PUNCT
ajb-7	84	24	htn	htn	PROPN
ajb-7	84	25	)	)	PUNCT
ajb-7	84	26	in	in	ADP
ajb-7	84	27	fh	fh	PROPN
ajb-7	84	28	individuals	individual	NOUN
ajb-7	84	29	(	(	PUNCT
ajb-7	84	30	civeira	civeira	PROPN
ajb-7	84	31	,	,	PUNCT
ajb-7	84	32	2004	2004	NUM
ajb-7	84	33	)	)	PUNCT
ajb-7	84	34	.	.	PUNCT
ajb-7	85	1	among	among	ADP
ajb-7	85	2	the	the	DET
ajb-7	85	3	environmental	environmental	ADJ
ajb-7	85	4	risk	risk	NOUN
ajb-7	85	5	factors	factor	NOUN
ajb-7	85	6	,	,	PUNCT
ajb-7	85	7	smoking	smoking	NOUN
ajb-7	85	8	is	be	AUX
ajb-7	85	9	the	the	DET
ajb-7	85	10	major	major	ADJ
ajb-7	85	11	contributor	contributor	NOUN
ajb-7	85	12	and	and	CCONJ
ajb-7	85	13	has	have	AUX
ajb-7	85	14	been	be	AUX
ajb-7	85	15	associated	associate	VERB
ajb-7	85	16	with	with	ADP
ajb-7	85	17	a	a	DET
ajb-7	85	18	nearly	nearly	ADV
ajb-7	85	19	two	two	NUM
ajb-7	85	20	fold	fold	ADJ
ajb-7	85	21	higher	high	ADJ
ajb-7	85	22	risk	risk	NOUN
ajb-7	85	23	(	(	PUNCT
ajb-7	85	24	hill	hill	NOUN
ajb-7	85	25	et	et	PROPN
ajb-7	85	26	al	al	PROPN
ajb-7	85	27	.	.	PROPN
ajb-7	85	28	,	,	PUNCT
ajb-7	85	29	1991	1991	NUM
ajb-7	85	30	)	)	PUNCT
ajb-7	85	31	.	.	PUNCT
ajb-7	86	1	lack	lack	NOUN
ajb-7	86	2	of	of	ADP
ajb-7	86	3	exercise	exercise	NOUN
ajb-7	86	4	and	and	CCONJ
ajb-7	86	5	the	the	DET
ajb-7	86	6	related	related	ADJ
ajb-7	86	7	adiposity	adiposity	NOUN
ajb-7	86	8	,	,	PUNCT
ajb-7	86	9	including	include	VERB
ajb-7	86	10	high	high	ADJ
ajb-7	86	11	intake	intake	NOUN
ajb-7	86	12	of	of	ADP
ajb-7	86	13	saturated	saturate	VERB
ajb-7	86	14	fats	fat	NOUN
ajb-7	86	15	and	and	CCONJ
ajb-7	86	16	a	a	DET
ajb-7	86	17	reduced	reduced	ADJ
ajb-7	86	18	intake	intake	NOUN
ajb-7	86	19	of	of	ADP
ajb-7	86	20	certain	certain	ADJ
ajb-7	86	21	vitamins	vitamin	NOUN
ajb-7	86	22	have	have	AUX
ajb-7	86	23	also	also	ADV
ajb-7	86	24	been	be	AUX
ajb-7	86	25	linked	link	VERB
ajb-7	86	26	with	with	ADP
ajb-7	86	27	increased	increase	VERB
ajb-7	86	28	risk	risk	NOUN
ajb-7	86	29	(	(	PUNCT
ajb-7	86	30	aha	aha	INTJ
ajb-7	86	31	,	,	PUNCT
ajb-7	86	32	2001	2001	NUM
ajb-7	86	33	)	)	PUNCT
ajb-7	86	34	.	.	PUNCT
ajb-7	87	1	the	the	DET
ajb-7	87	2	mechanism	mechanism	NOUN
ajb-7	87	3	of	of	ADP
ajb-7	87	4	action	action	NOUN
ajb-7	87	5	of	of	ADP
ajb-7	87	6	these	these	DET
ajb-7	87	7	factors	factor	NOUN
ajb-7	87	8	is	be	AUX
ajb-7	87	9	by	by	ADP
ajb-7	87	10	determining	determine	VERB
ajb-7	87	11	the	the	DET
ajb-7	87	12	differences	difference	NOUN
ajb-7	87	13	in	in	ADP
ajb-7	87	14	the	the	DET
ajb-7	87	15	plasma	plasma	NOUN
ajb-7	87	16	levels	level	NOUN
ajb-7	87	17	of	of	ADP
ajb-7	87	18	lipids	lipid	NOUN
ajb-7	87	19	and	and	CCONJ
ajb-7	87	20	lipoproteins	lipoprotein	NOUN
ajb-7	87	21	that	that	PRON
ajb-7	87	22	are	be	AUX
ajb-7	87	23	atherogenic	atherogenic	ADJ
ajb-7	87	24	and	and	CCONJ
ajb-7	87	25	high	high	ADJ
ajb-7	87	26	levels	level	NOUN
ajb-7	87	27	of	of	ADP
ajb-7	87	28	ldl	ldl	NOUN
ajb-7	87	29	-	-	PUNCT
ajb-7	87	30	c	c	PROPN
ajb-7	87	31	and	and	CCONJ
ajb-7	87	32	low	low	ADJ
ajb-7	87	33	levels	level	NOUN
ajb-7	87	34	of	of	ADP
ajb-7	87	35	hdl	hdl	PROPN
ajb-7	87	36	-	-	PUNCT
ajb-7	87	37	c	c	PROPN
ajb-7	87	38	have	have	AUX
ajb-7	87	39	been	be	AUX
ajb-7	87	40	associated	associate	VERB
ajb-7	87	41	with	with	ADP
ajb-7	87	42	chd	chd	PROPN
ajb-7	87	43	(	(	PUNCT
ajb-7	87	44	castelli	castelli	PROPN
ajb-7	87	45	et	et	PROPN
ajb-7	87	46	al	al	PROPN
ajb-7	87	47	.	.	PROPN
ajb-7	87	48	,	,	PUNCT
ajb-7	87	49	1986	1986	NUM
ajb-7	87	50	)	)	PUNCT
ajb-7	87	51	.	.	PUNCT
ajb-7	88	1	evidence	evidence	NOUN
ajb-7	88	2	for	for	ADP
ajb-7	88	3	strong	strong	ADJ
ajb-7	88	4	genetic	genetic	ADJ
ajb-7	88	5	component	component	NOUN
ajb-7	88	6	for	for	ADP
ajb-7	88	7	chd	chd	NOUN
ajb-7	88	8	risk	risk	NOUN
ajb-7	88	9	is	be	AUX
ajb-7	88	10	supported	support	VERB
ajb-7	88	11	by	by	ADP
ajb-7	88	12	the	the	DET
ajb-7	88	13	association	association	NOUN
ajb-7	88	14	between	between	ADP
ajb-7	88	15	a	a	DET
ajb-7	88	16	family	family	NOUN
ajb-7	88	17	history	history	NOUN
ajb-7	88	18	of	of	ADP
ajb-7	88	19	early	early	ADJ
ajb-7	88	20	chd	chd	NOUN
ajb-7	88	21	and	and	CCONJ
ajb-7	88	22	a	a	DET
ajb-7	88	23	personal	personal	ADJ
ajb-7	88	24	increased	increase	VERB
ajb-7	88	25	risk	risk	NOUN
ajb-7	88	26	(	(	PUNCT
ajb-7	88	27	kardia	kardia	NOUN
ajb-7	88	28	et	et	PROPN
ajb-7	88	29	al	al	PROPN
ajb-7	88	30	.	.	PROPN
ajb-7	88	31	,	,	PUNCT
ajb-7	88	32	2003	2003	NUM
ajb-7	88	33	)	)	PUNCT
ajb-7	88	34	in	in	ADP
ajb-7	88	35	the	the	DET
ajb-7	88	36	order	order	NOUN
ajb-7	88	37	of	of	ADP
ajb-7	88	38	1.7	1.7	NUM
ajb-7	88	39	-	-	ADJ
ajb-7	88	40	fold	fold	VERB
ajb-7	88	41	higher	high	ADJ
ajb-7	88	42	(	(	PUNCT
ajb-7	88	43	hawe	hawe	ADV
ajb-7	88	44	et	et	PROPN
ajb-7	88	45	al	al	PROPN
ajb-7	88	46	.	.	PROPN
ajb-7	88	47	,	,	PUNCT
ajb-7	88	48	2003	2003	NUM
ajb-7	88	49	)	)	PUNCT
ajb-7	88	50	.	.	PUNCT
ajb-7	89	1	the	the	DET
ajb-7	89	2	clinical	clinical	ADJ
ajb-7	89	3	phenotype	phenotype	NOUN
ajb-7	89	4	for	for	ADP
ajb-7	89	5	homozygotes	homozygote	NOUN
ajb-7	89	6	is	be	AUX
ajb-7	89	7	more	more	ADV
ajb-7	89	8	severe	severe	ADJ
ajb-7	89	9	than	than	ADP
ajb-7	89	10	heterozygotes	heterozygote	NOUN
ajb-7	89	11	;	;	PUNCT
ajb-7	89	12	however	however	ADV
ajb-7	89	13	the	the	DET
ajb-7	89	14	expression	expression	NOUN
ajb-7	89	15	of	of	ADP
ajb-7	89	16	heterozygous	heterozygous	ADJ
ajb-7	89	17	fh	fh	PROPN
ajb-7	89	18	is	be	AUX
ajb-7	89	19	highly	highly	ADV
ajb-7	89	20	variable	variable	ADJ
ajb-7	89	21	probably	probably	ADV
ajb-7	89	22	due	due	ADJ
ajb-7	89	23	to	to	ADP
ajb-7	89	24	other	other	ADJ
ajb-7	89	25	risk	risk	NOUN
ajb-7	89	26	factors	factor	NOUN
ajb-7	89	27	in	in	ADP
ajb-7	89	28	addition	addition	NOUN
ajb-7	89	29	to	to	ADP
ajb-7	89	30	the	the	DET
ajb-7	89	31	genes	gene	NOUN
ajb-7	89	32	affecting	affect	VERB
ajb-7	89	33	the	the	DET
ajb-7	89	34	lipoprotein	lipoprotein	ADJ
ajb-7	89	35	metabolism	metabolism	NOUN
ajb-7	89	36	(	(	PUNCT
ajb-7	89	37	bertolini	bertolini	NOUN
ajb-7	89	38	et	et	PROPN
ajb-7	89	39	al	al	PROPN
ajb-7	89	40	.	.	PROPN
ajb-7	89	41	,	,	PUNCT
ajb-7	89	42	2004	2004	NUM
ajb-7	89	43	)	)	PUNCT
ajb-7	89	44	.	.	PUNCT
ajb-7	90	1	we	we	PRON
ajb-7	90	2	have	have	AUX
ajb-7	90	3	previously	previously	ADV
ajb-7	90	4	reported	report	VERB
ajb-7	90	5	that	that	SCONJ
ajb-7	90	6	the	the	DET
ajb-7	90	7	cause	cause	NOUN
ajb-7	90	8	of	of	ADP
ajb-7	90	9	fh	fh	PROPN
ajb-7	90	10	in	in	ADP
ajb-7	90	11	pakistani	pakistani	ADJ
ajb-7	90	12	population	population	NOUN
ajb-7	90	13	is	be	AUX
ajb-7	90	14	partly	partly	ADV
ajb-7	90	15	due	due	ADJ
ajb-7	90	16	to	to	ADP
ajb-7	90	17	familial	familial	ADJ
ajb-7	90	18	resemblance	resemblance	NOUN
ajb-7	90	19	contributing	contribute	VERB
ajb-7	90	20	due	due	ADP
ajb-7	90	21	to	to	ADP
ajb-7	90	22	the	the	DET
ajb-7	90	23	genes	gene	NOUN
ajb-7	90	24	but	but	CCONJ
ajb-7	90	25	other	other	ADJ
ajb-7	90	26	risk	risk	NOUN
ajb-7	90	27	factors	factor	NOUN
ajb-7	90	28	may	may	AUX
ajb-7	90	29	also	also	ADV
ajb-7	90	30	play	play	VERB
ajb-7	90	31	a	a	DET
ajb-7	90	32	role	role	NOUN
ajb-7	90	33	in	in	ADP
ajb-7	90	34	the	the	DET
ajb-7	90	35	progression	progression	NOUN
ajb-7	90	36	of	of	ADP
ajb-7	90	37	the	the	DET
ajb-7	90	38	fh	fh	PROPN
ajb-7	90	39	disease	disease	NOUN
ajb-7	90	40	in	in	ADP
ajb-7	90	41	pakistani	pakistani	ADJ
ajb-7	90	42	population	population	NOUN
ajb-7	90	43	(	(	PUNCT
ajb-7	90	44	imtiaz	imtiaz	PROPN
ajb-7	90	45	,	,	PUNCT
ajb-7	90	46	2009	2009	NUM
ajb-7	90	47	)	)	PUNCT
ajb-7	90	48	.	.	PUNCT
ajb-7	91	1	in	in	ADP
ajb-7	91	2	the	the	DET
ajb-7	91	3	present	present	ADJ
ajb-7	91	4	study	study	NOUN
ajb-7	91	5	,	,	PUNCT
ajb-7	91	6	we	we	PRON
ajb-7	91	7	studied	study	VERB
ajb-7	91	8	and	and	CCONJ
ajb-7	91	9	assessed	assess	VERB
ajb-7	91	10	the	the	DET
ajb-7	91	11	contribution	contribution	NOUN
ajb-7	91	12	of	of	ADP
ajb-7	91	13	risk	risk	NOUN
ajb-7	91	14	factors	factor	NOUN
ajb-7	91	15	on	on	ADP
ajb-7	91	16	the	the	DET
ajb-7	91	17	phenotypic	phenotypic	ADJ
ajb-7	91	18	expression	expression	NOUN
ajb-7	91	19	of	of	ADP
ajb-7	91	20	fh	fh	PROPN
ajb-7	91	21	disease	disease	NOUN
ajb-7	91	22	in	in	ADP
ajb-7	91	23	a	a	DET
ajb-7	91	24	pakistani	pakistani	ADJ
ajb-7	91	25	population	population	NOUN
ajb-7	91	26	.	.	PUNCT
ajb-7	92	1	materials	material	NOUN
ajb-7	92	2	and	and	CCONJ
ajb-7	92	3	methods	method	NOUN
ajb-7	92	4	the	the	DET
ajb-7	92	5	study	study	NOUN
ajb-7	92	6	,	,	PUNCT
ajb-7	92	7	upon	upon	SCONJ
ajb-7	92	8	written	write	VERB
ajb-7	92	9	informed	informed	ADJ
ajb-7	92	10	consent	consent	NOUN
ajb-7	92	11	approval	approval	NOUN
ajb-7	92	12	,	,	PUNCT
ajb-7	92	13	included	include	VERB
ajb-7	92	14	a	a	DET
ajb-7	92	15	group	group	NOUN
ajb-7	92	16	of	of	ADP
ajb-7	92	17	1523	1523	NUM
ajb-7	92	18	unrelated	unrelated	ADJ
ajb-7	92	19	patients	patient	NOUN
ajb-7	92	20	with	with	ADP
ajb-7	92	21	the	the	DET
ajb-7	92	22	clinical	clinical	ADJ
ajb-7	92	23	diagnosis	diagnosis	NOUN
ajb-7	92	24	of	of	ADP
ajb-7	92	25	heterozygous	heterozygous	ADJ
ajb-7	92	26	fh	fh	PROPN
ajb-7	92	27	.	.	PUNCT
ajb-7	93	1	a	a	DET
ajb-7	93	2	detailed	detailed	ADJ
ajb-7	93	3	examination	examination	NOUN
ajb-7	93	4	of	of	ADP
ajb-7	93	5	the	the	DET
ajb-7	93	6	physical	physical	ADJ
ajb-7	93	7	and	and	CCONJ
ajb-7	93	8	biochemical	biochemical	ADJ
ajb-7	93	9	features	feature	NOUN
ajb-7	93	10	of	of	ADP
ajb-7	93	11	fh	fh	PROPN
ajb-7	93	12	was	be	AUX
ajb-7	93	13	obtained	obtain	VERB
ajb-7	93	14	in	in	ADP
ajb-7	93	15	this	this	DET
ajb-7	93	16	cohort	cohort	NOUN
ajb-7	93	17	.	.	PUNCT
ajb-7	94	1	clinical	clinical	ADJ
ajb-7	94	2	examination	examination	NOUN
ajb-7	94	3	physical	physical	PROPN
ajb-7	94	4	fh	fh	PROPN
ajb-7	94	5	characteristics	characteristic	VERB
ajb-7	94	6	the	the	DET
ajb-7	94	7	physical	physical	ADJ
ajb-7	94	8	characteristics	characteristic	NOUN
ajb-7	94	9	that	that	PRON
ajb-7	94	10	were	be	AUX
ajb-7	94	11	examined	examine	VERB
ajb-7	94	12	in	in	ADP
ajb-7	94	13	fh	fh	PROPN
ajb-7	94	14	patients	patient	NOUN
ajb-7	94	15	included	include	VERB
ajb-7	94	16	presence	presence	NOUN
ajb-7	94	17	of	of	ADP
ajb-7	94	18	tendinous	tendinous	ADJ
ajb-7	94	19	xanthoma	xanthoma	NOUN
ajb-7	94	20	(	(	PUNCT
ajb-7	94	21	tx	tx	PROPN
ajb-7	94	22	)	)	PUNCT
ajb-7	94	23	,	,	PUNCT
ajb-7	94	24	xanthelesma	xanthelesma	PROPN
ajb-7	94	25	,	,	PUNCT
ajb-7	94	26	arcus	arcus	PROPN
ajb-7	94	27	cornea	cornea	PROPN
ajb-7	94	28	(	(	PUNCT
ajb-7	94	29	ac	ac	PROPN
ajb-7	94	30	)	)	PUNCT
ajb-7	94	31	and	and	CCONJ
ajb-7	94	32	polyarthritis	polyarthritis	NOUN
ajb-7	94	33	.	.	PUNCT
ajb-7	95	1	a	a	DET
ajb-7	95	2	xanthelasma	xanthelasma	NOUN
ajb-7	95	3	is	be	AUX
ajb-7	95	4	a	a	DET
ajb-7	95	5	clearly	clearly	ADV
ajb-7	95	6	distinguishable	distinguishable	ADJ
ajb-7	95	7	yellowish	yellowish	ADJ
ajb-7	95	8	collection	collection	NOUN
ajb-7	95	9	of	of	ADP
ajb-7	95	10	cholesterol	cholesterol	NOUN
ajb-7	95	11	underneath	underneath	ADP
ajb-7	95	12	the	the	DET
ajb-7	95	13	skin	skin	NOUN
ajb-7	95	14	,	,	PUNCT
ajb-7	95	15	typically	typically	ADV
ajb-7	95	16	on	on	ADP
ajb-7	95	17	or	or	CCONJ
ajb-7	95	18	in	in	ADP
ajb-7	95	19	the	the	DET
ajb-7	95	20	region	region	NOUN
ajb-7	95	21	of	of	ADP
ajb-7	95	22	the	the	DET
ajb-7	95	23	eyelids	eyelid	NOUN
ajb-7	95	24	.	.	PUNCT
ajb-7	96	1	the	the	DET
ajb-7	96	2	xanthelasma	xanthelasma	NOUN
ajb-7	96	3	is	be	AUX
ajb-7	96	4	a	a	DET
ajb-7	96	5	distinctive	distinctive	ADJ
ajb-7	96	6	condition	condition	NOUN
ajb-7	96	7	and	and	CCONJ
ajb-7	96	8	is	be	AUX
ajb-7	96	9	called	call	VERB
ajb-7	96	10	a	a	DET
ajb-7	96	11	xanthoma	xanthoma	NOUN
ajb-7	96	12	when	when	SCONJ
ajb-7	96	13	it	it	PRON
ajb-7	96	14	becomes	become	VERB
ajb-7	96	15	bigger	big	ADJ
ajb-7	96	16	and	and	CCONJ
ajb-7	96	17	nodular	nodular	ADJ
ajb-7	96	18	.	.	PUNCT
ajb-7	97	1	the	the	DET
ajb-7	97	2	tx	tx	PROPN
ajb-7	97	3	is	be	AUX
ajb-7	97	4	clinically	clinically	ADV
ajb-7	97	5	characterized	characterize	VERB
ajb-7	97	6	by	by	ADP
ajb-7	97	7	papules	papule	NOUN
ajb-7	97	8	and	and	CCONJ
ajb-7	97	9	nodules	nodule	NOUN
ajb-7	97	10	found	find	VERB
ajb-7	97	11	in	in	ADP
ajb-7	97	12	the	the	DET
ajb-7	97	13	tendons	tendon	NOUN
ajb-7	97	14	of	of	ADP
ajb-7	97	15	the	the	DET
ajb-7	97	16	hands	hand	NOUN
ajb-7	97	17	.	.	PUNCT
ajb-7	98	1	the	the	DET
ajb-7	98	2	ac	ac	PROPN
ajb-7	98	3	is	be	AUX
ajb-7	98	4	due	due	ADJ
ajb-7	98	5	to	to	ADP
ajb-7	98	6	the	the	DET
ajb-7	98	7	white	white	ADJ
ajb-7	98	8	arc	arc	NOUN
ajb-7	98	9	appearance	appearance	NOUN
ajb-7	98	10	on	on	ADP
ajb-7	98	11	the	the	DET
ajb-7	98	12	cornea	cornea	NOUN
ajb-7	98	13	as	as	ADP
ajb-7	98	14	a	a	DET
ajb-7	98	15	result	result	NOUN
ajb-7	98	16	of	of	ADP
ajb-7	98	17	abnormal	abnormal	ADJ
ajb-7	98	18	deposits	deposit	NOUN
ajb-7	98	19	of	of	ADP
ajb-7	98	20	phospholipids	phospholipid	NOUN
ajb-7	98	21	and	and	CCONJ
ajb-7	98	22	cholesterol	cholesterol	NOUN
ajb-7	98	23	.	.	PUNCT
ajb-7	99	1	the	the	DET
ajb-7	99	2	polyarthritis	polyarthritis	NOUN
ajb-7	99	3	is	be	AUX
ajb-7	99	4	a	a	DET
ajb-7	99	5	condition	condition	NOUN
ajb-7	99	6	when	when	SCONJ
ajb-7	99	7	any	any	DET
ajb-7	99	8	type	type	NOUN
ajb-7	99	9	of	of	ADP
ajb-7	99	10	arthritis	arthritis	NOUN
ajb-7	99	11	involving	involve	VERB
ajb-7	99	12	five	five	NUM
ajb-7	99	13	or	or	CCONJ
ajb-7	99	14	more	more	ADJ
ajb-7	99	15	joints	joint	NOUN
ajb-7	99	16	of	of	ADP
ajb-7	99	17	the	the	DET
ajb-7	99	18	body	body	NOUN
ajb-7	99	19	was	be	AUX
ajb-7	99	20	present	present	ADJ
ajb-7	99	21	in	in	ADP
ajb-7	99	22	patients	patient	NOUN
ajb-7	99	23	.	.	PUNCT
ajb-7	100	1	three	three	NUM
ajb-7	100	2	hundred	hundred	NUM
ajb-7	100	3	thirty	thirty	NUM
ajb-7	100	4	-	-	PUNCT
ajb-7	100	5	five	five	NUM
ajb-7	100	6	(	(	PUNCT
ajb-7	100	7	335	335	NUM
ajb-7	100	8	)	)	PUNCT
ajb-7	100	9	subjects	subject	NOUN
ajb-7	100	10	fitting	fitting	ADJ
ajb-7	100	11	to	to	ADP
ajb-7	100	12	“	"	PUNCT
ajb-7	100	13	definite	definite	ADJ
ajb-7	100	14	fh	fh	PROPN
ajb-7	100	15	”	"	PUNCT
ajb-7	100	16	criteria	criterion	NOUN
ajb-7	100	17	had	have	VERB
ajb-7	100	18	increased	increase	VERB
ajb-7	100	19	levels	level	NOUN
ajb-7	100	20	of	of	ADP
ajb-7	100	21	ldl	ldl	NOUN
ajb-7	100	22	-	-	PUNCT
ajb-7	100	23	c	c	NOUN
ajb-7	100	24	,	,	PUNCT
ajb-7	100	25	presence	presence	NOUN
ajb-7	100	26	of	of	ADP
ajb-7	100	27	early	early	ADJ
ajb-7	100	28	heart	heart	NOUN
ajb-7	100	29	attacks	attack	NOUN
ajb-7	100	30	in	in	ADP
ajb-7	100	31	the	the	DET
ajb-7	100	32	family	family	NOUN
ajb-7	100	33	and	and	CCONJ
ajb-7	100	34	tendon	tendon	PROPN
ajb-7	100	35	xanthomatosis	xanthomatosis	PROPN
ajb-7	100	36	.	.	PUNCT
ajb-7	101	1	five	five	NUM
ajb-7	101	2	probands	proband	NOUN
ajb-7	101	3	were	be	AUX
ajb-7	101	4	examined	examine	VERB
ajb-7	101	5	and	and	CCONJ
ajb-7	101	6	their	their	PRON
ajb-7	101	7	family	family	NOUN
ajb-7	101	8	pedigree	pedigree	NOUN
ajb-7	101	9	trees	tree	NOUN
ajb-7	101	10	were	be	AUX
ajb-7	101	11	constructed	construct	VERB
ajb-7	101	12	to	to	PART
ajb-7	101	13	observe	observe	VERB
ajb-7	101	14	the	the	DET
ajb-7	101	15	dominant	dominant	ADJ
ajb-7	101	16	inheritance	inheritance	NOUN
ajb-7	101	17	pattern	pattern	NOUN
ajb-7	101	18	of	of	ADP
ajb-7	101	19	the	the	DET
ajb-7	101	20	disease	disease	NOUN
ajb-7	101	21	.	.	PUNCT
ajb-7	102	1	biochemical	biochemical	ADJ
ajb-7	102	2	analysis	analysis	NOUN
ajb-7	102	3	the	the	DET
ajb-7	102	4	biochemical	biochemical	ADJ
ajb-7	102	5	tests	test	NOUN
ajb-7	102	6	were	be	AUX
ajb-7	102	7	performed	perform	VERB
ajb-7	102	8	following	follow	VERB
ajb-7	102	9	overnight	overnight	ADV
ajb-7	102	10	(	(	PUNCT
ajb-7	102	11	12–14	12–14	NUM
ajb-7	102	12	hrs	hrs	NOUN
ajb-7	102	13	)	)	PUNCT
ajb-7	102	14	fasting	fasting	NOUN
ajb-7	102	15	.	.	PUNCT
ajb-7	103	1	about	about	ADV
ajb-7	103	2	5	5	NUM
ajb-7	103	3	ml	ml	NOUN
ajb-7	103	4	blood	blood	NOUN
ajb-7	103	5	samples	sample	NOUN
ajb-7	103	6	were	be	AUX
ajb-7	103	7	drawn	draw	VERB
ajb-7	103	8	to	to	PART
ajb-7	103	9	analyze	analyze	VERB
ajb-7	103	10	the	the	DET
ajb-7	103	11	total	total	ADJ
ajb-7	103	12	cholesterol	cholesterol	NOUN
ajb-7	103	13	(	(	PUNCT
ajb-7	103	14	tc	tc	NOUN
ajb-7	103	15	)	)	PUNCT
ajb-7	103	16	levels	level	NOUN
ajb-7	103	17	,	,	PUNCT
ajb-7	103	18	triglyceride	triglyceride	INTJ
ajb-7	103	19	(	(	PUNCT
ajb-7	103	20	tg	tg	PROPN
ajb-7	103	21	)	)	PUNCT
ajb-7	103	22	,	,	PUNCT
ajb-7	103	23	hdl	hdl	PROPN
ajb-7	103	24	and	and	CCONJ
ajb-7	103	25	ldl	ldl	PROPN
ajb-7	103	26	.	.	PUNCT
ajb-7	104	1	the	the	DET
ajb-7	104	2	concentration	concentration	NOUN
ajb-7	104	3	of	of	ADP
ajb-7	104	4	serum	serum	NOUN
ajb-7	104	5	cholesterol	cholesterol	NOUN
ajb-7	104	6	,	,	PUNCT
ajb-7	104	7	hdl	hdl	PROPN
ajb-7	104	8	-	-	PUNCT
ajb-7	104	9	c	c	PROPN
ajb-7	104	10	,	,	PUNCT
ajb-7	104	11	and	and	CCONJ
ajb-7	104	12	tg	tg	PROPN
ajb-7	104	13	were	be	AUX
ajb-7	104	14	determined	determine	VERB
ajb-7	104	15	enzymatically	enzymatically	ADV
ajb-7	104	16	by	by	ADP
ajb-7	104	17	the	the	DET
ajb-7	104	18	chod	chod	PROPN
ajb-7	104	19	-	-	PUNCT
ajb-7	104	20	pap	pap	NOUN
ajb-7	104	21	and	and	CCONJ
ajb-7	104	22	gpopap	gpopap	NOUN
ajb-7	104	23	methods	method	NOUN
ajb-7	104	24	(	(	PUNCT
ajb-7	104	25	boehringer	boehringer	PROPN
ajb-7	104	26	mannheim	mannheim	PROPN
ajb-7	104	27	,	,	PUNCT
ajb-7	104	28	germany	germany	PROPN
ajb-7	104	29	)	)	PUNCT
ajb-7	104	30	(	(	PUNCT
ajb-7	104	31	tietz	tietz	VERB
ajb-7	104	32	,	,	PUNCT
ajb-7	104	33	1986	1986	NUM
ajb-7	104	34	)	)	PUNCT
ajb-7	104	35	.	.	PUNCT
ajb-7	105	1	the	the	DET
ajb-7	105	2	hdl	hdl	PROPN
ajb-7	105	3	-	-	PUNCT
ajb-7	105	4	c	c	PROPN
ajb-7	105	5	was	be	AUX
ajb-7	105	6	isolated	isolate	VERB
ajb-7	105	7	from	from	ADP
ajb-7	105	8	serum	serum	NOUN
ajb-7	105	9	by	by	ADP
ajb-7	105	10	heparin	heparin	ADJ
ajb-7	105	11	manganese	manganese	ADJ
ajb-7	105	12	precipitation	precipitation	NOUN
ajb-7	105	13	of	of	ADP
ajb-7	105	14	the	the	DET
ajb-7	105	15	other	other	ADJ
ajb-7	105	16	lipoproteins	lipoprotein	NOUN
ajb-7	105	17	.	.	PUNCT
ajb-7	106	1	all	all	DET
ajb-7	106	2	the	the	DET
ajb-7	106	3	lipid	lipid	NOUN
ajb-7	106	4	profile	profile	VERB
ajb-7	106	5	analysis	analysis	NOUN
ajb-7	106	6	of	of	ADP
ajb-7	106	7	tc	tc	NOUN
ajb-7	106	8	,	,	PUNCT
ajb-7	106	9	hdl	hdl	PROPN
ajb-7	106	10	-	-	PUNCT
ajb-7	106	11	c	c	PROPN
ajb-7	106	12	,	,	PUNCT
ajb-7	106	13	ldl	ldl	NOUN
ajb-7	106	14	-	-	PUNCT
ajb-7	106	15	c	c	PROPN
ajb-7	106	16	and	and	CCONJ
ajb-7	106	17	tg	tg	PROPN
ajb-7	106	18	concentrations	concentration	NOUN
ajb-7	106	19	were	be	AUX
ajb-7	106	20	observed	observe	VERB
ajb-7	106	21	in	in	ADP
ajb-7	106	22	the	the	DET
ajb-7	106	23	serum	serum	NOUN
ajb-7	106	24	of	of	ADP
ajb-7	106	25	all	all	DET
ajb-7	106	26	1523	1523	NUM
ajb-7	106	27	pakistani	pakistani	ADJ
ajb-7	106	28	individuals	individual	NOUN
ajb-7	106	29	diagnosed	diagnose	VERB
ajb-7	106	30	with	with	ADP
ajb-7	106	31	fh	fh	PROPN
ajb-7	106	32	,	,	PUNCT
ajb-7	106	33	cholesterol	cholesterol	NOUN
ajb-7	106	34	content	content	NOUN
ajb-7	106	35	of	of	ADP
ajb-7	106	36	the	the	DET
ajb-7	106	37	serum	serum	NOUN
ajb-7	106	38	ldl	ldl	PROPN
ajb-7	106	39	-	-	PUNCT
ajb-7	106	40	c	c	PROPN
ajb-7	106	41	was	be	AUX
ajb-7	106	42	estimated	estimate	VERB
ajb-7	106	43	using	use	VERB
ajb-7	106	44	friedewald	friedewald	ADJ
ajb-7	106	45	formula	formula	NOUN
ajb-7	106	46	(	(	PUNCT
ajb-7	106	47	friedewald	friedewald	INTJ
ajb-7	106	48	et	et	PROPN
ajb-7	106	49	al	al	PROPN
ajb-7	106	50	.	.	PROPN
ajb-7	106	51	,	,	PUNCT
ajb-7	106	52	1972	1972	NUM
ajb-7	106	53	)	)	PUNCT
ajb-7	106	54	.	.	PUNCT
ajb-7	107	1	statistical	statistical	ADJ
ajb-7	107	2	analysis	analysis	NOUN
ajb-7	107	3	the	the	DET
ajb-7	107	4	obtained	obtain	VERB
ajb-7	107	5	data	datum	NOUN
ajb-7	107	6	were	be	AUX
ajb-7	107	7	analyzed	analyze	VERB
ajb-7	107	8	for	for	ADP
ajb-7	107	9	correlation	correlation	NOUN
ajb-7	107	10	among	among	ADP
ajb-7	107	11	different	different	ADJ
ajb-7	107	12	risk	risk	NOUN
ajb-7	107	13	factors	factor	NOUN
ajb-7	107	14	using	use	VERB
ajb-7	107	15	the	the	DET
ajb-7	107	16	statistical	statistical	ADJ
ajb-7	107	17	package	package	NOUN
ajb-7	107	18	for	for	ADP
ajb-7	107	19	social	social	ADJ
ajb-7	107	20	sciences	science	NOUN
ajb-7	107	21	version	version	NOUN
ajb-7	107	22	12	12	NUM
ajb-7	107	23	(	(	PUNCT
ajb-7	107	24	spss	spss	PROPN
ajb-7	107	25	,	,	PUNCT
ajb-7	107	26	inc	inc	PROPN
ajb-7	107	27	)	)	PUNCT
ajb-7	107	28	.	.	PUNCT
ajb-7	108	1	statistically	statistically	ADV
ajb-7	108	2	significant	significant	ADJ
ajb-7	108	3	differences	difference	NOUN
ajb-7	108	4	between	between	ADP
ajb-7	108	5	groups	group	NOUN
ajb-7	108	6	or	or	CCONJ
ajb-7	108	7	among	among	ADP
ajb-7	108	8	groups	group	NOUN
ajb-7	108	9	for	for	ADP
ajb-7	108	10	continuous	continuous	ADJ
ajb-7	108	11	variables	variable	NOUN
ajb-7	108	12	were	be	AUX
ajb-7	108	13	evaluated	evaluate	VERB
ajb-7	108	14	using	use	VERB
ajb-7	108	15	student	student	NOUN
ajb-7	108	16	’s	’s	PART
ajb-7	108	17	t	t	PROPN
ajb-7	108	18	test	test	NOUN
ajb-7	108	19	for	for	ADP
ajb-7	108	20	unpaired	unpaired	ADJ
ajb-7	108	21	data	datum	NOUN
ajb-7	108	22	and	and	CCONJ
ajb-7	108	23	anova	anova	X
ajb-7	108	24	respectively	respectively	ADV
ajb-7	108	25	.	.	PUNCT
ajb-7	109	1	the	the	DET
ajb-7	109	2	pedigree	pedigree	NOUN
ajb-7	109	3	was	be	AUX
ajb-7	109	4	made	make	VERB
ajb-7	109	5	by	by	ADP
ajb-7	109	6	using	use	VERB
ajb-7	109	7	the	the	DET
ajb-7	109	8	computer	computer	NOUN
ajb-7	109	9	based	base	VERB
ajb-7	109	10	software	software	PROPN
ajb-7	109	11	cyrillic	cyrillic	PROPN
ajb-7	109	12	version	version	PROPN
ajb-7	109	13	2.10	2.10	NUM
ajb-7	109	14	(	(	PUNCT
ajb-7	109	15	oxford	oxford	PROPN
ajb-7	109	16	,	,	PUNCT
ajb-7	109	17	uk	uk	PROPN
ajb-7	109	18	)	)	PUNCT
ajb-7	109	19	.	.	PUNCT
ajb-7	110	1	results	result	VERB
ajb-7	110	2	our	our	PRON
ajb-7	110	3	previous	previous	ADJ
ajb-7	110	4	study	study	NOUN
ajb-7	110	5	on	on	ADP
ajb-7	110	6	the	the	DET
ajb-7	110	7	heritability	heritability	NOUN
ajb-7	110	8	of	of	ADP
ajb-7	110	9	pakistani	pakistani	PROPN
ajb-7	110	10	fh	fh	PROPN
ajb-7	110	11	population	population	NOUN
ajb-7	110	12	showed	show	VERB
ajb-7	110	13	that	that	SCONJ
ajb-7	110	14	the	the	DET
ajb-7	110	15	genetic	genetic	ADJ
ajb-7	110	16	factors	factor	NOUN
ajb-7	110	17	are	be	AUX
ajb-7	110	18	the	the	DET
ajb-7	110	19	major	major	ADJ
ajb-7	110	20	determinant	determinant	NOUN
ajb-7	110	21	of	of	ADP
ajb-7	110	22	fh	fh	PROPN
ajb-7	110	23	,	,	PUNCT
ajb-7	110	24	however	however	ADV
ajb-7	110	25	because	because	SCONJ
ajb-7	110	26	heritability	heritability	NOUN
ajb-7	110	27	is	be	AUX
ajb-7	110	28	the	the	DET
ajb-7	110	29	proportion	proportion	NOUN
ajb-7	110	30	of	of	ADP
ajb-7	110	31	variation	variation	NOUN
ajb-7	110	32	due	due	ADP
ajb-7	110	33	to	to	PART
ajb-7	110	34	additive	additive	VERB
ajb-7	110	35	familial	familial	ADJ
ajb-7	110	36	effects	effect	NOUN
ajb-7	110	37	of	of	ADP
ajb-7	110	38	genetic	genetic	ADJ
ajb-7	110	39	and	and	CCONJ
ajb-7	110	40	nongenetic	nongenetic	ADJ
ajb-7	110	41	sources	source	NOUN
ajb-7	110	42	,	,	PUNCT
ajb-7	110	43	therefore	therefore	ADV
ajb-7	110	44	we	we	PRON
ajb-7	110	45	concluded	conclude	VERB
ajb-7	110	46	that	that	SCONJ
ajb-7	110	47	other	other	ADJ
ajb-7	110	48	non	non	ADJ
ajb-7	110	49	-	-	ADJ
ajb-7	110	50	genetic	genetic	ADJ
ajb-7	110	51	risk	risk	NOUN
ajb-7	110	52	factors	factor	NOUN
ajb-7	110	53	may	may	AUX
ajb-7	110	54	also	also	ADV
ajb-7	110	55	contribute	contribute	VERB
ajb-7	110	56	in	in	ADP
ajb-7	110	57	the	the	DET
ajb-7	110	58	progression	progression	NOUN
ajb-7	110	59	of	of	ADP
ajb-7	110	60	the	the	DET
ajb-7	110	61	disease	disease	NOUN
ajb-7	110	62	(	(	PUNCT
ajb-7	110	63	imtiaz	imtiaz	PROPN
ajb-7	110	64	,	,	PUNCT
ajb-7	110	65	2009	2009	NUM
ajb-7	110	66	)	)	PUNCT
ajb-7	110	67	.	.	PUNCT
ajb-7	111	1	the	the	DET
ajb-7	111	2	present	present	ADJ
ajb-7	111	3	study	study	NOUN
ajb-7	111	4	was	be	AUX
ajb-7	111	5	conducted	conduct	VERB
ajb-7	111	6	to	to	PART
ajb-7	111	7	examine	examine	VERB
ajb-7	111	8	the	the	DET
ajb-7	111	9	involvement	involvement	NOUN
ajb-7	111	10	of	of	ADP
ajb-7	111	11	risk	risk	NOUN
ajb-7	111	12	factors	factor	NOUN
ajb-7	111	13	such	such	ADJ
ajb-7	111	14	as	as	ADP
ajb-7	111	15	age	age	NOUN
ajb-7	111	16	,	,	PUNCT
ajb-7	111	17	sex	sex	NOUN
ajb-7	111	18	,	,	PUNCT
ajb-7	111	19	htn	htn	PROPN
ajb-7	111	20	,	,	PUNCT
ajb-7	111	21	smoking	smoking	NOUN
ajb-7	111	22	and	and	CCONJ
ajb-7	111	23	tc	tc	NOUN
ajb-7	111	24	concentrations	concentration	NOUN
ajb-7	111	25	in	in	ADP
ajb-7	111	26	the	the	DET
ajb-7	111	27	phenotypic	phenotypic	ADJ
ajb-7	111	28	expression	expression	NOUN
ajb-7	111	29	of	of	ADP
ajb-7	111	30	heterozygous	heterozygous	ADJ
ajb-7	111	31	familial	familial	ADJ
ajb-7	111	32	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	111	33	in	in	ADP
ajb-7	111	34	a	a	DET
ajb-7	111	35	cohort	cohort	NOUN
ajb-7	111	36	of	of	ADP
ajb-7	111	37	pakistani	pakistani	ADJ
ajb-7	111	38	population	population	NOUN
ajb-7	111	39	living	live	VERB
ajb-7	111	40	in	in	ADP
ajb-7	111	41	the	the	DET
ajb-7	111	42	city	city	PROPN
ajb-7	111	43	karachi	karachi	PROPN
ajb-7	111	44	.	.	PUNCT
ajb-7	112	1	we	we	PRON
ajb-7	112	2	have	have	AUX
ajb-7	112	3	studied	study	VERB
ajb-7	112	4	a	a	DET
ajb-7	112	5	total	total	NOUN
ajb-7	112	6	of	of	ADP
ajb-7	112	7	1523	1523	NUM
ajb-7	112	8	unrelated	unrelated	ADJ
ajb-7	112	9	patients	patient	NOUN
ajb-7	112	10	with	with	ADP
ajb-7	112	11	the	the	DET
ajb-7	112	12	clinical	clinical	ADJ
ajb-7	112	13	diagnosis	diagnosis	NOUN
ajb-7	112	14	of	of	ADP
ajb-7	112	15	heterozygous	heterozygous	ADJ
ajb-7	112	16	fh	fh	PROPN
ajb-7	112	17	.	.	PROPN
ajb-7	112	18	out	out	ADP
ajb-7	112	19	of	of	ADP
ajb-7	112	20	these	these	DET
ajb-7	112	21	1523	1523	NUM
ajb-7	112	22	,	,	PUNCT
ajb-7	112	23	only	only	ADV
ajb-7	112	24	335	335	NUM
ajb-7	112	25	subjects	subject	NOUN
ajb-7	112	26	with	with	ADP
ajb-7	112	27	“	"	PUNCT
ajb-7	112	28	definite	definite	ADJ
ajb-7	112	29	fh	fh	PROPN
ajb-7	112	30	”	"	PUNCT
ajb-7	112	31	diagnosis	diagnosis	NOUN
ajb-7	112	32	belonged	belong	VERB
ajb-7	112	33	to	to	ADP
ajb-7	112	34	five	five	NUM
ajb-7	112	35	probands	proband	NOUN
ajb-7	112	36	with	with	ADP
ajb-7	112	37	cholesterol	cholesterol	NOUN
ajb-7	112	38	level	level	NOUN
ajb-7	112	39	>	>	PUNCT
ajb-7	112	40	300	300	NUM
ajb-7	112	41	mg	mg	NOUN
ajb-7	112	42	dl-1	dl-1	PART
ajb-7	112	43	(	(	PUNCT
ajb-7	112	44	normal	normal	ADJ
ajb-7	112	45	range	range	NOUN
ajb-7	112	46	140	140	NUM
ajb-7	112	47	-	-	SYM
ajb-7	112	48	240	240	NUM
ajb-7	112	49	mg	mg	NOUN
ajb-7	112	50	dl-1	dl-1	NOUN
ajb-7	112	51	)	)	PUNCT
ajb-7	112	52	.	.	PUNCT
ajb-7	113	1	among	among	ADP
ajb-7	113	2	them	they	PRON
ajb-7	113	3	kb	kb	PROPN
ajb-7	113	4	m	m	PROPN
ajb-7	113	5	j	j	PROPN
ajb-7	113	6	ou	ou	PROPN
ajb-7	113	7	rn	rn	PROPN
ajb-7	113	8	al	al	PROPN
ajb-7	113	9	o	o	PROPN
ajb-7	114	1	f	f	PROPN
ajb-7	114	2	bi	bi	NOUN
ajb-7	114	3	ol	ol	PROPN
ajb-7	114	4	og	og	PROPN
ajb-7	114	5	y	y	PROPN
ajb-7	114	6	is	be	AUX
ajb-7	114	7	sn	sn	PROPN
ajb-7	114	8	1	1	NUM
ajb-7	114	9	94	94	NUM
ajb-7	114	10	858	858	NUM
ajb-7	114	11	83	83	NUM
ajb-7	114	12	.	.	PUNCT
ajb-7	115	1	p	p	X
ajb-7	115	2	ub	ub	ADJ
ajb-7	115	3	lis	li	NOUN
ajb-7	115	4	he	he	PRON
ajb-7	115	5	d	d	NOUN
ajb-7	115	6	by	by	ADP
ajb-7	115	7	k	k	PROPN
ajb-7	115	8	bm	bm	PROPN
ajb-7	115	9	s	s	PROPN
ajb-7	115	10	ci	ci	PROPN
ajb-7	115	11	en	en	ADP
ajb-7	115	12	tifi	tifi	PROPN
ajb-7	115	13	c	c	AUX
ajb-7	115	14	pu	pu	PROPN
ajb-7	115	15	bl	bl	AUX
ajb-7	115	16	ish	ish	VERB
ajb-7	115	17	in	in	ADP
ajb-7	115	18	g	g	PROPN
ajb-7	115	19	,	,	PUNCT
ajb-7	116	1	l	l	NOUN
ajb-7	116	2	p	p	X
ajb-7	117	1	(	(	PUNCT
ajb-7	117	2	w	w	PROPN
ajb-7	117	3	w	w	PROPN
ajb-7	117	4	w	w	PROPN
ajb-7	117	5	.k	.k	PROPN
ajb-7	117	6	bm	bm	PROPN
ajb-7	118	1	-s	-s	X
ajb-7	118	2	ci	ci	PROPN
ajb-7	118	3	en	en	INTJ
ajb-7	118	4	tifi	tifi	PROPN
ajb-7	118	5	cpu	cpu	NOUN
ajb-7	118	6	bl	bl	AUX
ajb-7	118	7	ish	ish	VERB
ajb-7	118	8	in	in	ADP
ajb-7	118	9	g.	g.	PROPN
ajb-7	118	10	or	or	CCONJ
ajb-7	118	11	g	g	NOUN
ajb-7	118	12	)	)	PUNCT
ajb-7	119	1	kb	kb	PROPN
ajb-7	119	2	m	m	PROPN
ajb-7	119	3	j	j	PROPN
ajb-7	119	4	ou	ou	PROPN
ajb-7	119	5	rn	rn	PROPN
ajb-7	119	6	al	al	PROPN
ajb-7	120	1	o	o	PROPN
ajb-7	121	1	f	f	PROPN
ajb-7	121	2	bi	bi	NOUN
ajb-7	121	3	ol	ol	PROPN
ajb-7	121	4	og	og	PROPN
ajb-7	121	5	y	y	PROPN
ajb-7	121	6	is	be	AUX
ajb-7	121	7	sn	sn	PROPN
ajb-7	121	8	1	1	NUM
ajb-7	121	9	94	94	NUM
ajb-7	121	10	858	858	NUM
ajb-7	121	11	83	83	NUM
ajb-7	121	12	.	.	PUNCT
ajb-7	122	1	p	p	X
ajb-7	122	2	ub	ub	ADJ
ajb-7	122	3	lis	li	NOUN
ajb-7	122	4	he	he	PRON
ajb-7	122	5	d	d	NOUN
ajb-7	122	6	by	by	ADP
ajb-7	122	7	k	k	PROPN
ajb-7	122	8	bm	bm	PROPN
ajb-7	122	9	s	s	PROPN
ajb-7	122	10	ci	ci	PROPN
ajb-7	122	11	en	en	ADP
ajb-7	122	12	tifi	tifi	PROPN
ajb-7	122	13	c	c	AUX
ajb-7	122	14	pu	pu	PROPN
ajb-7	122	15	bl	bl	AUX
ajb-7	122	16	ish	ish	VERB
ajb-7	122	17	in	in	ADP
ajb-7	122	18	g	g	PROPN
ajb-7	122	19	,	,	PUNCT
ajb-7	123	1	l	l	NOUN
ajb-7	123	2	p	p	X
ajb-7	124	1	(	(	PUNCT
ajb-7	124	2	w	w	PROPN
ajb-7	124	3	w	w	PROPN
ajb-7	124	4	w	w	PROPN
ajb-7	124	5	.k	.k	PROPN
ajb-7	124	6	bm	bm	PROPN
ajb-7	125	1	-s	-s	X
ajb-7	125	2	ci	ci	PROPN
ajb-7	125	3	en	en	INTJ
ajb-7	125	4	tifi	tifi	PROPN
ajb-7	125	5	cpu	cpu	NOUN
ajb-7	125	6	bl	bl	AUX
ajb-7	125	7	ish	ish	VERB
ajb-7	125	8	in	in	ADP
ajb-7	125	9	g.	g.	PROPN
ajb-7	125	10	or	or	CCONJ
ajb-7	125	11	g	g	NOUN
ajb-7	125	12	)	)	PUNCT
ajb-7	125	13	36	36	NUM
ajb-7	125	14	202	202	NUM
ajb-7	125	15	were	be	AUX
ajb-7	125	16	males	male	NOUN
ajb-7	125	17	and	and	CCONJ
ajb-7	125	18	133	133	NUM
ajb-7	125	19	were	be	AUX
ajb-7	125	20	females	female	NOUN
ajb-7	125	21	.	.	PUNCT
ajb-7	126	1	upon	upon	SCONJ
ajb-7	126	2	clinical	clinical	ADJ
ajb-7	126	3	physical	physical	ADJ
ajb-7	126	4	examination	examination	NOUN
ajb-7	126	5	,	,	PUNCT
ajb-7	126	6	out	out	ADP
ajb-7	126	7	of	of	ADP
ajb-7	126	8	these	these	DET
ajb-7	126	9	335	335	NUM
ajb-7	126	10	individuals	individual	NOUN
ajb-7	126	11	(	(	PUNCT
ajb-7	126	12	202	202	NUM
ajb-7	126	13	males	male	NOUN
ajb-7	126	14	and	and	CCONJ
ajb-7	126	15	133	133	NUM
ajb-7	126	16	females	female	NOUN
ajb-7	126	17	)	)	PUNCT
ajb-7	126	18	224	224	NUM
ajb-7	126	19	(	(	PUNCT
ajb-7	126	20	70	70	NUM
ajb-7	126	21	%	%	NOUN
ajb-7	126	22	)	)	PUNCT
ajb-7	126	23	showed	show	VERB
ajb-7	126	24	tx	tx	PROPN
ajb-7	126	25	.	.	PUNCT
ajb-7	127	1	a	a	DET
ajb-7	127	2	total	total	NOUN
ajb-7	127	3	of	of	ADP
ajb-7	127	4	146	146	NUM
ajb-7	127	5	males	male	NOUN
ajb-7	127	6	(	(	PUNCT
ajb-7	127	7	72	72	NUM
ajb-7	127	8	%	%	NOUN
ajb-7	127	9	)	)	PUNCT
ajb-7	127	10	and	and	CCONJ
ajb-7	127	11	78	78	NUM
ajb-7	127	12	females	female	NOUN
ajb-7	127	13	(	(	PUNCT
ajb-7	127	14	58	58	NUM
ajb-7	127	15	%	%	NOUN
ajb-7	127	16	)	)	PUNCT
ajb-7	127	17	aged	age	VERB
ajb-7	127	18	between	between	ADP
ajb-7	127	19	30	30	NUM
ajb-7	127	20	-	-	SYM
ajb-7	127	21	40	40	NUM
ajb-7	127	22	showed	show	VERB
ajb-7	127	23	tx	tx	PROPN
ajb-7	127	24	symptoms	symptom	NOUN
ajb-7	127	25	(	(	PUNCT
ajb-7	127	26	table	table	NOUN
ajb-7	127	27	1	1	NUM
ajb-7	127	28	)	)	PUNCT
ajb-7	127	29	.	.	PUNCT
ajb-7	128	1	xanthelesma	xanthelesma	PROPN
ajb-7	128	2	was	be	AUX
ajb-7	128	3	detected	detect	VERB
ajb-7	128	4	in	in	ADP
ajb-7	128	5	258	258	NUM
ajb-7	128	6	individuals	individual	NOUN
ajb-7	128	7	(	(	PUNCT
ajb-7	128	8	80	80	NUM
ajb-7	128	9	%	%	NOUN
ajb-7	128	10	)	)	PUNCT
ajb-7	128	11	,	,	PUNCT
ajb-7	128	12	i.e.	i.e.	X
ajb-7	128	13	148	148	NUM
ajb-7	128	14	males	male	NOUN
ajb-7	128	15	(	(	PUNCT
ajb-7	128	16	73	73	NUM
ajb-7	128	17	%	%	NOUN
ajb-7	128	18	;	;	PUNCT
ajb-7	128	19	aged	aged	ADJ
ajb-7	128	20	40	40	NUM
ajb-7	128	21	-	-	SYM
ajb-7	128	22	50	50	NUM
ajb-7	128	23	)	)	PUNCT
ajb-7	128	24	and	and	CCONJ
ajb-7	128	25	110	110	NUM
ajb-7	128	26	females	female	NOUN
ajb-7	128	27	(	(	PUNCT
ajb-7	128	28	82	82	NUM
ajb-7	128	29	%	%	NOUN
ajb-7	128	30	;	;	PUNCT
ajb-7	128	31	aged	aged	ADJ
ajb-7	128	32	30	30	NUM
ajb-7	128	33	-	-	SYM
ajb-7	128	34	40	40	NUM
ajb-7	128	35	)	)	PUNCT
ajb-7	128	36	.	.	PUNCT
ajb-7	129	1	the	the	DET
ajb-7	129	2	ac	ac	PROPN
ajb-7	129	3	was	be	AUX
ajb-7	129	4	observed	observe	VERB
ajb-7	129	5	in	in	ADP
ajb-7	129	6	a	a	DET
ajb-7	129	7	total	total	NOUN
ajb-7	129	8	of	of	ADP
ajb-7	129	9	224	224	NUM
ajb-7	129	10	patients	patient	NOUN
ajb-7	129	11	(	(	PUNCT
ajb-7	129	12	70	70	NUM
ajb-7	129	13	%	%	NOUN
ajb-7	129	14	)	)	PUNCT
ajb-7	129	15	,	,	PUNCT
ajb-7	129	16	where	where	SCONJ
ajb-7	129	17	63	63	NUM
ajb-7	129	18	%	%	NOUN
ajb-7	129	19	males	male	NOUN
ajb-7	129	20	(	(	PUNCT
ajb-7	129	21	128	128	NUM
ajb-7	129	22	individuals	individual	NOUN
ajb-7	129	23	)	)	PUNCT
ajb-7	129	24	aged	aged	ADJ
ajb-7	129	25	40	40	NUM
ajb-7	129	26	-	-	SYM
ajb-7	129	27	50	50	NUM
ajb-7	129	28	and	and	CCONJ
ajb-7	129	29	72	72	NUM
ajb-7	129	30	%	%	NOUN
ajb-7	129	31	females	female	NOUN
ajb-7	129	32	(	(	PUNCT
ajb-7	129	33	96	96	NUM
ajb-7	129	34	individuals	individual	NOUN
ajb-7	129	35	)	)	PUNCT
ajb-7	129	36	aged	aged	ADJ
ajb-7	129	37	30	30	NUM
ajb-7	129	38	-	-	SYM
ajb-7	129	39	40	40	NUM
ajb-7	129	40	showed	show	VERB
ajb-7	129	41	the	the	DET
ajb-7	129	42	ac	ac	PROPN
ajb-7	129	43	symptoms	symptom	NOUN
ajb-7	129	44	.	.	PUNCT
ajb-7	130	1	the	the	DET
ajb-7	130	2	polyartheritis	polyartheritis	ADJ
ajb-7	130	3	symptoms	symptom	NOUN
ajb-7	130	4	were	be	AUX
ajb-7	130	5	less	less	ADV
ajb-7	130	6	common	common	ADJ
ajb-7	130	7	among	among	ADP
ajb-7	130	8	the	the	DET
ajb-7	130	9	observed	observe	VERB
ajb-7	130	10	individuals	individual	NOUN
ajb-7	130	11	and	and	CCONJ
ajb-7	130	12	only	only	ADV
ajb-7	130	13	7	7	NUM
ajb-7	130	14	individuals	individual	NOUN
ajb-7	130	15	(	(	PUNCT
ajb-7	130	16	2	2	NUM
ajb-7	130	17	%	%	NOUN
ajb-7	130	18	)	)	PUNCT
ajb-7	130	19	have	have	VERB
ajb-7	130	20	this	this	DET
ajb-7	130	21	condition	condition	NOUN
ajb-7	130	22	.	.	PUNCT
ajb-7	131	1	among	among	ADP
ajb-7	131	2	the	the	DET
ajb-7	131	3	202	202	NUM
ajb-7	131	4	males	male	NOUN
ajb-7	131	5	(	(	PUNCT
ajb-7	131	6	aged	aged	ADJ
ajb-7	131	7	40	40	NUM
ajb-7	131	8	-	-	SYM
ajb-7	131	9	50	50	NUM
ajb-7	131	10	)	)	PUNCT
ajb-7	131	11	,	,	PUNCT
ajb-7	131	12	only	only	ADV
ajb-7	131	13	2	2	NUM
ajb-7	131	14	males	male	NOUN
ajb-7	131	15	(	(	PUNCT
ajb-7	131	16	0.9	0.9	NUM
ajb-7	131	17	%	%	NOUN
ajb-7	131	18	)	)	PUNCT
ajb-7	131	19	and	and	CCONJ
ajb-7	131	20	5	5	NUM
ajb-7	131	21	females	female	NOUN
ajb-7	131	22	(	(	PUNCT
ajb-7	131	23	3.7	3.7	NUM
ajb-7	131	24	%	%	NOUN
ajb-7	131	25	)	)	PUNCT
ajb-7	131	26	showed	show	VERB
ajb-7	131	27	the	the	DET
ajb-7	131	28	clinical	clinical	ADJ
ajb-7	131	29	symptoms	symptom	NOUN
ajb-7	131	30	of	of	ADP
ajb-7	131	31	polyartheritis	polyartheritis	NOUN
ajb-7	131	32	(	(	PUNCT
ajb-7	131	33	table	table	NOUN
ajb-7	131	34	1	1	NUM
ajb-7	131	35	)	)	PUNCT
ajb-7	131	36	.	.	PUNCT
ajb-7	132	1	hence	hence	ADV
ajb-7	132	2	,	,	PUNCT
ajb-7	132	3	the	the	DET
ajb-7	132	4	occurrence	occurrence	NOUN
ajb-7	132	5	of	of	ADP
ajb-7	132	6	xanthoma	xanthoma	PROPN
ajb-7	132	7	(	(	PUNCT
ajb-7	132	8	i.e.	i.e.	X
ajb-7	132	9	tendinous	tendinous	ADJ
ajb-7	132	10	xanthomata	xanthomata	PROPN
ajb-7	132	11	and	and	CCONJ
ajb-7	132	12	xanthelesma	xanthelesma	NOUN
ajb-7	132	13	)	)	PUNCT
ajb-7	132	14	in	in	ADP
ajb-7	132	15	the	the	DET
ajb-7	132	16	present	present	ADJ
ajb-7	132	17	study	study	NOUN
ajb-7	132	18	in	in	ADP
ajb-7	132	19	general	general	ADJ
ajb-7	132	20	was	be	AUX
ajb-7	132	21	about	about	ADV
ajb-7	132	22	70	70	NUM
ajb-7	132	23	%	%	NOUN
ajb-7	132	24	in	in	ADP
ajb-7	132	25	the	the	DET
ajb-7	132	26	patients	patient	NOUN
ajb-7	132	27	diagnosed	diagnose	VERB
ajb-7	132	28	with	with	ADP
ajb-7	132	29	fh	fh	PROPN
ajb-7	132	30	.	.	PUNCT
ajb-7	133	1	a	a	DET
ajb-7	133	2	detailed	detailed	ADJ
ajb-7	133	3	examination	examination	NOUN
ajb-7	133	4	of	of	ADP
ajb-7	133	5	the	the	DET
ajb-7	133	6	physical	physical	ADJ
ajb-7	133	7	and	and	CCONJ
ajb-7	133	8	biochemical	biochemical	ADJ
ajb-7	133	9	features	feature	NOUN
ajb-7	133	10	of	of	ADP
ajb-7	133	11	fh	fh	PROPN
ajb-7	133	12	of	of	ADP
ajb-7	133	13	cohort	cohort	NOUN
ajb-7	133	14	of	of	ADP
ajb-7	133	15	208	208	NUM
ajb-7	133	16	females	female	NOUN
ajb-7	133	17	and	and	CCONJ
ajb-7	133	18	156	156	NUM
ajb-7	133	19	males	male	NOUN
ajb-7	133	20	showed	show	VERB
ajb-7	133	21	that	that	SCONJ
ajb-7	133	22	females	female	NOUN
ajb-7	133	23	with	with	ADP
ajb-7	133	24	fh	fh	PROPN
ajb-7	133	25	had	have	VERB
ajb-7	133	26	higher	high	ADJ
ajb-7	133	27	levels	level	NOUN
ajb-7	133	28	of	of	ADP
ajb-7	133	29	total	total	ADJ
ajb-7	133	30	ldl	ldl	NOUN
ajb-7	133	31	-	-	PUNCT
ajb-7	133	32	c	c	NOUN
ajb-7	133	33	(	(	PUNCT
ajb-7	133	34	196	196	NUM
ajb-7	133	35	to	to	ADP
ajb-7	133	36	358	358	NUM
ajb-7	133	37	mg	mg	NUM
ajb-7	133	38	dl-1	dl-1	PRON
ajb-7	133	39	)	)	PUNCT
ajb-7	133	40	compared	compare	VERB
ajb-7	133	41	to	to	ADP
ajb-7	133	42	the	the	DET
ajb-7	133	43	male	male	ADJ
ajb-7	133	44	subjects	subject	NOUN
ajb-7	133	45	(	(	PUNCT
ajb-7	133	46	201	201	NUM
ajb-7	133	47	to	to	ADP
ajb-7	133	48	301	301	NUM
ajb-7	133	49	mg	mg	PROPN
ajb-7	133	50	dlkb	dlkb	PROPN
ajb-7	133	51	m	m	PROPN
ajb-7	134	1	j	j	PROPN
ajb-7	134	2	ou	ou	PROPN
ajb-7	134	3	rn	rn	PROPN
ajb-7	134	4	al	al	PROPN
ajb-7	134	5	o	o	PROPN
ajb-7	135	1	f	f	PROPN
ajb-7	135	2	bi	bi	NOUN
ajb-7	135	3	ol	ol	PROPN
ajb-7	135	4	og	og	PROPN
ajb-7	135	5	y	y	PROPN
ajb-7	135	6	is	be	AUX
ajb-7	135	7	sn	sn	PROPN
ajb-7	135	8	1	1	NUM
ajb-7	135	9	94	94	NUM
ajb-7	135	10	858	858	NUM
ajb-7	135	11	83	83	NUM
ajb-7	135	12	.	.	PUNCT
ajb-7	136	1	p	p	X
ajb-7	136	2	ub	ub	ADJ
ajb-7	136	3	lis	li	NOUN
ajb-7	136	4	he	he	PRON
ajb-7	136	5	d	d	NOUN
ajb-7	136	6	by	by	ADP
ajb-7	136	7	k	k	PROPN
ajb-7	136	8	bm	bm	PROPN
ajb-7	136	9	s	s	PROPN
ajb-7	136	10	ci	ci	PROPN
ajb-7	136	11	en	en	ADP
ajb-7	136	12	tifi	tifi	PROPN
ajb-7	136	13	c	c	AUX
ajb-7	136	14	pu	pu	PROPN
ajb-7	136	15	bl	bl	AUX
ajb-7	136	16	ish	ish	VERB
ajb-7	136	17	in	in	ADP
ajb-7	136	18	g	g	PROPN
ajb-7	136	19	,	,	PUNCT
ajb-7	137	1	l	l	NOUN
ajb-7	137	2	p	p	X
ajb-7	138	1	(	(	PUNCT
ajb-7	138	2	w	w	PROPN
ajb-7	138	3	w	w	PROPN
ajb-7	138	4	w	w	PROPN
ajb-7	138	5	.k	.k	PROPN
ajb-7	138	6	bm	bm	PROPN
ajb-7	139	1	-s	-s	X
ajb-7	139	2	ci	ci	PROPN
ajb-7	139	3	en	en	INTJ
ajb-7	139	4	tifi	tifi	PROPN
ajb-7	139	5	cpu	cpu	NOUN
ajb-7	139	6	bl	bl	AUX
ajb-7	139	7	ish	ish	VERB
ajb-7	139	8	in	in	ADP
ajb-7	139	9	g.	g.	PROPN
ajb-7	139	10	or	or	CCONJ
ajb-7	139	11	g	g	NOUN
ajb-7	139	12	)	)	PUNCT
ajb-7	139	13	1	1	NUM
ajb-7	139	14	)	)	PUNCT
ajb-7	139	15	(	(	PUNCT
ajb-7	139	16	figure1	figure1	X
ajb-7	139	17	)	)	PUNCT
ajb-7	139	18	,	,	PUNCT
ajb-7	139	19	while	while	SCONJ
ajb-7	139	20	having	have	VERB
ajb-7	139	21	lower	low	ADJ
ajb-7	139	22	hdl	hdl	NOUN
ajb-7	139	23	-	-	PUNCT
ajb-7	139	24	c	c	NOUN
ajb-7	139	25	levels	level	NOUN
ajb-7	139	26	(	(	PUNCT
ajb-7	139	27	25	25	NUM
ajb-7	139	28	-	-	SYM
ajb-7	139	29	55	55	NUM
ajb-7	139	30	mg	mg	NOUN
ajb-7	139	31	dl-1	dl-1	NOUN
ajb-7	139	32	)	)	PUNCT
ajb-7	139	33	in	in	ADP
ajb-7	139	34	both	both	DET
ajb-7	139	35	genders	gender	NOUN
ajb-7	139	36	compared	compare	VERB
ajb-7	139	37	to	to	ADP
ajb-7	139	38	the	the	DET
ajb-7	139	39	normal	normal	ADJ
ajb-7	139	40	(	(	PUNCT
ajb-7	139	41	figure	figure	NOUN
ajb-7	139	42	1	1	NUM
ajb-7	139	43	)	)	PUNCT
ajb-7	139	44	.	.	PUNCT
ajb-7	140	1	our	our	PRON
ajb-7	140	2	results	result	NOUN
ajb-7	140	3	also	also	ADV
ajb-7	140	4	showed	show	VERB
ajb-7	140	5	that	that	SCONJ
ajb-7	140	6	the	the	DET
ajb-7	140	7	mean	mean	ADJ
ajb-7	140	8	age	age	NOUN
ajb-7	140	9	of	of	ADP
ajb-7	140	10	fh	fh	PROPN
ajb-7	140	11	showing	show	VERB
ajb-7	140	12	the	the	DET
ajb-7	140	13	symptoms	symptom	NOUN
ajb-7	140	14	in	in	ADP
ajb-7	140	15	males	male	NOUN
ajb-7	140	16	was	be	AUX
ajb-7	140	17	earlier	early	ADJ
ajb-7	140	18	than	than	ADP
ajb-7	140	19	normal	normal	ADJ
ajb-7	140	20	,	,	PUNCT
ajb-7	140	21	i.e.	i.e.	X
ajb-7	140	22	38	38	NUM
ajb-7	140	23	years	year	NOUN
ajb-7	140	24	compared	compare	VERB
ajb-7	140	25	to	to	ADP
ajb-7	140	26	45	45	NUM
ajb-7	140	27	years	year	NOUN
ajb-7	140	28	in	in	ADP
ajb-7	140	29	females	female	NOUN
ajb-7	140	30	.	.	PUNCT
ajb-7	141	1	the	the	DET
ajb-7	141	2	fh	fh	PROPN
ajb-7	141	3	disease	disease	NOUN
ajb-7	141	4	prevalence	prevalence	NOUN
ajb-7	141	5	rate	rate	NOUN
ajb-7	141	6	was	be	AUX
ajb-7	141	7	69	69	NUM
ajb-7	141	8	%	%	NOUN
ajb-7	141	9	in	in	ADP
ajb-7	141	10	males	male	NOUN
ajb-7	141	11	compared	compare	VERB
ajb-7	141	12	to	to	ADP
ajb-7	141	13	31	31	NUM
ajb-7	141	14	%	%	NOUN
ajb-7	141	15	in	in	ADP
ajb-7	141	16	females	female	NOUN
ajb-7	141	17	.	.	PUNCT
ajb-7	142	1	the	the	DET
ajb-7	142	2	risk	risk	NOUN
ajb-7	142	3	factors	factor	NOUN
ajb-7	142	4	such	such	ADJ
ajb-7	142	5	as	as	ADP
ajb-7	142	6	total	total	ADJ
ajb-7	142	7	cholesterol	cholesterol	NOUN
ajb-7	142	8	(	(	PUNCT
ajb-7	142	9	tc	tc	NOUN
ajb-7	142	10	)	)	PUNCT
ajb-7	142	11	,	,	PUNCT
ajb-7	142	12	smoking	smoking	NOUN
ajb-7	142	13	and	and	CCONJ
ajb-7	142	14	htn	htn	NOUN
ajb-7	142	15	were	be	AUX
ajb-7	142	16	found	find	VERB
ajb-7	142	17	to	to	PART
ajb-7	142	18	be	be	AUX
ajb-7	142	19	highly	highly	ADV
ajb-7	142	20	correlated	correlate	VERB
ajb-7	142	21	with	with	ADP
ajb-7	142	22	fh	fh	PROPN
ajb-7	142	23	appearance	appearance	NOUN
ajb-7	142	24	.	.	PUNCT
ajb-7	143	1	we	we	PRON
ajb-7	143	2	observed	observe	VERB
ajb-7	143	3	that	that	SCONJ
ajb-7	143	4	smoking	smoking	NOUN
ajb-7	143	5	and	and	CCONJ
ajb-7	143	6	htn	htn	NOUN
ajb-7	143	7	were	be	AUX
ajb-7	143	8	significantly	significantly	ADV
ajb-7	143	9	(	(	PUNCT
ajb-7	143	10	p	p	X
ajb-7	143	11	<	<	X
ajb-7	143	12	0.05	0.05	NUM
ajb-7	143	13	)	)	PUNCT
ajb-7	143	14	correlated	correlate	VERB
ajb-7	143	15	.	.	PUNCT
ajb-7	144	1	similarly	similarly	ADV
ajb-7	144	2	,	,	PUNCT
ajb-7	144	3	a	a	DET
ajb-7	144	4	high	high	ADJ
ajb-7	144	5	correlation	correlation	NOUN
ajb-7	144	6	(	(	PUNCT
ajb-7	144	7	p	p	X
ajb-7	144	8	<	<	X
ajb-7	144	9	0.05	0.05	NUM
ajb-7	144	10	)	)	PUNCT
ajb-7	144	11	was	be	AUX
ajb-7	144	12	found	find	VERB
ajb-7	144	13	between	between	ADP
ajb-7	144	14	smoking	smoking	NOUN
ajb-7	144	15	and	and	CCONJ
ajb-7	144	16	tc	tc	NOUN
ajb-7	144	17	in	in	ADP
ajb-7	144	18	the	the	DET
ajb-7	144	19	individuals	individual	NOUN
ajb-7	144	20	with	with	ADP
ajb-7	144	21	fh	fh	PROPN
ajb-7	144	22	.	.	PUNCT
ajb-7	145	1	however	however	ADV
ajb-7	145	2	,	,	PUNCT
ajb-7	145	3	tc	tc	PRON
ajb-7	145	4	and	and	CCONJ
ajb-7	145	5	htn	htn	PROPN
ajb-7	145	6	were	be	AUX
ajb-7	145	7	even	even	ADV
ajb-7	145	8	more	more	ADV
ajb-7	145	9	strongly	strongly	ADV
ajb-7	145	10	correlated	correlate	VERB
ajb-7	145	11	with	with	ADP
ajb-7	145	12	fh	fh	PROPN
ajb-7	145	13	at	at	ADP
ajb-7	145	14	p	p	NOUN
ajb-7	145	15	<	<	X
ajb-7	145	16	0.01	0.01	NUM
ajb-7	145	17	(	(	PUNCT
ajb-7	145	18	table	table	NOUN
ajb-7	145	19	2	2	NUM
ajb-7	145	20	)	)	PUNCT
ajb-7	145	21	.	.	PUNCT
ajb-7	146	1	the	the	DET
ajb-7	146	2	risk	risk	NOUN
ajb-7	146	3	factors	factor	NOUN
ajb-7	146	4	such	such	ADJ
ajb-7	146	5	as	as	ADP
ajb-7	146	6	smoking	smoking	NOUN
ajb-7	146	7	and	and	CCONJ
ajb-7	146	8	htn	htn	PROPN
ajb-7	146	9	exhibited	exhibit	VERB
ajb-7	146	10	significant	significant	ADJ
ajb-7	146	11	effects	effect	NOUN
ajb-7	146	12	in	in	ADP
ajb-7	146	13	the	the	DET
ajb-7	146	14	appearance	appearance	NOUN
ajb-7	146	15	of	of	ADP
ajb-7	146	16	the	the	DET
ajb-7	146	17	disease	disease	NOUN
ajb-7	146	18	.	.	PUNCT
ajb-7	147	1	our	our	PRON
ajb-7	147	2	study	study	NOUN
ajb-7	147	3	showed	show	VERB
ajb-7	147	4	that	that	SCONJ
ajb-7	147	5	smoking	smoking	NOUN
ajb-7	147	6	and	and	CCONJ
ajb-7	147	7	htn	htn	PROPN
ajb-7	147	8	were	be	AUX
ajb-7	147	9	significantly	significantly	ADV
ajb-7	147	10	correlated	correlate	VERB
ajb-7	147	11	with	with	ADP
ajb-7	147	12	the	the	DET
ajb-7	147	13	level	level	NOUN
ajb-7	147	14	of	of	ADP
ajb-7	147	15	total	total	ADJ
ajb-7	147	16	cholesterol	cholesterol	NOUN
ajb-7	147	17	at	at	ADP
ajb-7	147	18	p<0.05	p<0.05	NOUN
ajb-7	147	19	(	(	PUNCT
ajb-7	147	20	0.047	0.047	NUM
ajb-7	147	21	)	)	PUNCT
ajb-7	147	22	and	and	CCONJ
ajb-7	147	23	p<0.01	p<0.01	PROPN
ajb-7	147	24	(	(	PUNCT
ajb-7	147	25	0.000	0.000	NUM
ajb-7	147	26	)	)	PUNCT
ajb-7	147	27	,	,	PUNCT
ajb-7	147	28	respectively	respectively	ADV
ajb-7	147	29	(	(	PUNCT
ajb-7	147	30	table	table	NOUN
ajb-7	147	31	2	2	NUM
ajb-7	147	32	)	)	PUNCT
ajb-7	147	33	.	.	PUNCT
ajb-7	148	1	the	the	DET
ajb-7	148	2	smoking	smoking	NOUN
ajb-7	148	3	in	in	ADP
ajb-7	148	4	males	male	NOUN
ajb-7	148	5	had	have	VERB
ajb-7	148	6	profound	profound	ADJ
ajb-7	148	7	effect	effect	NOUN
ajb-7	148	8	in	in	ADP
ajb-7	148	9	observed	observed	ADJ
ajb-7	148	10	individuals	individual	NOUN
ajb-7	148	11	,	,	PUNCT
ajb-7	148	12	where	where	SCONJ
ajb-7	148	13	we	we	PRON
ajb-7	148	14	noticed	notice	VERB
ajb-7	148	15	that	that	SCONJ
ajb-7	148	16	70	70	NUM
ajb-7	148	17	%	%	NOUN
ajb-7	148	18	male	male	ADJ
ajb-7	148	19	smokers	smoker	NOUN
ajb-7	148	20	were	be	AUX
ajb-7	148	21	positive	positive	ADJ
ajb-7	148	22	for	for	ADP
ajb-7	148	23	chd	chd	PROPN
ajb-7	148	24	.	.	PUNCT
ajb-7	149	1	i:1	i:1	PROPN
ajb-7	149	2	(	(	PUNCT
ajb-7	149	3	2	2	NUM
ajb-7	149	4	60	60	NUM
ajb-7	149	5	m	m	NOUN
ajb-7	149	6	g/	g/	NOUN
ajb-7	149	7	dl	dl	INTJ
ajb-7	149	8	)	)	PUNCT
ajb-7	149	9	i:2	i:2	DET
ajb-7	149	10	ii:1	ii:1	PROPN
ajb-7	149	11	(	(	PUNCT
ajb-7	149	12	3	3	NUM
ajb-7	149	13	58	58	NUM
ajb-7	149	14	m	m	NOUN
ajb-7	149	15	g/	g/	NOUN
ajb-7	149	16	dl	dl	INTJ
ajb-7	149	17	)	)	PUNCT
ajb-7	150	1	ii:2	ii:2	PROPN
ajb-7	150	2	(	(	PUNCT
ajb-7	150	3	2	2	NUM
ajb-7	150	4	70	70	NUM
ajb-7	150	5	m	m	NOUN
ajb-7	150	6	g/	g/	NOUN
ajb-7	150	7	dl	dl	INTJ
ajb-7	150	8	)	)	PUNCT
ajb-7	150	9	ii:4	ii:4	PROPN
ajb-7	150	10	(	(	PUNCT
ajb-7	150	11	2	2	NUM
ajb-7	150	12	51	51	NUM
ajb-7	150	13	m	m	NOUN
ajb-7	150	14	g/	g/	NOUN
ajb-7	150	15	dl	dl	NOUN
ajb-7	150	16	)	)	PUNCT
ajb-7	150	17	ii:3	ii:3	NOUN
ajb-7	150	18	(	(	PUNCT
ajb-7	150	19	2	2	NUM
ajb-7	150	20	00	00	NUM
ajb-7	150	21	m	m	NOUN
ajb-7	150	22	g/	g/	NOUN
ajb-7	150	23	dl	dl	PROPN
ajb-7	150	24	)	)	PUNCT
ajb-7	150	25	ii:6	ii:6	PROPN
ajb-7	150	26	(	(	PUNCT
ajb-7	150	27	2	2	NUM
ajb-7	150	28	41	41	NUM
ajb-7	150	29	m	m	NOUN
ajb-7	150	30	g	g	NOUN
ajb-7	150	31	/d	/d	SYM
ajb-7	150	32	l	l	NOUN
ajb-7	150	33	)	)	PUNCT
ajb-7	151	1	ii:5	ii:5	ADP
ajb-7	151	2	(	(	PUNCT
ajb-7	151	3	2	2	NUM
ajb-7	151	4	01	01	NUM
ajb-7	151	5	m	m	NOUN
ajb-7	151	6	g/	g/	NOUN
ajb-7	151	7	dl	dl	PROPN
ajb-7	151	8	)	)	PUNCT
ajb-7	151	9	ii:7	ii:7	PROPN
ajb-7	151	10	(	(	PUNCT
ajb-7	151	11	2	2	NUM
ajb-7	151	12	50	50	NUM
ajb-7	151	13	m	m	NOUN
ajb-7	151	14	g/	g/	NOUN
ajb-7	151	15	dl	dl	PROPN
ajb-7	151	16	)	)	PUNCT
ajb-7	151	17	ii:8	ii:8	PROPN
ajb-7	152	1	ii:9	ii:9	PROPN
ajb-7	152	2	(	(	PUNCT
ajb-7	152	3	2	2	NUM
ajb-7	152	4	58	58	NUM
ajb-7	152	5	m	m	NOUN
ajb-7	152	6	g/	g/	NOUN
ajb-7	152	7	dl	dl	INTJ
ajb-7	152	8	)	)	PUNCT
ajb-7	152	9	ii:10	ii:10	PROPN
ajb-7	152	10	i:3	i:3	VERB
ajb-7	152	11	i:4	i:4	PROPN
ajb-7	152	12	ii:11	ii:11	PROPN
ajb-7	152	13	(	(	PUNCT
ajb-7	152	14	1	1	NUM
ajb-7	152	15	96	96	NUM
ajb-7	152	16	m	m	NOUN
ajb-7	152	17	g/	g/	NOUN
ajb-7	152	18	dl	dl	PROPN
ajb-7	152	19	)	)	PUNCT
ajb-7	152	20	ii:12	ii:12	PROPN
ajb-7	152	21	(	(	PUNCT
ajb-7	152	22	2	2	NUM
ajb-7	152	23	09	09	NUM
ajb-7	152	24	m	m	NOUN
ajb-7	152	25	g/	g/	NOUN
ajb-7	152	26	dl	dl	INTJ
ajb-7	152	27	)	)	PUNCT
ajb-7	153	1	ii:13	ii:13	PROPN
ajb-7	153	2	(	(	PUNCT
ajb-7	153	3	2	2	NUM
ajb-7	153	4	00	00	NUM
ajb-7	153	5	m	m	NOUN
ajb-7	154	1	g/	g/	NOUN
ajb-7	154	2	dl	dl	INTJ
ajb-7	154	3	)	)	PUNCT
ajb-7	154	4	ii:15	ii:15	PROPN
ajb-7	154	5	(	(	PUNCT
ajb-7	154	6	3	3	NUM
ajb-7	154	7	01	01	NUM
ajb-7	154	8	m	m	NOUN
ajb-7	154	9	g/	g/	NOUN
ajb-7	154	10	dl	dl	INTJ
ajb-7	154	11	)	)	PUNCT
ajb-7	154	12	ii:14	ii:14	PROPN
ajb-7	154	13	(	(	PUNCT
ajb-7	154	14	2	2	NUM
ajb-7	154	15	42	42	NUM
ajb-7	154	16	m	m	NOUN
ajb-7	154	17	g/	g/	NOUN
ajb-7	154	18	dl	dl	INTJ
ajb-7	154	19	)	)	PUNCT
ajb-7	154	20	ii:16	ii:16	PROPN
ajb-7	154	21	(	(	PUNCT
ajb-7	154	22	2	2	NUM
ajb-7	154	23	19	19	NUM
ajb-7	154	24	m	m	NOUN
ajb-7	154	25	g/	g/	NOUN
ajb-7	154	26	dl	dl	INTJ
ajb-7	154	27	)	)	PUNCT
ajb-7	154	28	iii:1	iii:1	PROPN
ajb-7	154	29	(	(	PUNCT
ajb-7	154	30	2	2	NUM
ajb-7	154	31	90	90	NUM
ajb-7	154	32	m	m	NOUN
ajb-7	154	33	g/	g/	NOUN
ajb-7	154	34	dl	dl	INTJ
ajb-7	154	35	)	)	PUNCT
ajb-7	154	36	iii:2	iii:2	ADV
ajb-7	154	37	(	(	PUNCT
ajb-7	154	38	2	2	NUM
ajb-7	154	39	41	41	NUM
ajb-7	154	40	m	m	NOUN
ajb-7	154	41	g/	g/	NOUN
ajb-7	154	42	dl	dl	NOUN
ajb-7	154	43	)	)	PUNCT
ajb-7	154	44	iii:3	iii:3	NOUN
ajb-7	154	45	(	(	PUNCT
ajb-7	154	46	2	2	NUM
ajb-7	154	47	28	28	NUM
ajb-7	154	48	m	m	NOUN
ajb-7	154	49	g/	g/	NOUN
ajb-7	154	50	dl	dl	NOUN
ajb-7	154	51	)	)	PUNCT
ajb-7	154	52	iii:4	iii:4	NOUN
ajb-7	154	53	(	(	PUNCT
ajb-7	154	54	2	2	NUM
ajb-7	154	55	60	60	NUM
ajb-7	154	56	m	m	NOUN
ajb-7	154	57	g/	g/	NOUN
ajb-7	154	58	dl	dl	NOUN
ajb-7	154	59	)	)	PUNCT
ajb-7	154	60	iii:5	iii:5	VERB
ajb-7	154	61	(	(	PUNCT
ajb-7	154	62	2	2	NUM
ajb-7	154	63	18	18	NUM
ajb-7	154	64	m	m	NOUN
ajb-7	154	65	g/	g/	NOUN
ajb-7	154	66	dl	dl	NOUN
ajb-7	154	67	)	)	PUNCT
ajb-7	154	68	iii:6	iii:6	NOUN
ajb-7	154	69	(	(	PUNCT
ajb-7	154	70	2	2	NUM
ajb-7	154	71	39	39	NUM
ajb-7	154	72	m	m	NOUN
ajb-7	154	73	g/	g/	NOUN
ajb-7	154	74	dl	dl	NOUN
ajb-7	154	75	)	)	PUNCT
ajb-7	154	76	iii:7	iii:7	X
ajb-7	154	77	(	(	PUNCT
ajb-7	154	78	2	2	NUM
ajb-7	154	79	11	11	NUM
ajb-7	154	80	m	m	NOUN
ajb-7	154	81	g/	g/	NOUN
ajb-7	154	82	dl	dl	INTJ
ajb-7	154	83	)	)	PUNCT
ajb-7	154	84	iii:9	iii:9	ADP
ajb-7	154	85	(	(	PUNCT
ajb-7	154	86	2	2	NUM
ajb-7	154	87	40	40	NUM
ajb-7	154	88	m	m	NOUN
ajb-7	154	89	g/	g/	NOUN
ajb-7	154	90	dl	dl	PROPN
ajb-7	154	91	)	)	PUNCT
ajb-7	154	92	iii:10	iii:10	NOUN
ajb-7	154	93	(	(	PUNCT
ajb-7	154	94	2	2	NUM
ajb-7	154	95	48	48	NUM
ajb-7	154	96	m	m	NOUN
ajb-7	154	97	g/	g/	NOUN
ajb-7	154	98	dl	dl	NOUN
ajb-7	154	99	)	)	PUNCT
ajb-7	154	100	iii:8	iii:8	NOUN
ajb-7	154	101	(	(	PUNCT
ajb-7	154	102	2	2	NUM
ajb-7	154	103	22	22	NUM
ajb-7	154	104	m	m	NOUN
ajb-7	154	105	g/	g/	NOUN
ajb-7	154	106	dl	dl	PROPN
ajb-7	154	107	)	)	PUNCT
ajb-7	154	108	iii:11	iii:11	PROPN
ajb-7	154	109	(	(	PUNCT
ajb-7	154	110	2	2	NUM
ajb-7	154	111	30	30	NUM
ajb-7	154	112	m	m	NOUN
ajb-7	154	113	g/	g/	NOUN
ajb-7	154	114	dl	dl	PROPN
ajb-7	154	115	)	)	PUNCT
ajb-7	154	116	iii:12	iii:12	X
ajb-7	154	117	(	(	PUNCT
ajb-7	154	118	2	2	NUM
ajb-7	154	119	14	14	NUM
ajb-7	154	120	m	m	NOUN
ajb-7	154	121	g/	g/	NOUN
ajb-7	154	122	dl	dl	PROPN
ajb-7	154	123	)	)	PUNCT
ajb-7	154	124	iii:13	iii:13	VERB
ajb-7	154	125	(	(	PUNCT
ajb-7	154	126	2	2	NUM
ajb-7	154	127	21	21	NUM
ajb-7	154	128	m	m	NOUN
ajb-7	154	129	g/	g/	NOUN
ajb-7	154	130	dl	dl	PROPN
ajb-7	154	131	)	)	PUNCT
ajb-7	154	132	iii:14	iii:14	PROPN
ajb-7	155	1	(	(	PUNCT
ajb-7	155	2	2	2	NUM
ajb-7	155	3	00	00	NUM
ajb-7	155	4	m	m	NOUN
ajb-7	155	5	g/	g/	NOUN
ajb-7	155	6	dl	dl	PROPN
ajb-7	155	7	)	)	PUNCT
ajb-7	155	8	iii:16	iii:16	PROPN
ajb-7	155	9	(	(	PUNCT
ajb-7	155	10	2	2	NUM
ajb-7	155	11	12	12	NUM
ajb-7	155	12	m	m	NOUN
ajb-7	155	13	g/	g/	NOUN
ajb-7	155	14	dl	dl	PROPN
ajb-7	155	15	)	)	PUNCT
ajb-7	155	16	iii:15	iii:15	NOUN
ajb-7	155	17	(	(	PUNCT
ajb-7	155	18	2	2	NUM
ajb-7	155	19	00	00	NUM
ajb-7	155	20	m	m	NOUN
ajb-7	155	21	g/	g/	NOUN
ajb-7	155	22	dl	dl	PROPN
ajb-7	155	23	)	)	PUNCT
ajb-7	155	24	iii:17	iii:17	VERB
ajb-7	155	25	(	(	PUNCT
ajb-7	155	26	2	2	NUM
ajb-7	155	27	14	14	NUM
ajb-7	155	28	m	m	NOUN
ajb-7	155	29	g/	g/	NOUN
ajb-7	155	30	dl	dl	PROPN
ajb-7	155	31	)	)	PUNCT
ajb-7	155	32	iii:18	iii:18	NOUN
ajb-7	156	1	(	(	PUNCT
ajb-7	156	2	2	2	NUM
ajb-7	156	3	20	20	NUM
ajb-7	156	4	m	m	NOUN
ajb-7	156	5	g/	g/	NOUN
ajb-7	156	6	dl	dl	PROPN
ajb-7	156	7	)	)	PUNCT
ajb-7	156	8	iii:19	iii:19	PROPN
ajb-7	156	9	(	(	PUNCT
ajb-7	156	10	2	2	NUM
ajb-7	156	11	58	58	NUM
ajb-7	156	12	m	m	NOUN
ajb-7	156	13	g/	g/	NOUN
ajb-7	156	14	dl	dl	PROPN
ajb-7	156	15	)	)	PUNCT
ajb-7	156	16	iii:20	iii:20	PROPN
ajb-7	157	1	(	(	PUNCT
ajb-7	157	2	2	2	NUM
ajb-7	157	3	40	40	NUM
ajb-7	157	4	m	m	NOUN
ajb-7	157	5	g/	g/	NOUN
ajb-7	157	6	dl	dl	INTJ
ajb-7	157	7	)	)	PUNCT
ajb-7	157	8	iv:3	iv:3	ADJ
ajb-7	157	9	(	(	PUNCT
ajb-7	157	10	2	2	NUM
ajb-7	157	11	00	00	NUM
ajb-7	157	12	m	m	NOUN
ajb-7	157	13	g/	g/	NOUN
ajb-7	157	14	dl	dl	INTJ
ajb-7	157	15	)	)	PUNCT
ajb-7	158	1	iv:1	iv:1	NOUN
ajb-7	158	2	(	(	PUNCT
ajb-7	158	3	2	2	NUM
ajb-7	158	4	12	12	NUM
ajb-7	158	5	m	m	NOUN
ajb-7	158	6	g/	g/	NOUN
ajb-7	158	7	dl	dl	PROPN
ajb-7	158	8	)	)	PUNCT
ajb-7	158	9	iv:2	iv:2	PROPN
ajb-7	158	10	(	(	PUNCT
ajb-7	158	11	2	2	NUM
ajb-7	158	12	16	16	NUM
ajb-7	158	13	m	m	NOUN
ajb-7	158	14	g/	g/	NOUN
ajb-7	158	15	dl	dl	PROPN
ajb-7	158	16	)	)	PUNCT
ajb-7	158	17	iv:5	iv:5	PROPN
ajb-7	158	18	(	(	PUNCT
ajb-7	158	19	1	1	NUM
ajb-7	158	20	96	96	NUM
ajb-7	158	21	m	m	NOUN
ajb-7	158	22	g/	g/	NOUN
ajb-7	158	23	dl	dl	PROPN
ajb-7	158	24	)	)	PUNCT
ajb-7	158	25	iv:4	iv:4	PROPN
ajb-7	158	26	(	(	PUNCT
ajb-7	158	27	2	2	NUM
ajb-7	158	28	09	09	NUM
ajb-7	158	29	m	m	NOUN
ajb-7	158	30	g/	g/	NOUN
ajb-7	158	31	dl	dl	NOUN
ajb-7	158	32	)	)	PUNCT
ajb-7	158	33	figure	figure	NOUN
ajb-7	158	34	1	1	NUM
ajb-7	158	35	.	.	PUNCT
ajb-7	158	36	fig	fig	NOUN
ajb-7	158	37	.	.	PUNCT
ajb-7	159	1	1	1	X
ajb-7	159	2	.	.	X
ajb-7	159	3	pedigree	pedigree	NOUN
ajb-7	159	4	showing	show	VERB
ajb-7	159	5	the	the	DET
ajb-7	159	6	presence	presence	NOUN
ajb-7	159	7	of	of	ADP
ajb-7	159	8	fh	fh	PROPN
ajb-7	159	9	in	in	ADP
ajb-7	159	10	every	every	DET
ajb-7	159	11	generation	generation	NOUN
ajb-7	159	12	of	of	ADP
ajb-7	159	13	the	the	DET
ajb-7	159	14	proband	proband	NOUN
ajb-7	159	15	confirming	confirm	VERB
ajb-7	159	16	the	the	DET
ajb-7	159	17	dominant	dominant	ADJ
ajb-7	159	18	inheritance	inheritance	NOUN
ajb-7	159	19	pattern	pattern	NOUN
ajb-7	159	20	.	.	PUNCT
ajb-7	160	1	the	the	DET
ajb-7	160	2	amount	amount	NOUN
ajb-7	160	3	of	of	ADP
ajb-7	160	4	ldl	ldl	NOUN
ajb-7	160	5	-	-	PUNCT
ajb-7	160	6	c	c	PROPN
ajb-7	160	7	is	be	AUX
ajb-7	160	8	mentioned	mention	VERB
ajb-7	160	9	as	as	ADP
ajb-7	160	10	mg	mg	PROPN
ajb-7	160	11	/	/	SYM
ajb-7	160	12	dl	dl	PROPN
ajb-7	160	13	.	.	PROPN
ajb-7	160	14	37	37	NUM
ajb-7	161	1	kb	kb	PROPN
ajb-7	161	2	m	m	PROPN
ajb-7	161	3	j	j	PROPN
ajb-7	161	4	ou	ou	PROPN
ajb-7	161	5	rn	rn	PROPN
ajb-7	161	6	al	al	PROPN
ajb-7	161	7	o	o	PROPN
ajb-7	162	1	f	f	PROPN
ajb-7	162	2	bi	bi	NOUN
ajb-7	162	3	ol	ol	PROPN
ajb-7	162	4	og	og	PROPN
ajb-7	162	5	y	y	PROPN
ajb-7	162	6	is	be	AUX
ajb-7	162	7	sn	sn	PROPN
ajb-7	162	8	1	1	NUM
ajb-7	162	9	94	94	NUM
ajb-7	162	10	858	858	NUM
ajb-7	162	11	83	83	NUM
ajb-7	162	12	.	.	PUNCT
ajb-7	163	1	p	p	X
ajb-7	163	2	ub	ub	ADJ
ajb-7	163	3	lis	li	NOUN
ajb-7	163	4	he	he	PRON
ajb-7	163	5	d	d	NOUN
ajb-7	163	6	by	by	ADP
ajb-7	163	7	k	k	PROPN
ajb-7	163	8	bm	bm	PROPN
ajb-7	163	9	s	s	PROPN
ajb-7	163	10	ci	ci	PROPN
ajb-7	163	11	en	en	ADP
ajb-7	163	12	tifi	tifi	PROPN
ajb-7	163	13	c	c	AUX
ajb-7	163	14	pu	pu	PROPN
ajb-7	163	15	bl	bl	AUX
ajb-7	163	16	ish	ish	VERB
ajb-7	163	17	in	in	ADP
ajb-7	163	18	g	g	PROPN
ajb-7	163	19	,	,	PUNCT
ajb-7	164	1	l	l	NOUN
ajb-7	164	2	p	p	X
ajb-7	165	1	(	(	PUNCT
ajb-7	165	2	w	w	PROPN
ajb-7	165	3	w	w	PROPN
ajb-7	165	4	w	w	PROPN
ajb-7	165	5	.k	.k	PROPN
ajb-7	165	6	bm	bm	PROPN
ajb-7	166	1	-s	-s	X
ajb-7	166	2	ci	ci	PROPN
ajb-7	166	3	en	en	INTJ
ajb-7	166	4	tifi	tifi	PROPN
ajb-7	166	5	cpu	cpu	NOUN
ajb-7	166	6	bl	bl	AUX
ajb-7	166	7	ish	ish	VERB
ajb-7	166	8	in	in	ADP
ajb-7	166	9	g.	g.	PROPN
ajb-7	166	10	or	or	CCONJ
ajb-7	166	11	g	g	NOUN
ajb-7	166	12	)	)	PUNCT
ajb-7	167	1	kb	kb	PROPN
ajb-7	167	2	m	m	PROPN
ajb-7	167	3	j	j	PROPN
ajb-7	167	4	ou	ou	PROPN
ajb-7	167	5	rn	rn	PROPN
ajb-7	167	6	al	al	PROPN
ajb-7	168	1	o	o	PROPN
ajb-7	169	1	f	f	PROPN
ajb-7	169	2	bi	bi	NOUN
ajb-7	169	3	ol	ol	PROPN
ajb-7	169	4	og	og	PROPN
ajb-7	169	5	y	y	PROPN
ajb-7	169	6	is	be	AUX
ajb-7	169	7	sn	sn	PROPN
ajb-7	169	8	1	1	NUM
ajb-7	169	9	94	94	NUM
ajb-7	169	10	858	858	NUM
ajb-7	169	11	83	83	NUM
ajb-7	169	12	.	.	PUNCT
ajb-7	170	1	p	p	X
ajb-7	170	2	ub	ub	ADJ
ajb-7	170	3	lis	li	NOUN
ajb-7	170	4	he	he	PRON
ajb-7	170	5	d	d	NOUN
ajb-7	170	6	by	by	ADP
ajb-7	170	7	k	k	PROPN
ajb-7	170	8	bm	bm	PROPN
ajb-7	170	9	s	s	PROPN
ajb-7	170	10	ci	ci	PROPN
ajb-7	170	11	en	en	ADP
ajb-7	170	12	tifi	tifi	PROPN
ajb-7	170	13	c	c	AUX
ajb-7	170	14	pu	pu	PROPN
ajb-7	170	15	bl	bl	AUX
ajb-7	170	16	ish	ish	VERB
ajb-7	170	17	in	in	ADP
ajb-7	170	18	g	g	PROPN
ajb-7	170	19	,	,	PUNCT
ajb-7	171	1	l	l	NOUN
ajb-7	171	2	p	p	X
ajb-7	172	1	(	(	PUNCT
ajb-7	172	2	w	w	PROPN
ajb-7	172	3	w	w	PROPN
ajb-7	172	4	w	w	PROPN
ajb-7	172	5	.k	.k	PROPN
ajb-7	172	6	bm	bm	PROPN
ajb-7	173	1	-s	-s	X
ajb-7	173	2	ci	ci	PROPN
ajb-7	173	3	en	en	INTJ
ajb-7	173	4	tifi	tifi	PROPN
ajb-7	173	5	cpu	cpu	NOUN
ajb-7	173	6	bl	bl	AUX
ajb-7	173	7	ish	ish	VERB
ajb-7	173	8	in	in	ADP
ajb-7	173	9	g.	g.	PROPN
ajb-7	173	10	or	or	CCONJ
ajb-7	173	11	g	g	NOUN
ajb-7	173	12	)	)	PUNCT
ajb-7	173	13	discussion	discussion	NOUN
ajb-7	173	14	fh	fh	PROPN
ajb-7	173	15	is	be	AUX
ajb-7	173	16	a	a	DET
ajb-7	173	17	public	public	ADJ
ajb-7	173	18	health	health	NOUN
ajb-7	173	19	problem	problem	NOUN
ajb-7	173	20	throughout	throughout	ADP
ajb-7	173	21	the	the	DET
ajb-7	173	22	world	world	NOUN
ajb-7	173	23	and	and	CCONJ
ajb-7	173	24	many	many	ADJ
ajb-7	173	25	heterozygous	heterozygous	ADJ
ajb-7	173	26	fh	fh	PROPN
ajb-7	173	27	remain	remain	VERB
ajb-7	173	28	undetected	undetected	ADJ
ajb-7	173	29	until	until	ADP
ajb-7	173	30	adulthood	adulthood	NOUN
ajb-7	173	31	.	.	PUNCT
ajb-7	174	1	the	the	DET
ajb-7	174	2	present	present	ADJ
ajb-7	174	3	study	study	NOUN
ajb-7	174	4	was	be	AUX
ajb-7	174	5	conducted	conduct	VERB
ajb-7	174	6	to	to	PART
ajb-7	174	7	study	study	VERB
ajb-7	174	8	the	the	DET
ajb-7	174	9	contribution	contribution	NOUN
ajb-7	174	10	of	of	ADP
ajb-7	174	11	risk	risk	NOUN
ajb-7	174	12	factors	factor	NOUN
ajb-7	174	13	(	(	PUNCT
ajb-7	174	14	age	age	NOUN
ajb-7	174	15	,	,	PUNCT
ajb-7	174	16	sex	sex	NOUN
ajb-7	174	17	,	,	PUNCT
ajb-7	174	18	smoking	smoking	NOUN
ajb-7	174	19	and	and	CCONJ
ajb-7	174	20	hdl	hdl	PROPN
ajb-7	174	21	-	-	PUNCT
ajb-7	174	22	c	c	NOUN
ajb-7	174	23	concentrations	concentration	NOUN
ajb-7	174	24	)	)	PUNCT
ajb-7	174	25	in	in	ADP
ajb-7	174	26	the	the	DET
ajb-7	174	27	phenotypic	phenotypic	ADJ
ajb-7	174	28	expression	expression	NOUN
ajb-7	174	29	of	of	ADP
ajb-7	174	30	heterozygous	heterozygous	ADJ
ajb-7	174	31	fh	fh	PROPN
ajb-7	174	32	in	in	ADP
ajb-7	174	33	a	a	DET
ajb-7	174	34	pakistani	pakistani	ADJ
ajb-7	174	35	population	population	NOUN
ajb-7	174	36	.	.	PUNCT
ajb-7	175	1	fh	fh	PROPN
ajb-7	175	2	may	may	AUX
ajb-7	175	3	also	also	ADV
ajb-7	175	4	cause	cause	VERB
ajb-7	175	5	premature	premature	ADJ
ajb-7	175	6	coronary	coronary	ADJ
ajb-7	175	7	artery	artery	NOUN
ajb-7	175	8	disease	disease	NOUN
ajb-7	175	9	and	and	CCONJ
ajb-7	175	10	atherosclerotic	atherosclerotic	ADJ
ajb-7	175	11	plaque	plaque	NOUN
ajb-7	175	12	formation	formation	NOUN
ajb-7	175	13	and	and	CCONJ
ajb-7	175	14	is	be	AUX
ajb-7	175	15	considered	consider	VERB
ajb-7	175	16	as	as	ADP
ajb-7	175	17	one	one	NUM
ajb-7	175	18	of	of	ADP
ajb-7	175	19	the	the	DET
ajb-7	175	20	first	first	ADJ
ajb-7	175	21	inherited	inherit	VERB
ajb-7	175	22	disorders	disorder	NOUN
ajb-7	175	23	as	as	ADP
ajb-7	175	24	being	be	AUX
ajb-7	175	25	a	a	DET
ajb-7	175	26	cause	cause	NOUN
ajb-7	175	27	of	of	ADP
ajb-7	175	28	myocardial	myocardial	ADJ
ajb-7	175	29	infarction	infarction	NOUN
ajb-7	175	30	(	(	PUNCT
ajb-7	175	31	heart	heart	NOUN
ajb-7	175	32	attack	attack	NOUN
ajb-7	175	33	)	)	PUNCT
ajb-7	175	34	.	.	PUNCT
ajb-7	176	1	in	in	ADP
ajb-7	176	2	the	the	DET
ajb-7	176	3	present	present	ADJ
ajb-7	176	4	study	study	NOUN
ajb-7	176	5	,	,	PUNCT
ajb-7	176	6	out	out	ADP
ajb-7	176	7	of	of	ADP
ajb-7	176	8	a	a	DET
ajb-7	176	9	total	total	NOUN
ajb-7	176	10	of	of	ADP
ajb-7	176	11	1523	1523	NUM
ajb-7	176	12	unrelated	unrelated	ADJ
ajb-7	176	13	patients	patient	NOUN
ajb-7	176	14	with	with	ADP
ajb-7	176	15	the	the	DET
ajb-7	176	16	clinical	clinical	ADJ
ajb-7	176	17	diagnosis	diagnosis	NOUN
ajb-7	176	18	of	of	ADP
ajb-7	176	19	heterozygous	heterozygous	ADJ
ajb-7	176	20	fh	fh	PROPN
ajb-7	176	21	,	,	PUNCT
ajb-7	176	22	only	only	ADV
ajb-7	176	23	335	335	NUM
ajb-7	176	24	individuals	individual	NOUN
ajb-7	176	25	diagnosed	diagnose	VERB
ajb-7	176	26	with	with	ADP
ajb-7	176	27	fh	fh	PROPN
ajb-7	176	28	belonged	belong	VERB
ajb-7	176	29	to	to	ADP
ajb-7	176	30	five	five	NUM
ajb-7	176	31	probands	proband	NOUN
ajb-7	176	32	(	(	PUNCT
ajb-7	176	33	202	202	NUM
ajb-7	176	34	males	male	NOUN
ajb-7	176	35	and	and	CCONJ
ajb-7	176	36	133	133	NUM
ajb-7	176	37	females	female	NOUN
ajb-7	176	38	)	)	PUNCT
ajb-7	176	39	.	.	PUNCT
ajb-7	177	1	similar	similar	ADJ
ajb-7	177	2	criteria	criterion	NOUN
ajb-7	177	3	have	have	AUX
ajb-7	177	4	previously	previously	ADV
ajb-7	177	5	been	be	AUX
ajb-7	177	6	used	use	VERB
ajb-7	177	7	to	to	PART
ajb-7	177	8	identify	identify	VERB
ajb-7	177	9	patients	patient	NOUN
ajb-7	177	10	with	with	ADP
ajb-7	177	11	fh	fh	PROPN
ajb-7	177	12	based	base	VERB
ajb-7	177	13	on	on	ADP
ajb-7	177	14	high	high	ADJ
ajb-7	177	15	plasma	plasma	NOUN
ajb-7	177	16	levels	level	NOUN
ajb-7	177	17	of	of	ADP
ajb-7	177	18	total	total	ADJ
ajb-7	177	19	and	and	CCONJ
ajb-7	177	20	ldl	ldl	NOUN
ajb-7	177	21	cholesterol	cholesterol	NOUN
ajb-7	177	22	,	,	PUNCT
ajb-7	177	23	family	family	NOUN
ajb-7	177	24	history	history	NOUN
ajb-7	177	25	of	of	ADP
ajb-7	177	26	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	177	27	,	,	PUNCT
ajb-7	177	28	tendon	tendon	NOUN
ajb-7	177	29	xanthomas	xanthomas	PROPN
ajb-7	177	30	or	or	CCONJ
ajb-7	177	31	corneal	corneal	ADJ
ajb-7	177	32	arcus	arcus	NOUN
ajb-7	177	33	,	,	PUNCT
ajb-7	177	34	and	and	CCONJ
ajb-7	177	35	personal	personal	ADJ
ajb-7	177	36	and	and	CCONJ
ajb-7	177	37	family	family	NOUN
ajb-7	177	38	history	history	NOUN
ajb-7	177	39	of	of	ADP
ajb-7	177	40	premature	premature	PROPN
ajb-7	177	41	chd	chd	PROPN
ajb-7	177	42	(	(	PUNCT
ajb-7	177	43	goldstein	goldstein	PROPN
ajb-7	177	44	et	et	PROPN
ajb-7	177	45	al	al	PROPN
ajb-7	177	46	.	.	PROPN
ajb-7	177	47	,	,	PUNCT
ajb-7	177	48	2001	2001	NUM
ajb-7	177	49	)	)	PUNCT
ajb-7	177	50	.	.	PUNCT
ajb-7	178	1	the	the	DET
ajb-7	178	2	fh	fh	PROPN
ajb-7	178	3	patients	patient	NOUN
ajb-7	178	4	have	have	VERB
ajb-7	178	5	ldl	ldl	NOUN
ajb-7	178	6	-	-	PUNCT
ajb-7	178	7	c	c	NOUN
ajb-7	178	8	levels	level	NOUN
ajb-7	178	9	almost	almost	ADV
ajb-7	178	10	twice	twice	ADV
ajb-7	178	11	than	than	ADP
ajb-7	178	12	the	the	DET
ajb-7	178	13	normal	normal	ADJ
ajb-7	178	14	population	population	NOUN
ajb-7	178	15	(	(	PUNCT
ajb-7	178	16	190	190	NUM
ajb-7	178	17	to	to	PART
ajb-7	178	18	400	400	NUM
ajb-7	178	19	mg	mg	NOUN
ajb-7	178	20	dl-1	dl-1	NOUN
ajb-7	178	21	)	)	PUNCT
ajb-7	178	22	.	.	PUNCT
ajb-7	179	1	the	the	DET
ajb-7	179	2	clinical	clinical	ADJ
ajb-7	179	3	examination	examination	NOUN
ajb-7	179	4	of	of	ADP
ajb-7	179	5	the	the	DET
ajb-7	179	6	335	335	NUM
ajb-7	179	7	individuals	individual	NOUN
ajb-7	179	8	with	with	ADP
ajb-7	179	9	fh	fh	PROPN
ajb-7	179	10	showed	show	VERB
ajb-7	179	11	that	that	SCONJ
ajb-7	179	12	72	72	NUM
ajb-7	179	13	%	%	NOUN
ajb-7	179	14	males	male	NOUN
ajb-7	179	15	and	and	CCONJ
ajb-7	179	16	58	58	NUM
ajb-7	179	17	%	%	NOUN
ajb-7	179	18	females	female	NOUN
ajb-7	179	19	had	have	VERB
ajb-7	179	20	tx	tx	NOUN
ajb-7	179	21	at	at	ADP
ajb-7	179	22	ages	age	NOUN
ajb-7	179	23	between	between	ADP
ajb-7	179	24	30	30	NUM
ajb-7	179	25	-	-	SYM
ajb-7	179	26	40	40	NUM
ajb-7	179	27	years	year	NOUN
ajb-7	179	28	.	.	PUNCT
ajb-7	180	1	xanthelesma	xanthelesma	PROPN
ajb-7	180	2	was	be	AUX
ajb-7	180	3	found	find	VERB
ajb-7	180	4	in	in	ADP
ajb-7	180	5	80	80	NUM
ajb-7	180	6	%	%	NOUN
ajb-7	180	7	males	male	NOUN
ajb-7	180	8	(	(	PUNCT
ajb-7	180	9	aged	aged	ADJ
ajb-7	180	10	40	40	NUM
ajb-7	180	11	-	-	SYM
ajb-7	180	12	50	50	NUM
ajb-7	180	13	)	)	PUNCT
ajb-7	180	14	and	and	CCONJ
ajb-7	180	15	in	in	ADP
ajb-7	180	16	82	82	NUM
ajb-7	180	17	%	%	NOUN
ajb-7	180	18	females	female	NOUN
ajb-7	180	19	(	(	PUNCT
ajb-7	180	20	aged	aged	ADJ
ajb-7	180	21	30	30	NUM
ajb-7	180	22	-	-	SYM
ajb-7	180	23	40	40	NUM
ajb-7	180	24	)	)	PUNCT
ajb-7	180	25	.	.	PUNCT
ajb-7	181	1	the	the	DET
ajb-7	181	2	ac	ac	PROPN
ajb-7	181	3	was	be	AUX
ajb-7	181	4	observed	observe	VERB
ajb-7	181	5	in	in	ADP
ajb-7	181	6	63	63	NUM
ajb-7	181	7	%	%	NOUN
ajb-7	181	8	males	male	NOUN
ajb-7	181	9	(	(	PUNCT
ajb-7	181	10	aged	aged	ADJ
ajb-7	181	11	40	40	NUM
ajb-7	181	12	-	-	SYM
ajb-7	181	13	50	50	NUM
ajb-7	181	14	)	)	PUNCT
ajb-7	181	15	and	and	CCONJ
ajb-7	181	16	72	72	NUM
ajb-7	181	17	%	%	NOUN
ajb-7	181	18	females	female	NOUN
ajb-7	181	19	(	(	PUNCT
ajb-7	181	20	aged	aged	ADJ
ajb-7	181	21	30	30	NUM
ajb-7	181	22	-	-	SYM
ajb-7	181	23	40	40	NUM
ajb-7	181	24	)	)	PUNCT
ajb-7	181	25	.	.	PUNCT
ajb-7	182	1	a	a	DET
ajb-7	182	2	very	very	ADV
ajb-7	182	3	few	few	ADJ
ajb-7	182	4	individuals	individual	NOUN
ajb-7	182	5	(	(	PUNCT
ajb-7	182	6	2	2	NUM
ajb-7	182	7	%	%	NOUN
ajb-7	182	8	i.e.	i.e.	X
ajb-7	182	9	7	7	NUM
ajb-7	182	10	individuals	individual	NOUN
ajb-7	182	11	)	)	PUNCT
ajb-7	182	12	showed	show	VERB
ajb-7	182	13	polyartheritis	polyartheritis	ADJ
ajb-7	182	14	symptoms	symptom	NOUN
ajb-7	182	15	among	among	ADP
ajb-7	182	16	them	they	PRON
ajb-7	182	17	were	be	AUX
ajb-7	182	18	only	only	ADV
ajb-7	182	19	2	2	NUM
ajb-7	182	20	males	male	NOUN
ajb-7	182	21	(	(	PUNCT
ajb-7	182	22	0.9	0.9	NUM
ajb-7	182	23	%	%	NOUN
ajb-7	182	24	)	)	PUNCT
ajb-7	182	25	aged	aged	ADJ
ajb-7	182	26	40	40	NUM
ajb-7	182	27	-	-	SYM
ajb-7	182	28	50	50	NUM
ajb-7	182	29	;	;	PUNCT
ajb-7	182	30	while	while	SCONJ
ajb-7	182	31	5	5	NUM
ajb-7	182	32	females	female	NOUN
ajb-7	182	33	(	(	PUNCT
ajb-7	182	34	3.7	3.7	NUM
ajb-7	182	35	%	%	NOUN
ajb-7	182	36	)	)	PUNCT
ajb-7	182	37	showed	show	VERB
ajb-7	182	38	the	the	DET
ajb-7	182	39	disease	disease	NOUN
ajb-7	182	40	symptoms	symptom	NOUN
ajb-7	182	41	.	.	PUNCT
ajb-7	183	1	the	the	DET
ajb-7	183	2	tx	tx	PROPN
ajb-7	183	3	is	be	AUX
ajb-7	183	4	pathognomonic	pathognomonic	ADJ
ajb-7	183	5	of	of	ADP
ajb-7	183	6	fh	fh	PROPN
ajb-7	183	7	but	but	CCONJ
ajb-7	183	8	its	its	PRON
ajb-7	183	9	identification	identification	NOUN
ajb-7	183	10	is	be	AUX
ajb-7	183	11	not	not	PART
ajb-7	183	12	always	always	ADV
ajb-7	183	13	straightforward	straightforward	ADJ
ajb-7	183	14	and	and	CCONJ
ajb-7	183	15	to	to	ADP
ajb-7	183	16	some	some	DET
ajb-7	183	17	extent	extent	NOUN
ajb-7	183	18	considered	consider	VERB
ajb-7	183	19	insensitive	insensitive	ADJ
ajb-7	183	20	diagnostic	diagnostic	ADJ
ajb-7	183	21	markers	marker	NOUN
ajb-7	183	22	.	.	PUNCT
ajb-7	184	1	however	however	ADV
ajb-7	184	2	,	,	PUNCT
ajb-7	184	3	other	other	ADJ
ajb-7	184	4	criteria	criterion	NOUN
ajb-7	184	5	should	should	AUX
ajb-7	184	6	be	be	AUX
ajb-7	184	7	taken	take	VERB
ajb-7	184	8	into	into	ADP
ajb-7	184	9	consideration	consideration	NOUN
ajb-7	184	10	for	for	ADP
ajb-7	184	11	the	the	DET
ajb-7	184	12	diagnosis	diagnosis	NOUN
ajb-7	184	13	of	of	ADP
ajb-7	184	14	fh	fh	PROPN
ajb-7	184	15	including	include	VERB
ajb-7	184	16	personal	personal	ADJ
ajb-7	184	17	and	and	CCONJ
ajb-7	184	18	familial	familial	ADJ
ajb-7	184	19	ldl	ldl	NOUN
ajb-7	184	20	-	-	PUNCT
ajb-7	184	21	c	c	NOUN
ajb-7	184	22	levels	level	NOUN
ajb-7	184	23	,	,	PUNCT
ajb-7	184	24	history	history	NOUN
ajb-7	184	25	of	of	ADP
ajb-7	184	26	chd	chd	NOUN
ajb-7	184	27	,	,	PUNCT
ajb-7	184	28	and	and	CCONJ
ajb-7	184	29	presence	presence	NOUN
ajb-7	184	30	of	of	ADP
ajb-7	184	31	ca	ca	NOUN
ajb-7	184	32	before	before	ADP
ajb-7	184	33	the	the	DET
ajb-7	184	34	age	age	NOUN
ajb-7	184	35	of	of	ADP
ajb-7	184	36	45	45	NUM
ajb-7	184	37	years	year	NOUN
ajb-7	184	38	and	and	CCONJ
ajb-7	184	39	xanthomas	xanthomas	PROPN
ajb-7	184	40	(	(	PUNCT
ajb-7	184	41	fernando	fernando	PROPN
ajb-7	184	42	,	,	PUNCT
ajb-7	184	43	2004	2004	NUM
ajb-7	184	44	)	)	PUNCT
ajb-7	184	45	.	.	PUNCT
ajb-7	185	1	overall	overall	ADV
ajb-7	185	2	,	,	PUNCT
ajb-7	185	3	the	the	DET
ajb-7	185	4	incidence	incidence	NOUN
ajb-7	185	5	of	of	ADP
ajb-7	185	6	xanthoma	xanthoma	PROPN
ajb-7	185	7	(	(	PUNCT
ajb-7	185	8	i.e.	i.e.	X
ajb-7	185	9	tendinous	tendinous	ADJ
ajb-7	185	10	xanthomata	xanthomata	PROPN
ajb-7	185	11	and	and	CCONJ
ajb-7	185	12	xanthelesma	xanthelesma	NOUN
ajb-7	185	13	)	)	PUNCT
ajb-7	185	14	in	in	ADP
ajb-7	185	15	the	the	DET
ajb-7	185	16	present	present	ADJ
ajb-7	185	17	study	study	NOUN
ajb-7	185	18	was	be	AUX
ajb-7	185	19	quite	quite	ADV
ajb-7	185	20	high	high	ADJ
ajb-7	185	21	i.e.	i.e.	X
ajb-7	185	22	7	7	NUM
ajb-7	185	23	out	out	ADP
ajb-7	185	24	of	of	ADP
ajb-7	185	25	10	10	NUM
ajb-7	185	26	(	(	PUNCT
ajb-7	185	27	70	70	NUM
ajb-7	185	28	%	%	NOUN
ajb-7	185	29	)	)	PUNCT
ajb-7	185	30	cases	case	NOUN
ajb-7	185	31	with	with	ADP
ajb-7	185	32	fh	fh	PROPN
ajb-7	185	33	had	have	AUX
ajb-7	185	34	it	it	PRON
ajb-7	185	35	.	.	PUNCT
ajb-7	186	1	recently	recently	ADV
ajb-7	186	2	,	,	PUNCT
ajb-7	186	3	junyent	junyent	PROPN
ajb-7	186	4	et	et	PROPN
ajb-7	186	5	al	al	PROPN
ajb-7	186	6	.	.	PROPN
ajb-7	187	1	(	(	PUNCT
ajb-7	187	2	2005	2005	NUM
ajb-7	187	3	)	)	PUNCT
ajb-7	187	4	has	have	AUX
ajb-7	187	5	reported	report	VERB
ajb-7	187	6	that	that	SCONJ
ajb-7	187	7	the	the	DET
ajb-7	187	8	occurrence	occurrence	NOUN
ajb-7	187	9	of	of	ADP
ajb-7	187	10	tx	tx	PROPN
ajb-7	187	11	is	be	AUX
ajb-7	187	12	very	very	ADV
ajb-7	187	13	much	much	ADV
ajb-7	187	14	linked	link	VERB
ajb-7	187	15	to	to	ADP
ajb-7	187	16	the	the	DET
ajb-7	187	17	fh	fh	PROPN
ajb-7	187	18	incidences	incidence	NOUN
ajb-7	187	19	in	in	ADP
ajb-7	187	20	individuals	individual	NOUN
ajb-7	187	21	with	with	ADP
ajb-7	187	22	family	family	NOUN
ajb-7	187	23	history	history	NOUN
ajb-7	187	24	of	of	ADP
ajb-7	187	25	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	187	26	,	,	PUNCT
ajb-7	187	27	primary	primary	ADJ
ajb-7	187	28	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	187	29	and	and	CCONJ
ajb-7	187	30	premature	premature	ADJ
ajb-7	187	31	coronary	coronary	ADJ
ajb-7	187	32	disease	disease	NOUN
ajb-7	187	33	.	.	PUNCT
ajb-7	188	1	although	although	SCONJ
ajb-7	188	2	tx	tx	PROPN
ajb-7	188	3	is	be	AUX
ajb-7	188	4	pathognomonic	pathognomonic	ADJ
ajb-7	188	5	of	of	ADP
ajb-7	188	6	fh	fh	PROPN
ajb-7	188	7	but	but	CCONJ
ajb-7	188	8	a	a	DET
ajb-7	188	9	high	high	ADJ
ajb-7	188	10	variability	variability	NOUN
ajb-7	188	11	of	of	ADP
ajb-7	188	12	xanthoma	xanthoma	NOUN
ajb-7	188	13	may	may	AUX
ajb-7	188	14	occur	occur	VERB
ajb-7	188	15	in	in	ADP
ajb-7	188	16	fh	fh	PROPN
ajb-7	188	17	patients	patient	NOUN
ajb-7	188	18	(	(	PUNCT
ajb-7	188	19	descamps	descamp	NOUN
ajb-7	188	20	et	et	PROPN
ajb-7	188	21	al	al	PROPN
ajb-7	188	22	.	.	PROPN
ajb-7	188	23	,	,	PUNCT
ajb-7	188	24	2001	2001	NUM
ajb-7	188	25	)	)	PUNCT
ajb-7	188	26	.	.	PUNCT
ajb-7	189	1	xanthelasmas	xanthelasmas	PROPN
ajb-7	189	2	occur	occur	VERB
ajb-7	189	3	commonly	commonly	ADV
ajb-7	189	4	in	in	ADP
ajb-7	189	5	heterozygotes	heterozygote	NOUN
ajb-7	189	6	,	,	PUNCT
ajb-7	189	7	and	and	CCONJ
ajb-7	189	8	are	be	AUX
ajb-7	189	9	rare	rare	ADJ
ajb-7	189	10	in	in	ADP
ajb-7	189	11	homozygotes	homozygote	NOUN
ajb-7	189	12	.	.	PUNCT
ajb-7	190	1	the	the	DET
ajb-7	190	2	presence	presence	NOUN
ajb-7	190	3	of	of	ADP
ajb-7	190	4	xanthelasmas	xanthelasmas	PROPN
ajb-7	190	5	is	be	AUX
ajb-7	190	6	not	not	PART
ajb-7	190	7	specific	specific	ADJ
ajb-7	190	8	for	for	ADP
ajb-7	190	9	fh	fh	PROPN
ajb-7	190	10	and	and	CCONJ
ajb-7	190	11	may	may	AUX
ajb-7	190	12	also	also	ADV
ajb-7	190	13	occur	occur	VERB
ajb-7	190	14	in	in	ADP
ajb-7	190	15	individuals	individual	NOUN
ajb-7	190	16	with	with	ADP
ajb-7	190	17	normal	normal	ADJ
ajb-7	190	18	lipid	lipid	NOUN
ajb-7	190	19	levels	level	NOUN
ajb-7	190	20	(	(	PUNCT
ajb-7	190	21	goldstein	goldstein	PROPN
ajb-7	190	22	et	et	PROPN
ajb-7	190	23	al	al	PROPN
ajb-7	190	24	.	.	PROPN
ajb-7	190	25	,	,	PUNCT
ajb-7	190	26	2001	2001	NUM
ajb-7	190	27	)	)	PUNCT
ajb-7	190	28	.	.	PUNCT
ajb-7	191	1	the	the	DET
ajb-7	191	2	frequency	frequency	NOUN
ajb-7	191	3	of	of	ADP
ajb-7	191	4	fh	fh	PROPN
ajb-7	191	5	among	among	ADP
ajb-7	191	6	caucasians	caucasian	NOUN
ajb-7	191	7	is	be	AUX
ajb-7	191	8	1:500	1:500	NUM
ajb-7	191	9	,	,	PUNCT
ajb-7	191	10	however	however	ADV
ajb-7	191	11	in	in	ADP
ajb-7	191	12	some	some	DET
ajb-7	191	13	populations	population	NOUN
ajb-7	191	14	there	there	PRON
ajb-7	191	15	is	be	VERB
ajb-7	191	16	high	high	ADJ
ajb-7	191	17	heterozygous	heterozygous	ADJ
ajb-7	191	18	fh	fh	PROPN
ajb-7	191	19	frequency	frequency	NOUN
ajb-7	191	20	such	such	ADJ
ajb-7	191	21	as	as	ADP
ajb-7	191	22	french	french	ADJ
ajb-7	191	23	canadians	canadian	NOUN
ajb-7	191	24	,	,	PUNCT
ajb-7	191	25	lebanese	lebanese	ADJ
ajb-7	191	26	christians	christians	PROPN
ajb-7	191	27	,	,	PUNCT
ajb-7	191	28	south	south	ADJ
ajb-7	191	29	african	african	ADJ
ajb-7	191	30	afrikaners	afrikaner	NOUN
ajb-7	191	31	,	,	PUNCT
ajb-7	191	32	lithuanian	lithuanian	NOUN
ajb-7	191	33	ashkenzai	ashkenzai	ADJ
ajb-7	191	34	jews	jews	PROPN
ajb-7	191	35	,	,	PUNCT
ajb-7	191	36	druze	druze	NOUN
ajb-7	191	37	and	and	CCONJ
ajb-7	191	38	finns	finns	PROPN
ajb-7	191	39	(	(	PUNCT
ajb-7	191	40	lehrman	lehrman	NOUN
ajb-7	191	41	et	et	PROPN
ajb-7	191	42	al	al	PROPN
ajb-7	191	43	.	.	PROPN
ajb-7	191	44	,	,	PUNCT
ajb-7	191	45	1987	1987	NUM
ajb-7	191	46	;	;	PUNCT
ajb-7	191	47	kotze	kotze	PROPN
ajb-7	191	48	et	et	PROPN
ajb-7	191	49	al	al	PROPN
ajb-7	191	50	.	.	PROPN
ajb-7	191	51	,	,	PUNCT
ajb-7	191	52	1991	1991	NUM
ajb-7	191	53	;	;	PUNCT
ajb-7	191	54	meiner	meiner	NOUN
ajb-7	191	55	et	et	PROPN
ajb-7	191	56	al	al	PROPN
ajb-7	191	57	.	.	PROPN
ajb-7	191	58	,	,	PUNCT
ajb-7	191	59	1991	1991	NUM
ajb-7	191	60	;	;	PUNCT
ajb-7	191	61	leitersdorf	leitersdorf	PROPN
ajb-7	191	62	et	et	PROPN
ajb-7	191	63	al	al	PROPN
ajb-7	191	64	.	.	PROPN
ajb-7	191	65	,1990	,1990	PROPN
ajb-7	191	66	;	;	PUNCT
ajb-7	191	67	landsberger	landsberger	PROPN
ajb-7	191	68	et	et	PROPN
ajb-7	191	69	al	al	PROPN
ajb-7	191	70	.	.	PROPN
ajb-7	191	71	,	,	PUNCT
ajb-7	191	72	1992	1992	NUM
ajb-7	191	73	;	;	PUNCT
ajb-7	191	74	koivisto	koivisto	PROPN
ajb-7	191	75	et	et	PROPN
ajb-7	191	76	al	al	PROPN
ajb-7	191	77	.	.	PROPN
ajb-7	191	78	,1992	,1992	PROPN
ajb-7	191	79	)	)	PUNCT
ajb-7	191	80	.	.	PUNCT
ajb-7	192	1	the	the	DET
ajb-7	192	2	heterozygote	heterozygote	PROPN
ajb-7	192	3	fh	fh	PROPN
ajb-7	192	4	individuals	individual	NOUN
ajb-7	192	5	have	have	VERB
ajb-7	192	6	about	about	ADV
ajb-7	192	7	two	two	NUM
ajb-7	192	8	fold	fold	ADJ
ajb-7	192	9	increase	increase	NOUN
ajb-7	192	10	in	in	ADP
ajb-7	192	11	their	their	PRON
ajb-7	192	12	plasma	plasma	NOUN
ajb-7	192	13	cholesterol	cholesterol	NOUN
ajb-7	192	14	.	.	PUNCT
ajb-7	193	1	the	the	DET
ajb-7	193	2	fh	fh	PROPN
ajb-7	193	3	subjects	subject	NOUN
ajb-7	193	4	show	show	VERB
ajb-7	193	5	4	4	NUM
ajb-7	193	6	-	-	SYM
ajb-7	193	7	5	5	NUM
ajb-7	193	8	time	time	NOUN
ajb-7	193	9	higher	high	ADJ
ajb-7	193	10	age	age	NOUN
ajb-7	193	11	-	-	PUNCT
ajb-7	193	12	sex	sex	NOUN
ajb-7	193	13	standardized	standardized	ADJ
ajb-7	193	14	mortality	mortality	NOUN
ajb-7	193	15	ratios	ratio	NOUN
ajb-7	193	16	in	in	ADP
ajb-7	193	17	the	the	DET
ajb-7	193	18	general	general	ADJ
ajb-7	193	19	populations	population	NOUN
ajb-7	193	20	(	(	PUNCT
ajb-7	193	21	castro	castro	NOUN
ajb-7	193	22	-	-	PUNCT
ajb-7	193	23	orós	orós	ADV
ajb-7	193	24	et	et	PROPN
ajb-7	193	25	al	al	PROPN
ajb-7	193	26	.	.	PROPN
ajb-7	193	27	,	,	PUNCT
ajb-7	193	28	2010	2010	NUM
ajb-7	193	29	)	)	PUNCT
ajb-7	193	30	.	.	PUNCT
ajb-7	194	1	the	the	DET
ajb-7	194	2	mean	mean	ADJ
ajb-7	194	3	age	age	NOUN
ajb-7	194	4	of	of	ADP
ajb-7	194	5	males	male	NOUN
ajb-7	194	6	that	that	PRON
ajb-7	194	7	showed	show	VERB
ajb-7	194	8	the	the	DET
ajb-7	194	9	symptoms	symptom	NOUN
ajb-7	194	10	of	of	ADP
ajb-7	194	11	fh	fh	PROPN
ajb-7	194	12	in	in	ADP
ajb-7	194	13	the	the	DET
ajb-7	194	14	present	present	ADJ
ajb-7	194	15	study	study	NOUN
ajb-7	194	16	was	be	AUX
ajb-7	194	17	38	38	NUM
ajb-7	194	18	years	year	NOUN
ajb-7	194	19	,	,	PUNCT
ajb-7	194	20	compared	compare	VERB
ajb-7	194	21	to	to	ADP
ajb-7	194	22	45	45	NUM
ajb-7	194	23	years	year	NOUN
ajb-7	194	24	in	in	ADP
ajb-7	194	25	females	female	NOUN
ajb-7	194	26	.	.	PUNCT
ajb-7	195	1	the	the	DET
ajb-7	195	2	incidence	incidence	NOUN
ajb-7	195	3	rate	rate	NOUN
ajb-7	195	4	in	in	ADP
ajb-7	195	5	the	the	DET
ajb-7	195	6	observed	observe	VERB
ajb-7	195	7	males	male	NOUN
ajb-7	195	8	was	be	AUX
ajb-7	195	9	69	69	NUM
ajb-7	195	10	%	%	NOUN
ajb-7	195	11	compared	compare	VERB
ajb-7	195	12	to	to	ADP
ajb-7	195	13	31	31	NUM
ajb-7	195	14	%	%	NOUN
ajb-7	195	15	in	in	ADP
ajb-7	195	16	females	female	NOUN
ajb-7	195	17	.	.	PUNCT
ajb-7	196	1	similar	similar	ADJ
ajb-7	196	2	results	result	NOUN
ajb-7	196	3	have	have	AUX
ajb-7	196	4	previously	previously	ADV
ajb-7	196	5	been	be	AUX
ajb-7	196	6	reported	report	VERB
ajb-7	196	7	where	where	SCONJ
ajb-7	196	8	the	the	DET
ajb-7	196	9	observed	observed	ADJ
ajb-7	196	10	age	age	NOUN
ajb-7	196	11	was	be	AUX
ajb-7	196	12	strongly	strongly	ADV
ajb-7	196	13	associated	associate	VERB
ajb-7	196	14	with	with	ADP
ajb-7	196	15	high	high	ADJ
ajb-7	196	16	cholesterol	cholesterol	NOUN
ajb-7	196	17	levels	level	NOUN
ajb-7	196	18	in	in	ADP
ajb-7	196	19	men	man	NOUN
ajb-7	196	20	,	,	PUNCT
ajb-7	196	21	whereas	whereas	SCONJ
ajb-7	196	22	women	woman	NOUN
ajb-7	196	23	had	have	VERB
ajb-7	196	24	significantly	significantly	ADV
ajb-7	196	25	lower	low	ADJ
ajb-7	196	26	non	non	ADJ
ajb-7	196	27	-	-	ADJ
ajb-7	196	28	hdl	hdl	ADJ
ajb-7	196	29	-	-	PUNCT
ajb-7	196	30	c	c	NOUN
ajb-7	196	31	level	level	NOUN
ajb-7	196	32	(	(	PUNCT
ajb-7	196	33	gardner	gardner	NOUN
ajb-7	196	34	et	et	PROPN
ajb-7	196	35	al	al	PROPN
ajb-7	196	36	.	.	PROPN
ajb-7	196	37	,	,	PUNCT
ajb-7	196	38	2000	2000	NUM
ajb-7	196	39	)	)	PUNCT
ajb-7	196	40	.	.	PUNCT
ajb-7	197	1	for	for	ADP
ajb-7	197	2	women	woman	NOUN
ajb-7	197	3	,	,	PUNCT
ajb-7	197	4	the	the	DET
ajb-7	197	5	age	age	NOUN
ajb-7	197	6	range	range	NOUN
ajb-7	197	7	was	be	AUX
ajb-7	197	8	25	25	NUM
ajb-7	197	9	to	to	PART
ajb-7	197	10	64	64	NUM
ajb-7	197	11	years	year	NOUN
ajb-7	197	12	,	,	PUNCT
ajb-7	197	13	whereas	whereas	SCONJ
ajb-7	197	14	for	for	ADP
ajb-7	197	15	men	man	NOUN
ajb-7	197	16	it	it	PRON
ajb-7	197	17	ranged	range	VERB
ajb-7	197	18	from	from	ADP
ajb-7	197	19	25	25	NUM
ajb-7	197	20	to	to	PART
ajb-7	197	21	54	54	NUM
ajb-7	197	22	years	year	NOUN
ajb-7	197	23	.	.	PUNCT
ajb-7	198	1	non	non	ADJ
ajb-7	198	2	-	-	ADJ
ajb-7	198	3	hdl	hdl	ADJ
ajb-7	198	4	concentration	concentration	NOUN
ajb-7	198	5	was	be	AUX
ajb-7	198	6	higher	high	ADJ
ajb-7	198	7	in	in	ADP
ajb-7	198	8	individuals	individual	NOUN
ajb-7	198	9	with	with	ADP
ajb-7	198	10	increasing	increase	VERB
ajb-7	198	11	age	age	NOUN
ajb-7	198	12	.	.	PUNCT
ajb-7	199	1	however	however	ADV
ajb-7	199	2	,	,	PUNCT
ajb-7	199	3	this	this	DET
ajb-7	199	4	observation	observation	NOUN
ajb-7	199	5	seemed	seem	VERB
ajb-7	199	6	to	to	PART
ajb-7	199	7	be	be	AUX
ajb-7	199	8	not	not	PART
ajb-7	199	9	influenced	influence	VERB
ajb-7	199	10	by	by	ADP
ajb-7	199	11	age	age	NOUN
ajb-7	199	12	as	as	SCONJ
ajb-7	199	13	the	the	DET
ajb-7	199	14	total	total	ADJ
ajb-7	199	15	cholesterol	cholesterol	NOUN
ajb-7	199	16	levels	level	NOUN
ajb-7	199	17	were	be	AUX
ajb-7	199	18	found	find	VERB
ajb-7	199	19	to	to	PART
ajb-7	199	20	be	be	AUX
ajb-7	199	21	higher	high	ADJ
ajb-7	199	22	in	in	ADP
ajb-7	199	23	all	all	DET
ajb-7	199	24	age	age	NOUN
ajb-7	199	25	groups	group	NOUN
ajb-7	199	26	.	.	PUNCT
ajb-7	200	1	the	the	DET
ajb-7	200	2	mean	mean	ADJ
ajb-7	200	3	age	age	NOUN
ajb-7	200	4	of	of	ADP
ajb-7	200	5	males	male	NOUN
ajb-7	200	6	,	,	PUNCT
ajb-7	200	7	showing	show	VERB
ajb-7	200	8	symptoms	symptom	NOUN
ajb-7	200	9	of	of	ADP
ajb-7	200	10	fh	fh	PROPN
ajb-7	200	11	was	be	AUX
ajb-7	200	12	38	38	NUM
ajb-7	200	13	±	±	NUM
ajb-7	200	14	5	5	NUM
ajb-7	200	15	years	year	NOUN
ajb-7	200	16	,	,	PUNCT
ajb-7	200	17	which	which	PRON
ajb-7	200	18	is	be	AUX
ajb-7	200	19	earlier	early	ADV
ajb-7	200	20	as	as	SCONJ
ajb-7	200	21	compared	compare	VERB
ajb-7	200	22	to	to	ADP
ajb-7	200	23	females	female	NOUN
ajb-7	200	24	(	(	PUNCT
ajb-7	200	25	45±5	45±5	NUM
ajb-7	200	26	years	year	NOUN
ajb-7	200	27	)	)	PUNCT
ajb-7	200	28	.	.	PUNCT
ajb-7	201	1	the	the	DET
ajb-7	201	2	fh	fh	PROPN
ajb-7	201	3	should	should	AUX
ajb-7	201	4	immediately	immediately	ADV
ajb-7	201	5	be	be	AUX
ajb-7	201	6	treated	treat	VERB
ajb-7	201	7	upon	upon	SCONJ
ajb-7	201	8	diagnosis	diagnosis	NOUN
ajb-7	201	9	and	and	CCONJ
ajb-7	201	10	if	if	SCONJ
ajb-7	201	11	left	leave	VERB
ajb-7	201	12	untreated	untreated	ADJ
ajb-7	201	13	approximately	approximately	ADV
ajb-7	201	14	85	85	NUM
ajb-7	201	15	%	%	NOUN
ajb-7	201	16	of	of	ADP
ajb-7	201	17	males	male	NOUN
ajb-7	201	18	and	and	CCONJ
ajb-7	201	19	50	50	NUM
ajb-7	201	20	%	%	NOUN
ajb-7	201	21	of	of	ADP
ajb-7	201	22	females	female	NOUN
ajb-7	201	23	will	will	AUX
ajb-7	201	24	develop	develop	VERB
ajb-7	201	25	a	a	DET
ajb-7	201	26	coronary	coronary	ADJ
ajb-7	201	27	problem	problem	NOUN
ajb-7	201	28	before	before	ADP
ajb-7	201	29	the	the	DET
ajb-7	201	30	age	age	NOUN
ajb-7	201	31	of	of	ADP
ajb-7	201	32	65	65	NUM
ajb-7	201	33	(	(	PUNCT
ajb-7	201	34	civeira	civeira	PROPN
ajb-7	201	35	,	,	PUNCT
ajb-7	201	36	2004	2004	NUM
ajb-7	201	37	)	)	PUNCT
ajb-7	201	38	.	.	PUNCT
ajb-7	202	1	it	it	PRON
ajb-7	202	2	is	be	AUX
ajb-7	202	3	striking	strike	VERB
ajb-7	202	4	that	that	SCONJ
ajb-7	202	5	up	up	ADP
ajb-7	202	6	to	to	PART
ajb-7	202	7	9	9	NUM
ajb-7	202	8	%	%	NOUN
ajb-7	202	9	of	of	ADP
ajb-7	202	10	the	the	DET
ajb-7	202	11	total	total	ADJ
ajb-7	202	12	premature	premature	ADJ
ajb-7	202	13	chd	chd	PROPN
ajb-7	202	14	in	in	ADP
ajb-7	202	15	eastern	eastern	PROPN
ajb-7	202	16	germany	germany	PROPN
ajb-7	202	17	and	and	CCONJ
ajb-7	202	18	table	table	NOUN
ajb-7	202	19	1	1	NUM
ajb-7	202	20	.	.	PUNCT
ajb-7	203	1	clinical	clinical	ADJ
ajb-7	203	2	features	feature	NOUN
ajb-7	203	3	of	of	ADP
ajb-7	203	4	335	335	NUM
ajb-7	203	5	participants	participant	NOUN
ajb-7	203	6	with	with	ADP
ajb-7	203	7	cholesterol	cholesterol	NOUN
ajb-7	203	8	level	level	NOUN
ajb-7	203	9	>	>	X
ajb-7	203	10	210	210	NUM
ajb-7	203	11	mg	mg	PROPN
ajb-7	203	12	/	/	SYM
ajb-7	203	13	dl	dl	PROPN
ajb-7	203	14	in	in	ADP
ajb-7	203	15	pakistani	pakistani	ADJ
ajb-7	203	16	population	population	NOUN
ajb-7	203	17	.	.	PUNCT
ajb-7	204	1	table	table	NOUN
ajb-7	204	2	2	2	NUM
ajb-7	204	3	.	.	PUNCT
ajb-7	204	4	correlation	correlation	NOUN
ajb-7	204	5	studies	study	NOUN
ajb-7	204	6	showing	show	VERB
ajb-7	204	7	relations	relation	NOUN
ajb-7	204	8	among	among	ADP
ajb-7	204	9	smoking	smoking	NOUN
ajb-7	204	10	,	,	PUNCT
ajb-7	204	11	hypertension	hypertension	NOUN
ajb-7	204	12	(	(	PUNCT
ajb-7	204	13	htn	htn	PROPN
ajb-7	204	14	)	)	PUNCT
ajb-7	204	15	and	and	CCONJ
ajb-7	204	16	total	total	ADJ
ajb-7	204	17	cholesterol	cholesterol	NOUN
ajb-7	204	18	levels	level	NOUN
ajb-7	204	19	in	in	ADP
ajb-7	204	20	pakistani	pakistani	ADJ
ajb-7	204	21	population	population	NOUN
ajb-7	204	22	.	.	PUNCT
ajb-7	205	1	significant	significant	ADJ
ajb-7	205	2	at	at	ADP
ajb-7	205	3	*	*	PUNCT
ajb-7	205	4	p	p	X
ajb-7	205	5	<	<	X
ajb-7	205	6	0.05	0.05	NUM
ajb-7	205	7	,	,	PUNCT
ajb-7	205	8	*	*	PUNCT
ajb-7	205	9	*	*	PUNCT
ajb-7	206	1	p	p	X
ajb-7	206	2	<	<	X
ajb-7	206	3	0.01	0.01	NUM
ajb-7	206	4	.	.	PUNCT
ajb-7	207	1	observed	observe	VERB
ajb-7	207	2	features	feature	NOUN
ajb-7	207	3	gender	gender	NOUN
ajb-7	207	4	age	age	NOUN
ajb-7	207	5	(	(	PUNCT
ajb-7	207	6	years	year	NOUN
ajb-7	207	7	)	)	PUNCT
ajb-7	207	8	total	total	ADJ
ajb-7	207	9	observed	observe	VERB
ajb-7	207	10	cases	case	NOUN
ajb-7	207	11	percentage	percentage	NOUN
ajb-7	207	12	(	(	PUNCT
ajb-7	207	13	%	%	INTJ
ajb-7	207	14	)	)	PUNCT
ajb-7	207	15	tandinous	tandinous	ADJ
ajb-7	207	16	xanthomata	xanthomata	ADJ
ajb-7	207	17	male	male	NOUN
ajb-7	207	18	30	30	NUM
ajb-7	207	19	-	-	SYM
ajb-7	207	20	40	40	NUM
ajb-7	207	21	40	40	NUM
ajb-7	207	22	-	-	SYM
ajb-7	207	23	50	50	NUM
ajb-7	207	24	50	50	NUM
ajb-7	207	25	-	-	SYM
ajb-7	207	26	60	60	NUM
ajb-7	207	27	202	202	NUM
ajb-7	207	28	0	0	NUM
ajb-7	207	29	0	0	NUM
ajb-7	207	30	146	146	NUM
ajb-7	207	31	0	0	NUM
ajb-7	207	32	0	0	NUM
ajb-7	207	33	72	72	NUM
ajb-7	207	34	0	0	NUM
ajb-7	207	35	0	0	NUM
ajb-7	207	36	female	female	ADJ
ajb-7	207	37	30	30	NUM
ajb-7	207	38	-	-	SYM
ajb-7	207	39	40	40	NUM
ajb-7	207	40	40	40	NUM
ajb-7	207	41	-	-	SYM
ajb-7	207	42	50	50	NUM
ajb-7	207	43	50	50	NUM
ajb-7	207	44	-	-	SYM
ajb-7	207	45	60	60	NUM
ajb-7	207	46	133	133	NUM
ajb-7	207	47	0	0	NUM
ajb-7	207	48	0	0	NUM
ajb-7	207	49	78	78	NUM
ajb-7	207	50	0	0	NUM
ajb-7	207	51	0	0	NUM
ajb-7	207	52	58	58	NUM
ajb-7	207	53	0	0	NUM
ajb-7	207	54	0	0	NUM
ajb-7	207	55	xanthelesma	xanthelesma	NOUN
ajb-7	207	56	male	male	NOUN
ajb-7	207	57	30	30	NUM
ajb-7	207	58	-	-	SYM
ajb-7	207	59	40	40	NUM
ajb-7	207	60	40	40	NUM
ajb-7	207	61	-	-	SYM
ajb-7	207	62	50	50	NUM
ajb-7	207	63	50	50	NUM
ajb-7	207	64	-	-	SYM
ajb-7	207	65	60	60	NUM
ajb-7	207	66	0	0	NUM
ajb-7	208	1	202	202	NUM
ajb-7	208	2	0	0	NUM
ajb-7	208	3	0	0	NUM
ajb-7	208	4	148	148	NUM
ajb-7	208	5	0	0	NUM
ajb-7	208	6	0	0	NUM
ajb-7	208	7	73	73	NUM
ajb-7	208	8	0	0	NUM
ajb-7	208	9	female	female	ADJ
ajb-7	208	10	30	30	NUM
ajb-7	208	11	-	-	SYM
ajb-7	208	12	40	40	NUM
ajb-7	208	13	40	40	NUM
ajb-7	208	14	-	-	SYM
ajb-7	208	15	50	50	NUM
ajb-7	208	16	50	50	NUM
ajb-7	208	17	-	-	SYM
ajb-7	208	18	60	60	NUM
ajb-7	208	19	133	133	NUM
ajb-7	208	20	0	0	NUM
ajb-7	208	21	0	0	NUM
ajb-7	208	22	110	110	NUM
ajb-7	208	23	0	0	NUM
ajb-7	208	24	0	0	NUM
ajb-7	208	25	82	82	NUM
ajb-7	208	26	0	0	SYM
ajb-7	208	27	0	0	NUM
ajb-7	208	28	arcus	arcus	NOUN
ajb-7	208	29	cornea	cornea	NOUN
ajb-7	208	30	male	male	NOUN
ajb-7	208	31	30	30	NUM
ajb-7	208	32	-	-	SYM
ajb-7	208	33	40	40	NUM
ajb-7	208	34	40	40	NUM
ajb-7	208	35	-	-	SYM
ajb-7	208	36	50	50	NUM
ajb-7	208	37	50	50	NUM
ajb-7	208	38	-	-	SYM
ajb-7	208	39	60	60	NUM
ajb-7	208	40	0	0	NUM
ajb-7	208	41	202	202	NUM
ajb-7	208	42	0	0	NUM
ajb-7	208	43	0	0	NUM
ajb-7	208	44	128	128	NUM
ajb-7	208	45	0	0	NUM
ajb-7	208	46	0	0	NUM
ajb-7	208	47	63	63	NUM
ajb-7	208	48	0	0	NUM
ajb-7	208	49	female	female	ADJ
ajb-7	208	50	30	30	NUM
ajb-7	208	51	-	-	SYM
ajb-7	208	52	40	40	NUM
ajb-7	208	53	40	40	NUM
ajb-7	208	54	-	-	SYM
ajb-7	208	55	50	50	NUM
ajb-7	208	56	50	50	NUM
ajb-7	208	57	-	-	SYM
ajb-7	208	58	60	60	NUM
ajb-7	208	59	133	133	NUM
ajb-7	208	60	0	0	NUM
ajb-7	208	61	0	0	NUM
ajb-7	208	62	96	96	NUM
ajb-7	208	63	0	0	NUM
ajb-7	208	64	0	0	NUM
ajb-7	208	65	72	72	NUM
ajb-7	208	66	0	0	NUM
ajb-7	208	67	0	0	NUM
ajb-7	208	68	polyarthritis	polyarthritis	NOUN
ajb-7	208	69	male	male	NOUN
ajb-7	208	70	30	30	NUM
ajb-7	208	71	-	-	SYM
ajb-7	208	72	40	40	NUM
ajb-7	208	73	40	40	NUM
ajb-7	208	74	-	-	SYM
ajb-7	208	75	50	50	NUM
ajb-7	208	76	50	50	NUM
ajb-7	208	77	-	-	SYM
ajb-7	208	78	60	60	NUM
ajb-7	208	79	0	0	NUM
ajb-7	208	80	202	202	NUM
ajb-7	208	81	0	0	NUM
ajb-7	208	82	0	0	NUM
ajb-7	208	83	2	2	NUM
ajb-7	208	84	0	0	NUM
ajb-7	208	85	0	0	NUM
ajb-7	208	86	0.9	0.9	NUM
ajb-7	208	87	0	0	NUM
ajb-7	208	88	female	female	ADJ
ajb-7	208	89	30	30	NUM
ajb-7	208	90	-	-	SYM
ajb-7	208	91	40	40	NUM
ajb-7	208	92	40	40	NUM
ajb-7	208	93	-	-	SYM
ajb-7	208	94	50	50	NUM
ajb-7	208	95	50	50	NUM
ajb-7	208	96	-	-	SYM
ajb-7	208	97	60	60	NUM
ajb-7	208	98	0	0	NUM
ajb-7	208	99	0	0	NUM
ajb-7	208	100	133	133	NUM
ajb-7	208	101	0	0	NUM
ajb-7	208	102	0	0	NUM
ajb-7	208	103	5	5	NUM
ajb-7	208	104	0	0	NUM
ajb-7	208	105	0	0	NUM
ajb-7	208	106	3.7	3.7	NUM
ajb-7	208	107	smoking	smoking	NOUN
ajb-7	208	108	htn	htn	NOUN
ajb-7	208	109	total	total	ADJ
ajb-7	208	110	cholesterol	cholesterol	NOUN
ajb-7	208	111	smoking	smoke	VERB
ajb-7	208	112	1.000	1.000	NUM
ajb-7	208	113	0.32	0.32	NUM
ajb-7	208	114	*	*	PUNCT
ajb-7	208	115	0.47	0.47	NUM
ajb-7	208	116	*	*	PUNCT
ajb-7	208	117	htn	htn	PROPN
ajb-7	208	118	1.000	1.000	NUM
ajb-7	208	119	0.000	0.000	NUM
ajb-7	208	120	*	*	PUNCT
ajb-7	208	121	*	*	PUNCT
ajb-7	208	122	total	total	ADJ
ajb-7	208	123	chlesterol	chlesterol	NOUN
ajb-7	208	124	1.000	1.000	NUM
ajb-7	208	125	38	38	NUM
ajb-7	208	126	kb	kb	PROPN
ajb-7	208	127	m	m	PROPN
ajb-7	208	128	j	j	PROPN
ajb-7	208	129	ou	ou	PROPN
ajb-7	208	130	rn	rn	PROPN
ajb-7	208	131	al	al	PROPN
ajb-7	208	132	o	o	PROPN
ajb-7	209	1	f	f	PROPN
ajb-7	209	2	bi	bi	NOUN
ajb-7	209	3	ol	ol	PROPN
ajb-7	209	4	og	og	PROPN
ajb-7	209	5	y	y	PROPN
ajb-7	209	6	is	be	AUX
ajb-7	209	7	sn	sn	PROPN
ajb-7	209	8	1	1	NUM
ajb-7	209	9	94	94	NUM
ajb-7	209	10	858	858	NUM
ajb-7	209	11	83	83	NUM
ajb-7	209	12	.	.	PUNCT
ajb-7	210	1	p	p	X
ajb-7	210	2	ub	ub	ADJ
ajb-7	210	3	lis	li	NOUN
ajb-7	210	4	he	he	PRON
ajb-7	210	5	d	d	NOUN
ajb-7	210	6	by	by	ADP
ajb-7	210	7	k	k	PROPN
ajb-7	210	8	bm	bm	PROPN
ajb-7	210	9	s	s	PROPN
ajb-7	210	10	ci	ci	PROPN
ajb-7	210	11	en	en	ADP
ajb-7	210	12	tifi	tifi	PROPN
ajb-7	210	13	c	c	AUX
ajb-7	210	14	pu	pu	PROPN
ajb-7	210	15	bl	bl	AUX
ajb-7	210	16	ish	ish	VERB
ajb-7	210	17	in	in	ADP
ajb-7	210	18	g	g	PROPN
ajb-7	210	19	,	,	PUNCT
ajb-7	211	1	l	l	NOUN
ajb-7	211	2	p	p	X
ajb-7	212	1	(	(	PUNCT
ajb-7	212	2	w	w	PROPN
ajb-7	212	3	w	w	PROPN
ajb-7	212	4	w	w	PROPN
ajb-7	212	5	.k	.k	PROPN
ajb-7	212	6	bm	bm	PROPN
ajb-7	213	1	-s	-s	X
ajb-7	213	2	ci	ci	PROPN
ajb-7	213	3	en	en	INTJ
ajb-7	213	4	tifi	tifi	PROPN
ajb-7	213	5	cpu	cpu	NOUN
ajb-7	213	6	bl	bl	AUX
ajb-7	213	7	ish	ish	VERB
ajb-7	213	8	in	in	ADP
ajb-7	213	9	g.	g.	PROPN
ajb-7	213	10	or	or	CCONJ
ajb-7	213	11	g	g	PROPN
ajb-7	213	12	)	)	PUNCT
ajb-7	213	13	finland	finland	PROPN
ajb-7	213	14	has	have	AUX
ajb-7	213	15	been	be	AUX
ajb-7	213	16	linked	link	VERB
ajb-7	213	17	with	with	ADP
ajb-7	213	18	fh	fh	PROPN
ajb-7	213	19	(	(	PUNCT
ajb-7	213	20	koivisto	koivisto	PROPN
ajb-7	213	21	et	et	PROPN
ajb-7	213	22	al	al	PROPN
ajb-7	213	23	.	.	PROPN
ajb-7	213	24	,	,	PUNCT
ajb-7	213	25	1993	1993	NUM
ajb-7	213	26	;	;	PUNCT
ajb-7	214	1	baron	baron	NOUN
ajb-7	214	2	et	et	PROPN
ajb-7	214	3	al	al	PROPN
ajb-7	214	4	.	.	PROPN
ajb-7	214	5	,1996	,1996	PROPN
ajb-7	214	6	;	;	PUNCT
ajb-7	214	7	schuster	schuster	NOUN
ajb-7	214	8	,	,	PUNCT
ajb-7	214	9	2002	2002	NUM
ajb-7	214	10	)	)	PUNCT
ajb-7	214	11	.	.	PUNCT
ajb-7	215	1	hence	hence	ADV
ajb-7	215	2	,	,	PUNCT
ajb-7	215	3	the	the	DET
ajb-7	215	4	major	major	ADJ
ajb-7	215	5	cause	cause	NOUN
ajb-7	215	6	of	of	ADP
ajb-7	215	7	death	death	NOUN
ajb-7	215	8	in	in	ADP
ajb-7	215	9	fh	fh	PROPN
ajb-7	215	10	patients	patient	NOUN
ajb-7	215	11	has	have	AUX
ajb-7	215	12	been	be	AUX
ajb-7	215	13	linked	link	VERB
ajb-7	215	14	with	with	ADP
ajb-7	215	15	the	the	DET
ajb-7	215	16	occurrence	occurrence	NOUN
ajb-7	215	17	of	of	ADP
ajb-7	215	18	chd	chd	PROPN
ajb-7	215	19	(	(	PUNCT
ajb-7	215	20	mabuchi	mabuchi	PROPN
ajb-7	215	21	et	et	PROPN
ajb-7	215	22	al	al	PROPN
ajb-7	215	23	.	.	PROPN
ajb-7	215	24	,	,	PUNCT
ajb-7	215	25	1989	1989	NUM
ajb-7	215	26	;	;	PUNCT
ajb-7	215	27	miettinen	miettinen	NOUN
ajb-7	215	28	and	and	CCONJ
ajb-7	215	29	gylling	gylling	NOUN
ajb-7	215	30	,	,	PUNCT
ajb-7	215	31	1988	1988	NUM
ajb-7	215	32	)	)	PUNCT
ajb-7	215	33	.	.	PUNCT
ajb-7	216	1	in	in	ADP
ajb-7	216	2	the	the	DET
ajb-7	216	3	present	present	ADJ
ajb-7	216	4	study	study	NOUN
ajb-7	216	5	,	,	PUNCT
ajb-7	216	6	we	we	PRON
ajb-7	216	7	found	find	VERB
ajb-7	216	8	that	that	SCONJ
ajb-7	216	9	the	the	DET
ajb-7	216	10	high	high	ADJ
ajb-7	216	11	levels	level	NOUN
ajb-7	216	12	of	of	ADP
ajb-7	216	13	ldl	ldl	NOUN
ajb-7	216	14	-	-	PUNCT
ajb-7	216	15	c	c	NOUN
ajb-7	216	16	(	(	PUNCT
ajb-7	216	17	>	>	X
ajb-7	216	18	190	190	NUM
ajb-7	216	19	mg	mg	NOUN
ajb-7	216	20	dl-1	dl-1	PRON
ajb-7	216	21	)	)	PUNCT
ajb-7	216	22	were	be	AUX
ajb-7	216	23	detected	detect	VERB
ajb-7	216	24	in	in	ADP
ajb-7	216	25	the	the	DET
ajb-7	216	26	proband	proband	NOUN
ajb-7	216	27	and	and	CCONJ
ajb-7	216	28	in	in	ADP
ajb-7	216	29	the	the	DET
ajb-7	216	30	related	related	ADJ
ajb-7	216	31	family	family	NOUN
ajb-7	216	32	members	member	NOUN
ajb-7	216	33	(	(	PUNCT
ajb-7	216	34	figure	figure	NOUN
ajb-7	216	35	1	1	NUM
ajb-7	216	36	)	)	PUNCT
ajb-7	216	37	.	.	PUNCT
ajb-7	217	1	the	the	DET
ajb-7	217	2	clinical	clinical	ADJ
ajb-7	217	3	diagnosis	diagnosis	NOUN
ajb-7	217	4	of	of	ADP
ajb-7	217	5	heterozygote	heterozygote	PROPN
ajb-7	217	6	fh	fh	PROPN
ajb-7	217	7	is	be	AUX
ajb-7	217	8	associated	associate	VERB
ajb-7	217	9	not	not	PART
ajb-7	217	10	only	only	ADV
ajb-7	217	11	with	with	ADP
ajb-7	217	12	the	the	DET
ajb-7	217	13	high	high	ADJ
ajb-7	217	14	plasma	plasma	NOUN
ajb-7	217	15	level	level	NOUN
ajb-7	217	16	of	of	ADP
ajb-7	217	17	ldl	ldl	NOUN
ajb-7	217	18	-	-	PUNCT
ajb-7	217	19	c	c	NOUN
ajb-7	217	20	but	but	CCONJ
ajb-7	217	21	also	also	ADV
ajb-7	217	22	with	with	ADP
ajb-7	217	23	the	the	DET
ajb-7	217	24	incidence	incidence	NOUN
ajb-7	217	25	of	of	ADP
ajb-7	217	26	other	other	ADJ
ajb-7	217	27	coronary	coronary	ADJ
ajb-7	217	28	risk	risk	NOUN
ajb-7	217	29	factors	factor	NOUN
ajb-7	217	30	(	(	PUNCT
ajb-7	217	31	hill	hill	NOUN
ajb-7	217	32	et	et	PROPN
ajb-7	217	33	al	al	PROPN
ajb-7	217	34	,	,	PUNCT
ajb-7	217	35	1991	1991	NUM
ajb-7	217	36	)	)	PUNCT
ajb-7	217	37	.	.	PUNCT
ajb-7	218	1	we	we	PRON
ajb-7	218	2	have	have	AUX
ajb-7	218	3	found	find	VERB
ajb-7	218	4	that	that	SCONJ
ajb-7	218	5	the	the	DET
ajb-7	218	6	females	female	NOUN
ajb-7	218	7	with	with	ADP
ajb-7	218	8	fh	fh	PROPN
ajb-7	218	9	had	have	VERB
ajb-7	218	10	higher	high	ADJ
ajb-7	218	11	levels	level	NOUN
ajb-7	218	12	of	of	ADP
ajb-7	218	13	total	total	ADJ
ajb-7	218	14	ldl	ldl	NOUN
ajb-7	218	15	-	-	PUNCT
ajb-7	218	16	c	c	PROPN
ajb-7	218	17	(	(	PUNCT
ajb-7	218	18	196	196	NUM
ajb-7	218	19	-	-	SYM
ajb-7	218	20	358	358	NUM
ajb-7	218	21	mg	mg	NOUN
ajb-7	218	22	dl-1	dl-1	NOUN
ajb-7	218	23	)	)	PUNCT
ajb-7	218	24	as	as	SCONJ
ajb-7	218	25	compared	compare	VERB
ajb-7	218	26	to	to	ADP
ajb-7	218	27	the	the	DET
ajb-7	218	28	male	male	ADJ
ajb-7	218	29	subjects	subject	NOUN
ajb-7	218	30	(	(	PUNCT
ajb-7	218	31	201	201	NUM
ajb-7	218	32	-	-	SYM
ajb-7	218	33	301	301	NUM
ajb-7	218	34	mg	mg	NOUN
ajb-7	218	35	dl-1	dl-1	NOUN
ajb-7	218	36	)	)	PUNCT
ajb-7	218	37	and	and	CCONJ
ajb-7	218	38	with	with	ADP
ajb-7	218	39	lower	low	ADJ
ajb-7	218	40	levels	level	NOUN
ajb-7	218	41	of	of	ADP
ajb-7	218	42	hdl	hdl	PROPN
ajb-7	218	43	-	-	PUNCT
ajb-7	218	44	c	c	PROPN
ajb-7	218	45	(	(	PUNCT
ajb-7	218	46	25–55	25–55	PROPN
ajb-7	218	47	md	md	PROPN
ajb-7	218	48	dl-1	dl-1	NOUN
ajb-7	218	49	)	)	PUNCT
ajb-7	218	50	.	.	PUNCT
ajb-7	219	1	the	the	DET
ajb-7	219	2	average	average	ADJ
ajb-7	219	3	age	age	NOUN
ajb-7	219	4	of	of	ADP
ajb-7	219	5	onset	onset	NOUN
ajb-7	219	6	of	of	ADP
ajb-7	219	7	coronary	coronary	ADJ
ajb-7	219	8	symptoms	symptom	NOUN
ajb-7	219	9	was	be	AUX
ajb-7	219	10	delayed	delay	VERB
ajb-7	219	11	in	in	ADP
ajb-7	219	12	females	female	NOUN
ajb-7	219	13	,	,	PUNCT
ajb-7	219	14	with	with	ADP
ajb-7	219	15	a	a	DET
ajb-7	219	16	mean	mean	ADJ
ajb-7	219	17	age	age	NOUN
ajb-7	219	18	of	of	ADP
ajb-7	219	19	55	55	NUM
ajb-7	219	20	years	year	NOUN
ajb-7	219	21	compared	compare	VERB
ajb-7	219	22	with	with	ADP
ajb-7	219	23	48	48	NUM
ajb-7	219	24	years	year	NOUN
ajb-7	219	25	for	for	ADP
ajb-7	219	26	males	male	NOUN
ajb-7	219	27	(	(	PUNCT
ajb-7	219	28	p	p	X
ajb-7	219	29	<	<	X
ajb-7	219	30	0.05	0.05	NUM
ajb-7	219	31	)	)	PUNCT
ajb-7	219	32	.	.	PUNCT
ajb-7	220	1	previous	previous	ADJ
ajb-7	220	2	studies	study	NOUN
ajb-7	220	3	have	have	AUX
ajb-7	220	4	shown	show	VERB
ajb-7	220	5	an	an	DET
ajb-7	220	6	association	association	NOUN
ajb-7	220	7	between	between	ADP
ajb-7	220	8	clinical	clinical	ADJ
ajb-7	220	9	heterozygous	heterozygous	ADJ
ajb-7	220	10	fh	fh	ADJ
ajb-7	220	11	and	and	CCONJ
ajb-7	220	12	coronary	coronary	ADJ
ajb-7	220	13	heart	heart	NOUN
ajb-7	220	14	disease	disease	NOUN
ajb-7	220	15	(	(	PUNCT
ajb-7	220	16	kalina	kalina	PROPN
ajb-7	220	17	et	et	PROPN
ajb-7	220	18	al	al	PROPN
ajb-7	220	19	.	.	PROPN
ajb-7	220	20	,	,	PUNCT
ajb-7	220	21	2001	2001	NUM
ajb-7	220	22	;	;	PUNCT
ajb-7	220	23	umans	uman	NOUN
ajb-7	220	24	-	-	PUNCT
ajb-7	220	25	eckenhausen	eckenhausen	NOUN
ajb-7	220	26	et	et	PROPN
ajb-7	220	27	al	al	PROPN
ajb-7	220	28	.	.	PROPN
ajb-7	220	29	,	,	PUNCT
ajb-7	220	30	2002	2002	NUM
ajb-7	220	31	)	)	PUNCT
ajb-7	220	32	.	.	PUNCT
ajb-7	221	1	however	however	ADV
ajb-7	221	2	,	,	PUNCT
ajb-7	221	3	the	the	DET
ajb-7	221	4	heterogeneity	heterogeneity	NOUN
ajb-7	221	5	in	in	ADP
ajb-7	221	6	fh	fh	PROPN
ajb-7	221	7	patients	patient	NOUN
ajb-7	221	8	with	with	ADP
ajb-7	221	9	regards	regard	NOUN
ajb-7	221	10	to	to	ADP
ajb-7	221	11	plasma	plasma	NOUN
ajb-7	221	12	ldl	ldl	NOUN
ajb-7	221	13	-	-	PUNCT
ajb-7	221	14	c	c	PROPN
ajb-7	221	15	and	and	CCONJ
ajb-7	221	16	chd	chd	PROPN
ajb-7	221	17	has	have	AUX
ajb-7	221	18	also	also	ADV
ajb-7	221	19	been	be	AUX
ajb-7	221	20	suggested	suggest	VERB
ajb-7	221	21	(	(	PUNCT
ajb-7	221	22	castroorós	castroorós	X
ajb-7	221	23	et	et	PROPN
ajb-7	221	24	al	al	PROPN
ajb-7	221	25	.	.	PROPN
ajb-7	221	26	,	,	PUNCT
ajb-7	221	27	2010	2010	NUM
ajb-7	221	28	)	)	PUNCT
ajb-7	221	29	.	.	PUNCT
ajb-7	222	1	multivariate	multivariate	NOUN
ajb-7	222	2	analyses	analysis	NOUN
ajb-7	222	3	have	have	AUX
ajb-7	222	4	revealed	reveal	VERB
ajb-7	222	5	that	that	SCONJ
ajb-7	222	6	in	in	ADP
ajb-7	222	7	fh	fh	PROPN
ajb-7	222	8	heterozygotes	heterozygote	NOUN
ajb-7	222	9	and	and	CCONJ
ajb-7	222	10	controls	control	NOUN
ajb-7	222	11	,	,	PUNCT
ajb-7	222	12	the	the	DET
ajb-7	222	13	hdl	hdl	PROPN
ajb-7	222	14	-	-	PUNCT
ajb-7	222	15	c	c	PROPN
ajb-7	222	16	levels	level	NOUN
ajb-7	222	17	may	may	AUX
ajb-7	222	18	contribute	contribute	VERB
ajb-7	222	19	to	to	ADP
ajb-7	222	20	a	a	DET
ajb-7	222	21	greater	great	ADJ
ajb-7	222	22	proportion	proportion	NOUN
ajb-7	222	23	of	of	ADP
ajb-7	222	24	the	the	DET
ajb-7	222	25	variation	variation	NOUN
ajb-7	222	26	in	in	ADP
ajb-7	222	27	tc	tc	NUM
ajb-7	222	28	to	to	ADP
ajb-7	222	29	hdl	hdl	PROPN
ajb-7	222	30	-	-	PUNCT
ajb-7	222	31	c	c	NOUN
ajb-7	222	32	ratio	ratio	NOUN
ajb-7	222	33	than	than	ADP
ajb-7	222	34	tc	tc	NUM
ajb-7	222	35	(	(	PUNCT
ajb-7	222	36	torres	torre	NOUN
ajb-7	222	37	et	et	PROPN
ajb-7	222	38	al	al	PROPN
ajb-7	222	39	.	.	PROPN
ajb-7	222	40	,	,	PUNCT
ajb-7	222	41	1996	1996	NUM
ajb-7	222	42	)	)	PUNCT
ajb-7	222	43	.	.	PUNCT
ajb-7	223	1	a	a	DET
ajb-7	223	2	number	number	NOUN
ajb-7	223	3	of	of	ADP
ajb-7	223	4	factors	factor	NOUN
ajb-7	223	5	,	,	PUNCT
ajb-7	223	6	including	include	VERB
ajb-7	223	7	age	age	NOUN
ajb-7	223	8	,	,	PUNCT
ajb-7	223	9	sex	sex	NOUN
ajb-7	223	10	,	,	PUNCT
ajb-7	223	11	smoking	smoking	NOUN
ajb-7	223	12	and	and	CCONJ
ajb-7	223	13	hdl	hdl	PROPN
ajb-7	223	14	-	-	PUNCT
ajb-7	223	15	c	c	NOUN
ajb-7	223	16	concentrations	concentration	NOUN
ajb-7	223	17	have	have	AUX
ajb-7	223	18	previously	previously	ADV
ajb-7	223	19	been	be	AUX
ajb-7	223	20	identified	identify	VERB
ajb-7	223	21	as	as	ADP
ajb-7	223	22	risk	risk	NOUN
ajb-7	223	23	factors	factor	NOUN
ajb-7	223	24	for	for	ADP
ajb-7	223	25	chd	chd	PROPN
ajb-7	223	26	in	in	ADP
ajb-7	223	27	fh	fh	PROPN
ajb-7	223	28	in	in	ADP
ajb-7	223	29	cross	cross	ADJ
ajb-7	223	30	-	-	ADJ
ajb-7	223	31	section	section	ADJ
ajb-7	223	32	studies	study	NOUN
ajb-7	223	33	worldwide	worldwide	ADV
ajb-7	223	34	(	(	PUNCT
ajb-7	223	35	jansen	jansen	PROPN
ajb-7	223	36	et	et	PROPN
ajb-7	223	37	al	al	PROPN
ajb-7	223	38	.	.	PROPN
ajb-7	223	39	,	,	PUNCT
ajb-7	223	40	2004	2004	NUM
ajb-7	223	41	)	)	PUNCT
ajb-7	223	42	.	.	PUNCT
ajb-7	224	1	there	there	PRON
ajb-7	224	2	are	be	VERB
ajb-7	224	3	100	100	NUM
ajb-7	224	4	million	million	NUM
ajb-7	224	5	people	people	NOUN
ajb-7	224	6	with	with	ADP
ajb-7	224	7	fh	fh	PROPN
ajb-7	224	8	worldwide	worldwide	ADV
ajb-7	224	9	,	,	PUNCT
ajb-7	224	10	mainly	mainly	ADV
ajb-7	224	11	heterozygotes	heterozygote	NOUN
ajb-7	224	12	,	,	PUNCT
ajb-7	224	13	and	and	CCONJ
ajb-7	224	14	approximately	approximately	ADV
ajb-7	224	15	85	85	NUM
ajb-7	224	16	%	%	NOUN
ajb-7	224	17	of	of	ADP
ajb-7	224	18	males	male	NOUN
ajb-7	224	19	and	and	CCONJ
ajb-7	224	20	50	50	NUM
ajb-7	224	21	%	%	NOUN
ajb-7	224	22	of	of	ADP
ajb-7	224	23	females	female	NOUN
ajb-7	224	24	with	with	ADP
ajb-7	224	25	fh	fh	PROPN
ajb-7	224	26	will	will	AUX
ajb-7	224	27	suffer	suffer	VERB
ajb-7	224	28	a	a	DET
ajb-7	224	29	coronary	coronary	ADJ
ajb-7	224	30	event	event	NOUN
ajb-7	224	31	before	before	SCONJ
ajb-7	224	32	they	they	PRON
ajb-7	224	33	are	be	AUX
ajb-7	224	34	65	65	NUM
ajb-7	224	35	years	year	NOUN
ajb-7	224	36	old	old	ADJ
ajb-7	224	37	,	,	PUNCT
ajb-7	224	38	if	if	SCONJ
ajb-7	224	39	appropriate	appropriate	ADJ
ajb-7	224	40	preventive	preventive	ADJ
ajb-7	224	41	measures	measure	NOUN
ajb-7	224	42	are	be	AUX
ajb-7	224	43	not	not	PART
ajb-7	224	44	implemented	implement	VERB
ajb-7	224	45	(	(	PUNCT
ajb-7	224	46	fernando	fernando	PROPN
ajb-7	224	47	,	,	PUNCT
ajb-7	224	48	2004	2004	NUM
ajb-7	224	49	)	)	PUNCT
ajb-7	224	50	.	.	PUNCT
ajb-7	225	1	the	the	DET
ajb-7	225	2	risk	risk	NOUN
ajb-7	225	3	factors	factor	NOUN
ajb-7	225	4	such	such	ADJ
ajb-7	225	5	as	as	ADP
ajb-7	225	6	smoking	smoking	NOUN
ajb-7	225	7	and	and	CCONJ
ajb-7	225	8	htn	htn	NOUN
ajb-7	225	9	showed	show	VERB
ajb-7	225	10	a	a	DET
ajb-7	225	11	significant	significant	ADJ
ajb-7	225	12	correlation	correlation	NOUN
ajb-7	225	13	in	in	ADP
ajb-7	225	14	the	the	DET
ajb-7	225	15	appearance	appearance	NOUN
ajb-7	225	16	of	of	ADP
ajb-7	225	17	the	the	DET
ajb-7	225	18	disease	disease	NOUN
ajb-7	225	19	.	.	PUNCT
ajb-7	226	1	our	our	PRON
ajb-7	226	2	study	study	NOUN
ajb-7	226	3	showed	show	VERB
ajb-7	226	4	that	that	SCONJ
ajb-7	226	5	a	a	DET
ajb-7	226	6	strong	strong	ADJ
ajb-7	226	7	correlation	correlation	NOUN
ajb-7	226	8	between	between	ADP
ajb-7	226	9	the	the	DET
ajb-7	226	10	risk	risk	NOUN
ajb-7	226	11	factors	factor	NOUN
ajb-7	226	12	,	,	PUNCT
ajb-7	226	13	smoking	smoking	NOUN
ajb-7	226	14	and	and	CCONJ
ajb-7	226	15	htn	htn	PROPN
ajb-7	226	16	,	,	PUNCT
ajb-7	226	17	was	be	AUX
ajb-7	226	18	present	present	ADJ
ajb-7	226	19	in	in	ADP
ajb-7	226	20	the	the	DET
ajb-7	226	21	individuals	individual	NOUN
ajb-7	226	22	with	with	ADP
ajb-7	226	23	fh	fh	PROPN
ajb-7	226	24	.	.	PUNCT
ajb-7	227	1	the	the	DET
ajb-7	227	2	tc	tc	NOUN
ajb-7	227	3	and	and	CCONJ
ajb-7	227	4	smoking	smoking	NOUN
ajb-7	227	5	were	be	AUX
ajb-7	227	6	significantly	significantly	ADV
ajb-7	227	7	correlated	correlate	VERB
ajb-7	227	8	(	(	PUNCT
ajb-7	227	9	p	p	X
ajb-7	227	10	<	<	X
ajb-7	227	11	0.05	0.05	NUM
ajb-7	227	12	)	)	PUNCT
ajb-7	227	13	in	in	ADP
ajb-7	227	14	the	the	DET
ajb-7	227	15	fh	fh	PROPN
ajb-7	227	16	pakistani	pakistani	PROPN
ajb-7	227	17	population	population	NOUN
ajb-7	227	18	.	.	PUNCT
ajb-7	228	1	similarly	similarly	ADV
ajb-7	228	2	,	,	PUNCT
ajb-7	228	3	smoking	smoking	NOUN
ajb-7	228	4	and	and	CCONJ
ajb-7	228	5	htn	htn	NOUN
ajb-7	228	6	were	be	AUX
ajb-7	228	7	also	also	ADV
ajb-7	228	8	significantly	significantly	ADV
ajb-7	228	9	(	(	PUNCT
ajb-7	228	10	p	p	X
ajb-7	228	11	<	<	X
ajb-7	228	12	0.05	0.05	NUM
ajb-7	228	13	)	)	PUNCT
ajb-7	228	14	correlated	correlate	VERB
ajb-7	228	15	.	.	PUNCT
ajb-7	229	1	but	but	CCONJ
ajb-7	229	2	a	a	DET
ajb-7	229	3	very	very	ADV
ajb-7	229	4	strong	strong	ADJ
ajb-7	229	5	correlation	correlation	NOUN
ajb-7	229	6	(	(	PUNCT
ajb-7	229	7	p	p	X
ajb-7	229	8	<	<	NOUN
ajb-7	229	9	0.001	0.001	NUM
ajb-7	229	10	)	)	PUNCT
ajb-7	229	11	between	between	ADP
ajb-7	229	12	htn	htn	PROPN
ajb-7	229	13	and	and	CCONJ
ajb-7	229	14	tc	tc	NOUN
ajb-7	229	15	was	be	AUX
ajb-7	229	16	observed	observe	VERB
ajb-7	229	17	in	in	ADP
ajb-7	229	18	the	the	DET
ajb-7	229	19	studied	study	VERB
ajb-7	229	20	individuals	individual	NOUN
ajb-7	229	21	.	.	PUNCT
ajb-7	230	1	smoking	smoke	VERB
ajb-7	230	2	in	in	ADP
ajb-7	230	3	males	male	NOUN
ajb-7	230	4	had	have	VERB
ajb-7	230	5	profound	profound	ADJ
ajb-7	230	6	effect	effect	NOUN
ajb-7	230	7	,	,	PUNCT
ajb-7	230	8	where	where	SCONJ
ajb-7	230	9	70	70	NUM
ajb-7	230	10	%	%	NOUN
ajb-7	230	11	males	male	NOUN
ajb-7	230	12	with	with	ADP
ajb-7	230	13	positive	positive	ADJ
ajb-7	230	14	chd	chd	NOUN
ajb-7	230	15	were	be	AUX
ajb-7	230	16	smokers	smoker	NOUN
ajb-7	230	17	.	.	PUNCT
ajb-7	231	1	however	however	ADV
ajb-7	231	2	,	,	PUNCT
ajb-7	231	3	the	the	DET
ajb-7	231	4	htn	htn	NOUN
ajb-7	231	5	in	in	ADP
ajb-7	231	6	females	female	NOUN
ajb-7	231	7	was	be	AUX
ajb-7	231	8	associated	associate	VERB
ajb-7	231	9	with	with	ADP
ajb-7	231	10	higher	high	ADJ
ajb-7	231	11	incidence	incidence	NOUN
ajb-7	231	12	of	of	ADP
ajb-7	231	13	chd	chd	NOUN
ajb-7	231	14	.	.	PUNCT
ajb-7	232	1	the	the	DET
ajb-7	232	2	htn	htn	PROPN
ajb-7	232	3	has	have	AUX
ajb-7	232	4	been	be	AUX
ajb-7	232	5	considered	consider	VERB
ajb-7	232	6	as	as	ADP
ajb-7	232	7	an	an	DET
ajb-7	232	8	independent	independent	ADJ
ajb-7	232	9	risk	risk	NOUN
ajb-7	232	10	factor	factor	NOUN
ajb-7	232	11	for	for	ADP
ajb-7	232	12	females	female	NOUN
ajb-7	232	13	with	with	ADP
ajb-7	232	14	fh	fh	PROPN
ajb-7	232	15	(	(	PUNCT
ajb-7	232	16	hill	hill	PROPN
ajb-7	232	17	et	et	PROPN
ajb-7	232	18	al	al	PROPN
ajb-7	232	19	.	.	PROPN
ajb-7	232	20	,	,	PUNCT
ajb-7	232	21	1991	1991	NUM
ajb-7	232	22	)	)	PUNCT
ajb-7	232	23	.	.	PUNCT
ajb-7	233	1	it	it	PRON
ajb-7	233	2	has	have	AUX
ajb-7	233	3	been	be	AUX
ajb-7	233	4	reported	report	VERB
ajb-7	233	5	that	that	SCONJ
ajb-7	233	6	the	the	DET
ajb-7	233	7	level	level	NOUN
ajb-7	233	8	of	of	ADP
ajb-7	233	9	total	total	ADJ
ajb-7	233	10	cholesterol	cholesterol	NOUN
ajb-7	233	11	was	be	AUX
ajb-7	233	12	positively	positively	ADV
ajb-7	233	13	related	relate	VERB
ajb-7	233	14	to	to	ADP
ajb-7	233	15	the	the	DET
ajb-7	233	16	prevalence	prevalence	NOUN
ajb-7	233	17	of	of	ADP
ajb-7	233	18	systolic	systolic	ADJ
ajb-7	233	19	htn	htn	NOUN
ajb-7	233	20	and	and	CCONJ
ajb-7	233	21	obesity	obesity	NOUN
ajb-7	233	22	,	,	PUNCT
ajb-7	233	23	in	in	ADP
ajb-7	233	24	addition	addition	NOUN
ajb-7	233	25	to	to	ADP
ajb-7	233	26	smoking	smoking	NOUN
ajb-7	233	27	(	(	PUNCT
ajb-7	233	28	rywik	rywik	PROPN
ajb-7	233	29	et	et	PROPN
ajb-7	233	30	al	al	PROPN
ajb-7	233	31	.	.	PROPN
ajb-7	233	32	,	,	PUNCT
ajb-7	233	33	1999	1999	NUM
ajb-7	233	34	)	)	PUNCT
ajb-7	233	35	.	.	PUNCT
ajb-7	234	1	a	a	DET
ajb-7	234	2	meta	meta	ADJ
ajb-7	234	3	-	-	PUNCT
ajb-7	234	4	analysis	analysis	NOUN
ajb-7	234	5	was	be	AUX
ajb-7	234	6	conducted	conduct	VERB
ajb-7	234	7	by	by	ADP
ajb-7	234	8	rywik	rywik	PROPN
ajb-7	234	9	et	et	PROPN
ajb-7	234	10	al	al	PROPN
ajb-7	234	11	.	.	PUNCT
ajb-7	235	1	(	(	PUNCT
ajb-7	235	2	1999	1999	NUM
ajb-7	235	3	)	)	PUNCT
ajb-7	235	4	,	,	PUNCT
ajb-7	235	5	where	where	SCONJ
ajb-7	235	6	they	they	PRON
ajb-7	235	7	concluded	conclude	VERB
ajb-7	235	8	that	that	SCONJ
ajb-7	235	9	for	for	ADP
ajb-7	235	10	every	every	DET
ajb-7	235	11	10	10	NUM
ajb-7	235	12	%	%	NOUN
ajb-7	235	13	reduction	reduction	NOUN
ajb-7	235	14	in	in	ADP
ajb-7	235	15	tc	tc	NOUN
ajb-7	235	16	,	,	PUNCT
ajb-7	235	17	there	there	PRON
ajb-7	235	18	was	be	VERB
ajb-7	235	19	2.5	2.5	NUM
ajb-7	235	20	%	%	NOUN
ajb-7	235	21	decrease	decrease	NOUN
ajb-7	235	22	in	in	ADP
ajb-7	235	23	the	the	DET
ajb-7	235	24	incidence	incidence	NOUN
ajb-7	235	25	of	of	ADP
ajb-7	235	26	chd	chd	NOUN
ajb-7	235	27	.	.	PUNCT
ajb-7	236	1	a	a	DET
ajb-7	236	2	multivariate	multivariate	NOUN
ajb-7	236	3	analysis	analysis	NOUN
ajb-7	236	4	performed	perform	VERB
ajb-7	236	5	on	on	ADP
ajb-7	236	6	a	a	DET
ajb-7	236	7	canadian	canadian	ADJ
ajb-7	236	8	population	population	NOUN
ajb-7	236	9	indicated	indicate	VERB
ajb-7	236	10	that	that	SCONJ
ajb-7	236	11	the	the	DET
ajb-7	236	12	low	low	ADJ
ajb-7	236	13	hdl	hdl	PROPN
ajb-7	236	14	-	-	PUNCT
ajb-7	236	15	c	c	PROPN
ajb-7	236	16	and	and	CCONJ
ajb-7	236	17	smoking	smoking	NOUN
ajb-7	236	18	were	be	AUX
ajb-7	236	19	the	the	DET
ajb-7	236	20	best	good	ADJ
ajb-7	236	21	predictors	predictor	NOUN
ajb-7	236	22	of	of	ADP
ajb-7	236	23	risk	risk	NOUN
ajb-7	236	24	and	and	CCONJ
ajb-7	236	25	the	the	DET
ajb-7	236	26	average	average	ADJ
ajb-7	236	27	age	age	NOUN
ajb-7	236	28	of	of	ADP
ajb-7	236	29	onset	onset	NOUN
ajb-7	236	30	of	of	ADP
ajb-7	236	31	coronary	coronary	ADJ
ajb-7	236	32	symptom	symptom	NOUN
ajb-7	236	33	were	be	AUX
ajb-7	236	34	delayed	delay	VERB
ajb-7	236	35	in	in	ADP
ajb-7	236	36	females	female	NOUN
ajb-7	236	37	(	(	PUNCT
ajb-7	236	38	55	55	NUM
ajb-7	236	39	years	year	NOUN
ajb-7	236	40	)	)	PUNCT
ajb-7	236	41	compared	compare	VERB
ajb-7	236	42	to	to	ADP
ajb-7	236	43	males	male	NOUN
ajb-7	236	44	(	(	PUNCT
ajb-7	236	45	48	48	NUM
ajb-7	236	46	years	year	NOUN
ajb-7	236	47	)	)	PUNCT
ajb-7	236	48	(	(	PUNCT
ajb-7	236	49	weber	weber	PROPN
ajb-7	236	50	et	et	PROPN
ajb-7	236	51	al	al	PROPN
ajb-7	236	52	.	.	PROPN
ajb-7	236	53	,	,	PUNCT
ajb-7	236	54	1997	1997	NUM
ajb-7	236	55	)	)	PUNCT
ajb-7	236	56	.	.	PUNCT
ajb-7	237	1	the	the	DET
ajb-7	237	2	risk	risk	NOUN
ajb-7	237	3	of	of	ADP
ajb-7	237	4	developing	develop	VERB
ajb-7	237	5	heart	heart	NOUN
ajb-7	237	6	related	relate	VERB
ajb-7	237	7	problems	problem	NOUN
ajb-7	237	8	has	have	AUX
ajb-7	237	9	also	also	ADV
ajb-7	237	10	been	be	AUX
ajb-7	237	11	connected	connect	VERB
ajb-7	237	12	with	with	ADP
ajb-7	237	13	the	the	DET
ajb-7	237	14	lower	low	ADJ
ajb-7	237	15	levels	level	NOUN
ajb-7	237	16	of	of	ADP
ajb-7	237	17	hdl	hdl	PROPN
ajb-7	237	18	-	-	PUNCT
ajb-7	237	19	c	c	PROPN
ajb-7	237	20	and	and	CCONJ
ajb-7	237	21	a	a	DET
ajb-7	237	22	history	history	NOUN
ajb-7	237	23	of	of	ADP
ajb-7	237	24	smoking	smoking	NOUN
ajb-7	237	25	;	;	PUNCT
ajb-7	237	26	however	however	ADV
ajb-7	237	27	,	,	PUNCT
ajb-7	237	28	in	in	ADP
ajb-7	237	29	women	woman	NOUN
ajb-7	237	30	,	,	PUNCT
ajb-7	237	31	the	the	DET
ajb-7	237	32	heart	heart	NOUN
ajb-7	237	33	related	relate	VERB
ajb-7	237	34	problems	problem	NOUN
ajb-7	237	35	were	be	AUX
ajb-7	237	36	mainly	mainly	ADV
ajb-7	237	37	associated	associate	VERB
ajb-7	237	38	with	with	ADP
ajb-7	237	39	elevated	elevated	ADJ
ajb-7	237	40	tg	tg	PROPN
ajb-7	237	41	levels	level	NOUN
ajb-7	237	42	and	and	CCONJ
ajb-7	237	43	the	the	DET
ajb-7	237	44	presence	presence	NOUN
ajb-7	237	45	of	of	ADP
ajb-7	237	46	htn	htn	PROPN
ajb-7	237	47	(	(	PUNCT
ajb-7	237	48	hill	hill	NOUN
ajb-7	237	49	et	et	PROPN
ajb-7	237	50	al	al	PROPN
ajb-7	237	51	.	.	PROPN
ajb-7	237	52	,	,	PUNCT
ajb-7	237	53	1991	1991	NUM
ajb-7	237	54	;	;	PUNCT
ajb-7	237	55	neil	neil	PROPN
ajb-7	237	56	et	et	PROPN
ajb-7	237	57	al	al	PROPN
ajb-7	237	58	.	.	PROPN
ajb-7	237	59	,	,	PUNCT
ajb-7	237	60	2004	2004	NUM
ajb-7	237	61	)	)	PUNCT
ajb-7	237	62	.	.	PUNCT
ajb-7	238	1	our	our	PRON
ajb-7	238	2	results	result	NOUN
ajb-7	238	3	are	be	AUX
ajb-7	238	4	in	in	ADP
ajb-7	238	5	agreement	agreement	NOUN
ajb-7	238	6	with	with	ADP
ajb-7	238	7	earlier	early	ADV
ajb-7	238	8	published	publish	VERB
ajb-7	238	9	reports	report	NOUN
ajb-7	238	10	(	(	PUNCT
ajb-7	238	11	vuario	vuario	NOUN
ajb-7	238	12	et	et	PROPN
ajb-7	238	13	al	al	PROPN
ajb-7	238	14	.	.	PROPN
ajb-7	238	15	,	,	PUNCT
ajb-7	238	16	1997	1997	NUM
ajb-7	238	17	;	;	PUNCT
ajb-7	238	18	jansen	jansen	PROPN
ajb-7	238	19	,	,	PUNCT
ajb-7	238	20	2004	2004	NUM
ajb-7	238	21	)	)	PUNCT
ajb-7	238	22	on	on	ADP
ajb-7	238	23	the	the	DET
ajb-7	238	24	risk	risk	NOUN
ajb-7	238	25	factors	factor	NOUN
ajb-7	238	26	like	like	ADP
ajb-7	238	27	age	age	NOUN
ajb-7	238	28	,	,	PUNCT
ajb-7	238	29	sex	sex	NOUN
ajb-7	238	30	,	,	PUNCT
ajb-7	238	31	smoking	smoking	NOUN
ajb-7	238	32	and	and	CCONJ
ajb-7	238	33	htn	htn	PROPN
ajb-7	238	34	.	.	PUNCT
ajb-7	239	1	our	our	PRON
ajb-7	239	2	results	result	NOUN
ajb-7	239	3	are	be	AUX
ajb-7	239	4	consistent	consistent	ADJ
ajb-7	239	5	with	with	ADP
ajb-7	239	6	accumulating	accumulate	VERB
ajb-7	239	7	evidence	evidence	NOUN
ajb-7	239	8	from	from	ADP
ajb-7	239	9	a	a	DET
ajb-7	239	10	number	number	NOUN
ajb-7	239	11	of	of	ADP
ajb-7	239	12	cross	cross	ADJ
ajb-7	239	13	-	-	ADJ
ajb-7	239	14	sectional	sectional	ADJ
ajb-7	239	15	population	population	NOUN
ajb-7	239	16	and	and	CCONJ
ajb-7	239	17	case	case	NOUN
ajb-7	239	18	control	control	NOUN
ajb-7	239	19	studies	study	NOUN
ajb-7	239	20	that	that	PRON
ajb-7	239	21	have	have	AUX
ajb-7	239	22	assessed	assess	VERB
ajb-7	239	23	the	the	DET
ajb-7	239	24	role	role	NOUN
ajb-7	239	25	of	of	ADP
ajb-7	239	26	established	establish	VERB
ajb-7	239	27	and	and	CCONJ
ajb-7	239	28	emerging	emerge	VERB
ajb-7	239	29	risk	risk	NOUN
ajb-7	239	30	factors	factor	NOUN
ajb-7	239	31	in	in	ADP
ajb-7	239	32	individuals	individual	NOUN
ajb-7	239	33	with	with	ADP
ajb-7	239	34	fh	fh	PROPN
ajb-7	239	35	.	.	PUNCT
ajb-7	240	1	this	this	DET
ajb-7	240	2	study	study	NOUN
ajb-7	240	3	on	on	ADP
ajb-7	240	4	a	a	DET
ajb-7	240	5	pakistani	pakistani	ADJ
ajb-7	240	6	population	population	NOUN
ajb-7	240	7	has	have	AUX
ajb-7	240	8	shown	show	VERB
ajb-7	240	9	that	that	SCONJ
ajb-7	240	10	fh	fh	PROPN
ajb-7	240	11	is	be	AUX
ajb-7	240	12	linked	link	VERB
ajb-7	240	13	to	to	PART
ajb-7	240	14	risk	risk	NOUN
ajb-7	240	15	factors	factor	NOUN
ajb-7	240	16	such	such	ADJ
ajb-7	240	17	as	as	ADP
ajb-7	240	18	age	age	NOUN
ajb-7	240	19	,	,	PUNCT
ajb-7	240	20	smoking	smoking	NOUN
ajb-7	240	21	and	and	CCONJ
ajb-7	240	22	htn	htn	NOUN
ajb-7	240	23	in	in	ADP
ajb-7	240	24	addition	addition	NOUN
ajb-7	240	25	to	to	ADP
ajb-7	240	26	total	total	ADJ
ajb-7	240	27	cholesterol	cholesterol	NOUN
ajb-7	240	28	levels	level	NOUN
ajb-7	240	29	and	and	CCONJ
ajb-7	240	30	to	to	ADP
ajb-7	240	31	a	a	DET
ajb-7	240	32	larger	large	ADJ
ajb-7	240	33	extent	extent	NOUN
ajb-7	240	34	was	be	AUX
ajb-7	240	35	associated	associate	VERB
ajb-7	240	36	with	with	ADP
ajb-7	240	37	the	the	DET
ajb-7	240	38	development	development	NOUN
ajb-7	240	39	of	of	ADP
ajb-7	240	40	premature	premature	ADJ
ajb-7	240	41	heart	heart	NOUN
ajb-7	240	42	diseases	disease	NOUN
ajb-7	240	43	as	as	ADV
ajb-7	240	44	well	well	ADV
ajb-7	240	45	as	as	ADP
ajb-7	240	46	in	in	ADP
ajb-7	240	47	the	the	DET
ajb-7	240	48	phenotypic	phenotypic	ADJ
ajb-7	240	49	expression	expression	NOUN
ajb-7	240	50	in	in	ADP
ajb-7	240	51	heterozygous	heterozygous	ADJ
ajb-7	240	52	fh	fh	PROPN
ajb-7	240	53	.	.	PUNCT
ajb-7	241	1	upon	upon	SCONJ
ajb-7	241	2	diagnosis	diagnosis	NOUN
ajb-7	241	3	the	the	DET
ajb-7	241	4	fh	fh	PROPN
ajb-7	241	5	patients	patient	NOUN
ajb-7	241	6	should	should	AUX
ajb-7	241	7	immediately	immediately	ADV
ajb-7	241	8	be	be	AUX
ajb-7	241	9	treated	treat	VERB
ajb-7	241	10	and	and	CCONJ
ajb-7	241	11	if	if	SCONJ
ajb-7	241	12	left	leave	VERB
ajb-7	241	13	untreated	untreated	ADJ
ajb-7	241	14	,	,	PUNCT
ajb-7	241	15	they	they	PRON
ajb-7	241	16	have	have	VERB
ajb-7	241	17	a	a	DET
ajb-7	241	18	high	high	ADJ
ajb-7	241	19	chance	chance	NOUN
ajb-7	241	20	(	(	PUNCT
ajb-7	241	21	about	about	ADV
ajb-7	241	22	8	8	NUM
ajb-7	241	23	times	time	NOUN
ajb-7	241	24	)	)	PUNCT
ajb-7	241	25	of	of	ADP
ajb-7	241	26	early	early	ADJ
ajb-7	241	27	coronary	coronary	ADJ
ajb-7	241	28	heart	heart	NOUN
ajb-7	241	29	disease	disease	NOUN
ajb-7	241	30	(	(	PUNCT
ajb-7	241	31	chd	chd	NOUN
ajb-7	241	32	)	)	PUNCT
ajb-7	241	33	.	.	PUNCT
ajb-7	242	1	cholesterol	cholesterol	NOUN
ajb-7	242	2	can	can	AUX
ajb-7	242	3	be	be	AUX
ajb-7	242	4	accumulated	accumulate	VERB
ajb-7	242	5	in	in	ADP
ajb-7	242	6	the	the	DET
ajb-7	242	7	coronary	coronary	ADJ
ajb-7	242	8	arteries	artery	NOUN
ajb-7	242	9	of	of	ADP
ajb-7	242	10	the	the	DET
ajb-7	242	11	heart	heart	NOUN
ajb-7	242	12	causing	cause	VERB
ajb-7	242	13	angina	angina	NOUN
ajb-7	242	14	or	or	CCONJ
ajb-7	242	15	heart	heart	NOUN
ajb-7	242	16	attacks	attack	NOUN
ajb-7	242	17	.	.	PUNCT
ajb-7	243	1	other	other	ADJ
ajb-7	243	2	factors	factor	NOUN
ajb-7	243	3	that	that	PRON
ajb-7	243	4	increase	increase	VERB
ajb-7	243	5	the	the	DET
ajb-7	243	6	risk	risk	NOUN
ajb-7	243	7	of	of	ADP
ajb-7	243	8	chd	chd	PROPN
ajb-7	243	9	are	be	AUX
ajb-7	243	10	smoking	smoking	NOUN
ajb-7	243	11	and	and	CCONJ
ajb-7	243	12	high	high	ADJ
ajb-7	243	13	blood	blood	NOUN
ajb-7	243	14	pressure	pressure	NOUN
ajb-7	243	15	.	.	PUNCT
ajb-7	244	1	however	however	ADV
ajb-7	244	2	,	,	PUNCT
ajb-7	244	3	fh	fh	PROPN
ajb-7	244	4	is	be	AUX
ajb-7	244	5	a	a	DET
ajb-7	244	6	very	very	ADV
ajb-7	244	7	treatable	treatable	ADJ
ajb-7	244	8	condition	condition	NOUN
ajb-7	244	9	which	which	PRON
ajb-7	244	10	can	can	AUX
ajb-7	244	11	be	be	AUX
ajb-7	244	12	controlled	control	VERB
ajb-7	244	13	with	with	ADP
ajb-7	244	14	the	the	DET
ajb-7	244	15	use	use	NOUN
ajb-7	244	16	of	of	ADP
ajb-7	244	17	cholesterol	cholesterol	NOUN
ajb-7	244	18	-	-	PUNCT
ajb-7	244	19	lowering	lower	VERB
ajb-7	244	20	drugs	drug	NOUN
ajb-7	244	21	combined	combine	VERB
ajb-7	244	22	with	with	ADP
ajb-7	244	23	a	a	DET
ajb-7	244	24	healthy	healthy	ADJ
ajb-7	244	25	lifestyle	lifestyle	NOUN
ajb-7	244	26	.	.	PUNCT
ajb-7	245	1	it	it	PRON
ajb-7	245	2	is	be	AUX
ajb-7	245	3	now	now	ADV
ajb-7	245	4	known	know	VERB
ajb-7	245	5	that	that	SCONJ
ajb-7	245	6	people	people	NOUN
ajb-7	245	7	with	with	ADP
ajb-7	245	8	fh	fh	PROPN
ajb-7	245	9	who	who	PRON
ajb-7	245	10	are	be	AUX
ajb-7	245	11	treated	treat	VERB
ajb-7	245	12	can	can	AUX
ajb-7	245	13	expect	expect	VERB
ajb-7	245	14	to	to	PART
ajb-7	245	15	have	have	VERB
ajb-7	245	16	a	a	DET
ajb-7	245	17	life	life	NOUN
ajb-7	245	18	expectancy	expectancy	NOUN
ajb-7	245	19	which	which	PRON
ajb-7	245	20	is	be	AUX
ajb-7	245	21	the	the	DET
ajb-7	245	22	same	same	ADJ
ajb-7	245	23	as	as	ADP
ajb-7	245	24	the	the	DET
ajb-7	245	25	general	general	ADJ
ajb-7	245	26	population	population	NOUN
ajb-7	245	27	.	.	PUNCT
ajb-7	246	1	therefore	therefore	ADV
ajb-7	246	2	it	it	PRON
ajb-7	246	3	is	be	AUX
ajb-7	246	4	vitally	vitally	ADV
ajb-7	246	5	important	important	ADJ
ajb-7	246	6	to	to	PART
ajb-7	246	7	diagnose	diagnose	VERB
ajb-7	246	8	this	this	DET
ajb-7	246	9	condition	condition	NOUN
ajb-7	246	10	as	as	ADV
ajb-7	246	11	early	early	ADV
ajb-7	246	12	as	as	ADP
ajb-7	246	13	possible	possible	ADJ
ajb-7	246	14	so	so	SCONJ
ajb-7	246	15	that	that	SCONJ
ajb-7	246	16	the	the	DET
ajb-7	246	17	right	right	ADJ
ajb-7	246	18	treatment	treatment	NOUN
ajb-7	246	19	can	can	AUX
ajb-7	246	20	be	be	AUX
ajb-7	246	21	started	start	VERB
ajb-7	246	22	and	and	CCONJ
ajb-7	246	23	heart	heart	NOUN
ajb-7	246	24	attacks	attack	NOUN
ajb-7	246	25	can	can	AUX
ajb-7	246	26	be	be	AUX
ajb-7	246	27	prevented	prevent	VERB
ajb-7	246	28	.	.	PUNCT
ajb-7	247	1	references	reference	NOUN
ajb-7	247	2	abifadel	abifadel	PROPN
ajb-7	247	3	m	m	PROPN
ajb-7	247	4	,	,	PUNCT
ajb-7	247	5	varret	varret	PROPN
ajb-7	247	6	m	m	PROPN
ajb-7	247	7	,	,	PUNCT
ajb-7	247	8	rabes	rabe	NOUN
ajb-7	247	9	jp	jp	PROPN
ajb-7	247	10	,	,	PUNCT
ajb-7	247	11	allard	allard	PROPN
ajb-7	247	12	d	d	PROPN
ajb-7	247	13	,	,	PUNCT
ajb-7	247	14	ouguerram	ouguerram	PROPN
ajb-7	247	15	k	k	PROPN
ajb-7	247	16	,	,	PUNCT
ajb-7	247	17	devillers	devillers	PROPN
ajb-7	247	18	m	m	PROPN
ajb-7	247	19	,	,	PUNCT
ajb-7	247	20	cruaud	cruaud	VERB
ajb-7	247	21	c	c	X
ajb-7	247	22	,	,	PUNCT
ajb-7	247	23	benjannet	benjannet	PROPN
ajb-7	247	24	s	s	PROPN
ajb-7	247	25	,	,	PUNCT
ajb-7	247	26	wickham	wickham	PROPN
ajb-7	247	27	l	l	PROPN
ajb-7	247	28	,	,	PUNCT
ajb-7	247	29	erlich	erlich	PROPN
ajb-7	247	30	d	d	NOUN
ajb-7	247	31	,	,	PUNCT
ajb-7	247	32	derre	derre	VERB
ajb-7	247	33	a	a	DET
ajb-7	247	34	,	,	PUNCT
ajb-7	247	35	villeger	villeger	ADJ
ajb-7	247	36	l	l	NOUN
ajb-7	247	37	,	,	PUNCT
ajb-7	247	38	farnier	farnier	PROPN
ajb-7	247	39	m	m	PROPN
ajb-7	247	40	,	,	PUNCT
ajb-7	247	41	beucler	beucler	NOUN
ajb-7	247	42	i	i	PROPN
ajb-7	247	43	,	,	PUNCT
ajb-7	247	44	bruckert	bruckert	PROPN
ajb-7	247	45	e	e	PROPN
ajb-7	247	46	,	,	PUNCT
ajb-7	247	47	chambaz	chambaz	PROPN
ajb-7	247	48	j	j	PROPN
ajb-7	247	49	,	,	PUNCT
ajb-7	247	50	chanu	chanu	PROPN
ajb-7	247	51	b	b	NUM
ajb-7	247	52	,	,	PUNCT
ajb-7	247	53	lecerf	lecerf	PROPN
ajb-7	247	54	jm	jm	PROPN
ajb-7	247	55	,	,	PUNCT
ajb-7	247	56	luc	luc	PROPN
ajb-7	247	57	g	g	PROPN
ajb-7	247	58	,	,	PUNCT
ajb-7	247	59	moulin	moulin	PROPN
ajb-7	247	60	p	p	PROPN
ajb-7	247	61	,	,	PUNCT
ajb-7	247	62	weissenbach	weissenbach	ADJ
ajb-7	247	63	j	j	NOUN
ajb-7	247	64	,	,	PUNCT
ajb-7	247	65	prat	prat	VERB
ajb-7	247	66	a	a	NOUN
ajb-7	247	67	,	,	PUNCT
ajb-7	247	68	krempf	krempf	PROPN
ajb-7	247	69	m	m	PROPN
ajb-7	247	70	,	,	PUNCT
ajb-7	247	71	junien	junien	PROPN
ajb-7	247	72	c	c	PROPN
ajb-7	247	73	,	,	PUNCT
ajb-7	247	74	seidah	seidah	NOUN
ajb-7	247	75	ng	ng	PROPN
ajb-7	247	76	,	,	PUNCT
ajb-7	247	77	boileau	boileau	PROPN
ajb-7	247	78	c	c	PROPN
ajb-7	247	79	(	(	PUNCT
ajb-7	247	80	2003	2003	NUM
ajb-7	247	81	)	)	PUNCT
ajb-7	247	82	mutations	mutation	NOUN
ajb-7	247	83	in	in	ADP
ajb-7	247	84	pcsk9	pcsk9	PROPN
ajb-7	247	85	cause	cause	VERB
ajb-7	247	86	autosomal	autosomal	ADJ
ajb-7	247	87	dominant	dominant	ADJ
ajb-7	247	88	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	247	89	.	.	PUNCT
ajb-7	248	1	nat	nat	PROPN
ajb-7	248	2	genet	genet	PROPN
ajb-7	248	3	.	.	PUNCT
ajb-7	249	1	34	34	NUM
ajb-7	249	2	:	:	PUNCT
ajb-7	249	3	154–156	154–156	NUM
ajb-7	249	4	.	.	PUNCT
ajb-7	250	1	alonso	alonso	PROPN
ajb-7	250	2	r	r	PROPN
ajb-7	250	3	,	,	PUNCT
ajb-7	250	4	defesche	defesche	PROPN
ajb-7	250	5	jc	jc	PROPN
ajb-7	250	6	,	,	PUNCT
ajb-7	250	7	tejedor	tejedor	PROPN
ajb-7	250	8	d	d	PROPN
ajb-7	250	9	,	,	PUNCT
ajb-7	250	10	castillo	castillo	PROPN
ajb-7	250	11	s	s	PROPN
ajb-7	250	12	,	,	PUNCT
ajb-7	250	13	stef	stef	PROPN
ajb-7	250	14	m	m	PROPN
ajb-7	250	15	,	,	PUNCT
ajb-7	250	16	mata	mata	PROPN
ajb-7	250	17	n	n	CCONJ
ajb-7	250	18	,	,	PUNCT
ajb-7	250	19	gomezenterria	gomezenterria	PROPN
ajb-7	250	20	p	p	PROPN
ajb-7	250	21	,	,	PUNCT
ajb-7	250	22	martinez	martinez	PROPN
ajb-7	250	23	-	-	PUNCT
ajb-7	250	24	faedo	faedo	VERB
ajb-7	250	25	c	c	NOUN
ajb-7	250	26	,	,	PUNCT
ajb-7	250	27	forga	forga	PROPN
ajb-7	250	28	l	l	NOUN
ajb-7	250	29	,	,	PUNCT
ajb-7	250	30	pedro	pedro	PROPN
ajb-7	250	31	mata	mata	PROPN
ajb-7	250	32	(	(	PUNCT
ajb-7	250	33	2009	2009	NUM
ajb-7	250	34	)	)	PUNCT
ajb-7	250	35	genetic	genetic	ADJ
ajb-7	250	36	diagnosis	diagnosis	NOUN
ajb-7	250	37	of	of	ADP
ajb-7	250	38	familial	familial	ADJ
ajb-7	250	39	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	250	40	using	use	VERB
ajb-7	250	41	a	a	DET
ajb-7	250	42	dna	dna	NOUN
ajb-7	250	43	-	-	PUNCT
ajb-7	250	44	array	array	NOUN
ajb-7	250	45	based	base	VERB
ajb-7	250	46	platform	platform	NOUN
ajb-7	250	47	.	.	PUNCT
ajb-7	251	1	clin	clin	PROPN
ajb-7	251	2	biochem	biochem	PROPN
ajb-7	251	3	.	.	PUNCT
ajb-7	252	1	42	42	NUM
ajb-7	252	2	(	(	PUNCT
ajb-7	252	3	9	9	NUM
ajb-7	252	4	):	):	PUNCT
ajb-7	252	5	899	899	NUM
ajb-7	252	6	-	-	SYM
ajb-7	252	7	903	903	NUM
ajb-7	252	8	.	.	PUNCT
ajb-7	253	1	austin	austin	PROPN
ajb-7	253	2	ma	ma	PROPN
ajb-7	253	3	,	,	PUNCT
ajb-7	253	4	cm	cm	NOUN
ajb-7	253	5	hutter	hutter	NOUN
ajb-7	253	6	,	,	PUNCT
ajb-7	253	7	rl	rl	PROPN
ajb-7	253	8	zimmern	zimmern	PROPN
ajb-7	253	9	,	,	PUNCT
ajb-7	253	10	and	and	CCONJ
ajb-7	253	11	se	se	PROPN
ajb-7	253	12	humphries	humphries	PROPN
ajb-7	253	13	(	(	PUNCT
ajb-7	253	14	2004	2004	NUM
ajb-7	253	15	)	)	PUNCT
ajb-7	253	16	familial	familial	ADJ
ajb-7	253	17	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	253	18	and	and	CCONJ
ajb-7	253	19	coronary	coronary	ADJ
ajb-7	253	20	heart	heart	NOUN
ajb-7	253	21	disease	disease	NOUN
ajb-7	253	22	:	:	PUNCT
ajb-7	253	23	a	a	DET
ajb-7	253	24	huge	huge	ADJ
ajb-7	253	25	association	association	NOUN
ajb-7	253	26	review	review	NOUN
ajb-7	253	27	:	:	PUNCT
ajb-7	253	28	am	be	AUX
ajb-7	253	29	j	j	PROPN
ajb-7	253	30	epidemiol	epidemiol	PROPN
ajb-7	253	31	160	160	NUM
ajb-7	253	32	:	:	PUNCT
ajb-7	253	33	421	421	NUM
ajb-7	253	34	-	-	SYM
ajb-7	253	35	429	429	NUM
ajb-7	253	36	.	.	PUNCT
ajb-7	254	1	baron	baron	PROPN
ajb-7	254	2	h	h	PROPN
ajb-7	254	3	,	,	PUNCT
ajb-7	254	4	fung	fung	PROPN
ajb-7	254	5	s	s	PROPN
ajb-7	254	6	,	,	PUNCT
ajb-7	254	7	aydin	aydin	VERB
ajb-7	254	8	a	a	PRON
ajb-7	254	9	,	,	PUNCT
ajb-7	254	10	bahring	bahre	VERB
ajb-7	254	11	s	s	PART
ajb-7	254	12	,	,	PUNCT
ajb-7	254	13	luft	luft	PROPN
ajb-7	254	14	fc	fc	PROPN
ajb-7	254	15	,	,	PUNCT
ajb-7	254	16	schuster	schuster	PROPN
ajb-7	254	17	h	h	PROPN
ajb-7	254	18	(	(	PUNCT
ajb-7	254	19	1996	1996	NUM
ajb-7	254	20	)	)	PUNCT
ajb-7	254	21	oligonucleotide	oligonucleotide	NOUN
ajb-7	254	22	ligation	ligation	NOUN
ajb-7	254	23	assay	assay	PROPN
ajb-7	254	24	(	(	PUNCT
ajb-7	254	25	ola	ola	PROPN
ajb-7	254	26	)	)	PUNCT
ajb-7	254	27	for	for	ADP
ajb-7	254	28	the	the	DET
ajb-7	254	29	diagnosis	diagnosis	NOUN
ajb-7	254	30	of	of	ADP
ajb-7	254	31	familial	familial	ADJ
ajb-7	254	32	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	254	33	.	.	PUNCT
ajb-7	255	1	nat	nat	PROPN
ajb-7	255	2	biotechnol	biotechnol	NOUN
ajb-7	255	3	.	.	PUNCT
ajb-7	256	1	14:1279–1282	14:1279–1282	NUM
ajb-7	256	2	.	.	PUNCT
ajb-7	257	1	bertolini	bertolini	PROPN
ajb-7	257	2	s	s	PROPN
ajb-7	257	3	,	,	PUNCT
ajb-7	257	4	l	l	NOUN
ajb-7	257	5	pisciotta	pisciotta	NOUN
ajb-7	257	6	,	,	PUNCT
ajb-7	257	7	l	l	PROPN
ajb-7	257	8	di	di	X
ajb-7	257	9	scala	scala	PROPN
ajb-7	257	10	,	,	PUNCT
ajb-7	257	11	s	s	PART
ajb-7	257	12	langheim	langheim	NOUN
ajb-7	257	13	,	,	PUNCT
ajb-7	257	14	a	a	DET
ajb-7	257	15	bellocchio	bellocchio	NOUN
ajb-7	257	16	,	,	PUNCT
ajb-7	257	17	p	p	NOUN
ajb-7	257	18	masturzo	masturzo	NOUN
ajb-7	257	19	,	,	PUNCT
ajb-7	257	20	a	a	DET
ajb-7	257	21	cantafora	cantafora	NOUN
ajb-7	257	22	,	,	PUNCT
ajb-7	257	23	s	s	NOUN
ajb-7	257	24	martini	martini	NOUN
ajb-7	257	25	,	,	PUNCT
ajb-7	257	26	m	m	NOUN
ajb-7	257	27	averna	averna	NOUN
ajb-7	257	28	,	,	PUNCT
ajb-7	257	29	g	g	PROPN
ajb-7	257	30	pes	pes	PROPN
ajb-7	257	31	,	,	PUNCT
ajb-7	257	32	c	c	NOUN
ajb-7	257	33	stefanutti	stefanutti	NOUN
ajb-7	257	34	,	,	PUNCT
ajb-7	257	35	and	and	CCONJ
ajb-7	257	36	s	s	PROPN
ajb-7	257	37	calandra	calandra	PROPN
ajb-7	257	38	(	(	PUNCT
ajb-7	257	39	2004	2004	NUM
ajb-7	257	40	)	)	PUNCT
ajb-7	257	41	genetic	genetic	ADJ
ajb-7	257	42	polymorphisms	polymorphism	NOUN
ajb-7	257	43	affecting	affect	VERB
ajb-7	257	44	the	the	DET
ajb-7	257	45	phenotypic	phenotypic	ADJ
ajb-7	257	46	expression	expression	NOUN
ajb-7	257	47	of	of	ADP
ajb-7	257	48	familial	familial	ADJ
ajb-7	257	49	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	257	50	.	.	PUNCT
ajb-7	258	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	258	2	174	174	NUM
ajb-7	258	3	(	(	PUNCT
ajb-7	258	4	1	1	NUM
ajb-7	258	5	):	):	PUNCT
ajb-7	258	6	57	57	NUM
ajb-7	258	7	-	-	SYM
ajb-7	258	8	65	65	NUM
ajb-7	258	9	.	.	PUNCT
ajb-7	259	1	castelli	castelli	PROPN
ajb-7	259	2	wp	wp	PROPN
ajb-7	259	3	,	,	PUNCT
ajb-7	259	4	rj	rj	PROPN
ajb-7	259	5	garrison	garrison	NOUN
ajb-7	259	6	,	,	PUNCT
ajb-7	259	7	pwf	pwf	PROPN
ajb-7	259	8	wilson	wilson	PROPN
ajb-7	259	9	,	,	PUNCT
ajb-7	259	10	rd	rd	PROPN
ajb-7	259	11	abbott	abbott	PROPN
ajb-7	259	12	,	,	PUNCT
ajb-7	259	13	s.	s.	PROPN
ajb-7	259	14	kalousdian	kalousdian	PROPN
ajb-7	259	15	,	,	PUNCT
ajb-7	259	16	and	and	CCONJ
ajb-7	259	17	w.	w.	PROPN
ajb-7	259	18	b.	b.	PROPN
ajb-7	259	19	kannel	kannel	PROPN
ajb-7	259	20	(	(	PUNCT
ajb-7	259	21	1986	1986	NUM
ajb-7	259	22	)	)	PUNCT
ajb-7	259	23	incidence	incidence	NOUN
ajb-7	259	24	of	of	ADP
ajb-7	259	25	coronary	coronary	ADJ
ajb-7	259	26	heart	heart	NOUN
ajb-7	259	27	disease	disease	NOUN
ajb-7	259	28	and	and	CCONJ
ajb-7	259	29	lipoprotein	lipoprotein	ADJ
ajb-7	259	30	cholesterol	cholesterol	NOUN
ajb-7	259	31	levels	level	NOUN
ajb-7	259	32	.	.	PUNCT
ajb-7	260	1	the	the	DET
ajb-7	260	2	framingham	framingham	PROPN
ajb-7	260	3	study	study	PROPN
ajb-7	260	4	.	.	PUNCT
ajb-7	261	1	jama	jama	PROPN
ajb-7	261	2	256	256	NUM
ajb-7	261	3	:	:	SYM
ajb-7	261	4	28352838	28352838	NUM
ajb-7	261	5	.	.	PUNCT
ajb-7	262	1	castro	castro	NOUN
ajb-7	262	2	-	-	PUNCT
ajb-7	262	3	orós	orós	ADV
ajb-7	262	4	i	i	PROPN
ajb-7	262	5	d	d	PROPN
ajb-7	262	6	,	,	PUNCT
ajb-7	262	7	pocoví	pocoví	NOUN
ajb-7	262	8	m	m	PROPN
ajb-7	262	9	,	,	PUNCT
ajb-7	262	10	civeira	civeira	PROPN
ajb-7	262	11	f	f	PROPN
ajb-7	262	12	(	(	PUNCT
ajb-7	262	13	2010	2010	NUM
ajb-7	262	14	)	)	PUNCT
ajb-7	262	15	the	the	DET
ajb-7	262	16	genetic	genetic	ADJ
ajb-7	262	17	basis	basis	NOUN
ajb-7	262	18	of	of	ADP
ajb-7	262	19	familial	familial	ADJ
ajb-7	262	20	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	262	21	:	:	PUNCT
ajb-7	262	22	inheritance	inheritance	NOUN
ajb-7	262	23	,	,	PUNCT
ajb-7	262	24	linkage	linkage	NOUN
ajb-7	262	25	,	,	PUNCT
ajb-7	262	26	and	and	CCONJ
ajb-7	262	27	mutations.the	mutations.the	DET
ajb-7	262	28	application	application	NOUN
ajb-7	262	29	of	of	ADP
ajb-7	262	30	clinical	clinical	ADJ
ajb-7	262	31	genetics	genetic	NOUN
ajb-7	262	32	3	3	NUM
ajb-7	262	33	:	:	PUNCT
ajb-7	262	34	53–64	53–64	NUM
ajb-7	262	35	civeira	civeira	PROPN
ajb-7	262	36	f	f	PROPN
ajb-7	262	37	(	(	PUNCT
ajb-7	262	38	2004	2004	NUM
ajb-7	262	39	)	)	PUNCT
ajb-7	262	40	international	international	ADJ
ajb-7	262	41	panel	panel	NOUN
ajb-7	262	42	on	on	ADP
ajb-7	262	43	management	management	NOUN
ajb-7	262	44	of	of	ADP
ajb-7	262	45	familial	familial	ADJ
ajb-7	262	46	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	262	47	.	.	PUNCT
ajb-7	263	1	guidelines	guideline	NOUN
ajb-7	263	2	for	for	ADP
ajb-7	263	3	the	the	DET
ajb-7	263	4	diagnosis	diagnosis	NOUN
ajb-7	263	5	and	and	CCONJ
ajb-7	263	6	management	management	NOUN
ajb-7	263	7	of	of	ADP
ajb-7	263	8	heterozygous	heterozygous	ADJ
ajb-7	263	9	familial	familial	ADJ
ajb-7	263	10	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	263	11	.	.	PUNCT
ajb-7	264	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	264	2	.	.	PUNCT
ajb-7	265	1	mar;173(1):55	mar;173(1):55	NOUN
ajb-7	265	2	-	-	PUNCT
ajb-7	265	3	68	68	NUM
ajb-7	265	4	.	.	PUNCT
ajb-7	266	1	damgaard	damgaard	PROPN
ajb-7	266	2	d	d	PROPN
ajb-7	266	3	,	,	PUNCT
ajb-7	266	4	jensen	jensen	PROPN
ajb-7	266	5	jm	jm	PROPN
ajb-7	266	6	,	,	PUNCT
ajb-7	266	7	larsen	larsen	PROPN
ajb-7	266	8	ml	ml	PROPN
ajb-7	266	9	,	,	PUNCT
ajb-7	266	10	soerensen	soerensen	PROPN
ajb-7	266	11	vr	vr	PROPN
ajb-7	266	12	,	,	PUNCT
ajb-7	266	13	jensen	jensen	PROPN
ajb-7	266	14	hk	hk	PROPN
ajb-7	266	15	,	,	PUNCT
ajb-7	266	16	gre39	gre39	PROPN
ajb-7	266	17	kb	kb	PROPN
ajb-7	266	18	m	m	PROPN
ajb-7	266	19	j	j	PROPN
ajb-7	266	20	ou	ou	PROPN
ajb-7	266	21	rn	rn	PROPN
ajb-7	266	22	al	al	PROPN
ajb-7	266	23	o	o	PROPN
ajb-7	267	1	f	f	PROPN
ajb-7	267	2	bi	bi	NOUN
ajb-7	267	3	ol	ol	PROPN
ajb-7	267	4	og	og	PROPN
ajb-7	267	5	y	y	PROPN
ajb-7	267	6	is	be	AUX
ajb-7	267	7	sn	sn	PROPN
ajb-7	267	8	1	1	NUM
ajb-7	267	9	94	94	NUM
ajb-7	267	10	858	858	NUM
ajb-7	267	11	83	83	NUM
ajb-7	267	12	.	.	PUNCT
ajb-7	268	1	p	p	X
ajb-7	268	2	ub	ub	ADJ
ajb-7	268	3	lis	li	NOUN
ajb-7	268	4	he	he	PRON
ajb-7	268	5	d	d	NOUN
ajb-7	268	6	by	by	ADP
ajb-7	268	7	k	k	PROPN
ajb-7	268	8	bm	bm	PROPN
ajb-7	268	9	s	s	PROPN
ajb-7	268	10	ci	ci	PROPN
ajb-7	268	11	en	en	ADP
ajb-7	268	12	tifi	tifi	PROPN
ajb-7	268	13	c	c	AUX
ajb-7	268	14	pu	pu	PROPN
ajb-7	268	15	bl	bl	AUX
ajb-7	268	16	ish	ish	VERB
ajb-7	268	17	in	in	ADP
ajb-7	268	18	g	g	PROPN
ajb-7	268	19	,	,	PUNCT
ajb-7	269	1	l	l	NOUN
ajb-7	269	2	p	p	X
ajb-7	270	1	(	(	PUNCT
ajb-7	270	2	w	w	PROPN
ajb-7	270	3	w	w	PROPN
ajb-7	270	4	w	w	PROPN
ajb-7	270	5	.k	.k	PROPN
ajb-7	270	6	bm	bm	PROPN
ajb-7	271	1	-s	-s	X
ajb-7	271	2	ci	ci	PROPN
ajb-7	271	3	en	en	INTJ
ajb-7	271	4	tifi	tifi	PROPN
ajb-7	271	5	cpu	cpu	NOUN
ajb-7	271	6	bl	bl	AUX
ajb-7	271	7	ish	ish	VERB
ajb-7	271	8	in	in	ADP
ajb-7	271	9	g.	g.	PROPN
ajb-7	271	10	or	or	CCONJ
ajb-7	271	11	g	g	NOUN
ajb-7	271	12	)	)	PUNCT
ajb-7	272	1	kb	kb	PROPN
ajb-7	272	2	m	m	PROPN
ajb-7	272	3	j	j	PROPN
ajb-7	272	4	ou	ou	PROPN
ajb-7	272	5	rn	rn	PROPN
ajb-7	272	6	al	al	PROPN
ajb-7	273	1	o	o	PROPN
ajb-7	274	1	f	f	PROPN
ajb-7	274	2	bi	bi	NOUN
ajb-7	274	3	ol	ol	PROPN
ajb-7	274	4	og	og	PROPN
ajb-7	274	5	y	y	PROPN
ajb-7	274	6	is	be	AUX
ajb-7	274	7	sn	sn	PROPN
ajb-7	274	8	1	1	NUM
ajb-7	274	9	94	94	NUM
ajb-7	274	10	858	858	NUM
ajb-7	274	11	83	83	NUM
ajb-7	274	12	.	.	PUNCT
ajb-7	275	1	p	p	X
ajb-7	275	2	ub	ub	ADJ
ajb-7	275	3	lis	li	NOUN
ajb-7	275	4	he	he	PRON
ajb-7	275	5	d	d	NOUN
ajb-7	275	6	by	by	ADP
ajb-7	275	7	k	k	PROPN
ajb-7	275	8	bm	bm	PROPN
ajb-7	275	9	s	s	PROPN
ajb-7	275	10	ci	ci	PROPN
ajb-7	275	11	en	en	ADP
ajb-7	275	12	tifi	tifi	PROPN
ajb-7	275	13	c	c	AUX
ajb-7	275	14	pu	pu	PROPN
ajb-7	275	15	bl	bl	AUX
ajb-7	275	16	ish	ish	VERB
ajb-7	275	17	in	in	ADP
ajb-7	275	18	g	g	PROPN
ajb-7	275	19	,	,	PUNCT
ajb-7	276	1	l	l	NOUN
ajb-7	276	2	p	p	X
ajb-7	277	1	(	(	PUNCT
ajb-7	277	2	w	w	PROPN
ajb-7	277	3	w	w	PROPN
ajb-7	277	4	w	w	PROPN
ajb-7	277	5	.k	.k	PROPN
ajb-7	277	6	bm	bm	PROPN
ajb-7	278	1	-s	-s	X
ajb-7	278	2	ci	ci	PROPN
ajb-7	278	3	en	en	INTJ
ajb-7	278	4	tifi	tifi	PROPN
ajb-7	278	5	cpu	cpu	NOUN
ajb-7	278	6	bl	bl	AUX
ajb-7	278	7	ish	ish	VERB
ajb-7	278	8	in	in	ADP
ajb-7	278	9	g.	g.	PROPN
ajb-7	278	10	or	or	CCONJ
ajb-7	278	11	g	g	NOUN
ajb-7	278	12	)	)	PUNCT
ajb-7	278	13	gersen	gersen	PROPN
ajb-7	279	1	n	n	CCONJ
ajb-7	279	2	,	,	PUNCT
ajb-7	279	3	jensen	jensen	PROPN
ajb-7	279	4	lg	lg	PROPN
ajb-7	279	5	,	,	PUNCT
ajb-7	279	6	faergeman	faergeman	NOUN
ajb-7	279	7	o	o	PROPN
ajb-7	279	8	(	(	PUNCT
ajb-7	279	9	2004	2004	NUM
ajb-7	279	10	)	)	PUNCT
ajb-7	280	1	no	no	DET
ajb-7	280	2	genetic	genetic	ADJ
ajb-7	280	3	linkage	linkage	NOUN
ajb-7	280	4	or	or	CCONJ
ajb-7	280	5	molecular	molecular	ADJ
ajb-7	280	6	evidence	evidence	NOUN
ajb-7	280	7	for	for	ADP
ajb-7	280	8	involvement	involvement	NOUN
ajb-7	280	9	of	of	ADP
ajb-7	280	10	the	the	DET
ajb-7	280	11	pcsk9	pcsk9	NOUN
ajb-7	280	12	,	,	PUNCT
ajb-7	280	13	arh	arh	ADJ
ajb-7	280	14	or	or	CCONJ
ajb-7	280	15	cyp7a1	cyp7a1	ADJ
ajb-7	280	16	genes	gene	NOUN
ajb-7	280	17	in	in	ADP
ajb-7	280	18	the	the	DET
ajb-7	280	19	familial	familial	ADJ
ajb-7	280	20	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	280	21	phenotype	phenotype	NOUN
ajb-7	280	22	in	in	ADP
ajb-7	280	23	a	a	DET
ajb-7	280	24	sample	sample	NOUN
ajb-7	280	25	of	of	ADP
ajb-7	280	26	danish	danish	ADJ
ajb-7	280	27	families	family	NOUN
ajb-7	280	28	without	without	ADP
ajb-7	280	29	pathogenic	pathogenic	ADJ
ajb-7	280	30	mutations	mutation	NOUN
ajb-7	280	31	in	in	ADP
ajb-7	280	32	the	the	DET
ajb-7	280	33	ldl	ldl	NOUN
ajb-7	280	34	receptor	receptor	NOUN
ajb-7	280	35	and	and	CCONJ
ajb-7	280	36	apob	apob	ADJ
ajb-7	280	37	genes	gene	NOUN
ajb-7	280	38	.	.	PUNCT
ajb-7	281	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	281	2	.	.	PUNCT
ajb-7	282	1	177	177	NUM
ajb-7	282	2	:	:	PUNCT
ajb-7	283	1	415–422	415–422	NUM
ajb-7	283	2	.	.	PUNCT
ajb-7	284	1	descamps	descamps	PROPN
ajb-7	284	2	os	os	ADV
ajb-7	284	3	,	,	PUNCT
ajb-7	284	4	leysen	leysen	VERB
ajb-7	284	5	x	x	PROPN
ajb-7	284	6	,	,	PUNCT
ajb-7	284	7	van	van	PROPN
ajb-7	284	8	leuven	leuven	PROPN
ajb-7	284	9	f	f	PROPN
ajb-7	284	10	,	,	PUNCT
ajb-7	284	11	heller	heller	NOUN
ajb-7	284	12	fr	fr	PROPN
ajb-7	284	13	.	.	PUNCT
ajb-7	285	1	the	the	DET
ajb-7	285	2	use	use	NOUN
ajb-7	285	3	of	of	ADP
ajb-7	285	4	achilles	achille	NOUN
ajb-7	285	5	tendon	tendon	VERB
ajb-7	285	6	ultrasonography	ultrasonography	NOUN
ajb-7	285	7	for	for	ADP
ajb-7	285	8	the	the	DET
ajb-7	285	9	diagnosis	diagnosis	NOUN
ajb-7	285	10	of	of	ADP
ajb-7	285	11	familial	familial	ADJ
ajb-7	285	12	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	285	13	.	.	PUNCT
ajb-7	286	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	286	2	.	.	PUNCT
ajb-7	287	1	2001;157:514–518	2001;157:514–518	X
ajb-7	287	2	.	.	PUNCT
ajb-7	288	1	doll	doll	NOUN
ajb-7	288	2	r	r	NOUN
ajb-7	288	3	,	,	PUNCT
ajb-7	288	4	and	and	CCONJ
ajb-7	288	5	ab	ab	PROPN
ajb-7	288	6	hill	hill	PROPN
ajb-7	288	7	(	(	PUNCT
ajb-7	288	8	1966	1966	NUM
ajb-7	288	9	)	)	PUNCT
ajb-7	288	10	mortality	mortality	NOUN
ajb-7	288	11	of	of	ADP
ajb-7	288	12	british	british	ADJ
ajb-7	288	13	doctors	doctor	NOUN
ajb-7	288	14	in	in	ADP
ajb-7	288	15	relation	relation	NOUN
ajb-7	288	16	to	to	ADP
ajb-7	288	17	smoking	smoking	NOUN
ajb-7	288	18	:	:	PUNCT
ajb-7	288	19	observations	observation	NOUN
ajb-7	288	20	on	on	ADP
ajb-7	288	21	coronary	coronary	ADJ
ajb-7	288	22	thrombosis	thrombosis	NOUN
ajb-7	288	23	.	.	PUNCT
ajb-7	289	1	j	j	PROPN
ajb-7	289	2	natl	natl	PROPN
ajb-7	289	3	cancer	cancer	PROPN
ajb-7	289	4	inst	inst	PROPN
ajb-7	289	5	monogr	monogr	PROPN
ajb-7	289	6	19	19	NUM
ajb-7	289	7	:	:	SYM
ajb-7	289	8	205	205	NUM
ajb-7	289	9	-	-	SYM
ajb-7	289	10	268	268	NUM
ajb-7	289	11	.	.	PUNCT
ajb-7	290	1	fernando	fernando	PROPN
ajb-7	290	2	c	c	PROPN
ajb-7	290	3	(	(	PUNCT
ajb-7	290	4	2004	2004	NUM
ajb-7	290	5	)	)	PUNCT
ajb-7	290	6	guidelines	guideline	NOUN
ajb-7	290	7	for	for	ADP
ajb-7	290	8	the	the	DET
ajb-7	290	9	diagnosis	diagnosis	NOUN
ajb-7	290	10	and	and	CCONJ
ajb-7	290	11	management	management	NOUN
ajb-7	290	12	of	of	ADP
ajb-7	290	13	heterozygous	heterozygous	ADJ
ajb-7	290	14	familial	familial	ADJ
ajb-7	290	15	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	290	16	.	.	PUNCT
ajb-7	291	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	291	2	173	173	NUM
ajb-7	291	3	:	:	PUNCT
ajb-7	291	4	55–68	55–68	NOUN
ajb-7	291	5	.	.	PUNCT
ajb-7	292	1	friedewald	friedewald	ADJ
ajb-7	292	2	wt	wt	PROPN
ajb-7	292	3	,	,	PUNCT
ajb-7	292	4	ri	ri	NOUN
ajb-7	292	5	levy	levy	NOUN
ajb-7	292	6	,	,	PUNCT
ajb-7	292	7	and	and	CCONJ
ajb-7	292	8	ds	ds	PRON
ajb-7	292	9	fredickson	fredickson	NOUN
ajb-7	292	10	(	(	PUNCT
ajb-7	292	11	1972	1972	NUM
ajb-7	292	12	)	)	PUNCT
ajb-7	292	13	estimation	estimation	NOUN
ajb-7	292	14	of	of	ADP
ajb-7	292	15	the	the	DET
ajb-7	292	16	concentration	concentration	NOUN
ajb-7	292	17	of	of	ADP
ajb-7	292	18	low	low	ADJ
ajb-7	292	19	density	density	NOUN
ajb-7	292	20	lipoprotein	lipoprotein	ADJ
ajb-7	292	21	cholesterol	cholesterol	NOUN
ajb-7	292	22	in	in	ADP
ajb-7	292	23	plasma	plasma	NOUN
ajb-7	292	24	without	without	ADP
ajb-7	292	25	use	use	NOUN
ajb-7	292	26	of	of	ADP
ajb-7	292	27	preparative	preparative	ADJ
ajb-7	292	28	ultracentrifuge	ultracentrifuge	NOUN
ajb-7	292	29	.	.	PUNCT
ajb-7	293	1	clin	clin	PROPN
ajb-7	293	2	chem	chem	NOUN
ajb-7	293	3	18	18	NUM
ajb-7	293	4	:	:	SYM
ajb-7	293	5	499	499	NUM
ajb-7	293	6	-	-	SYM
ajb-7	293	7	502	502	NUM
ajb-7	293	8	.	.	PUNCT
ajb-7	294	1	gagn´e	gagn´e	PROPN
ajb-7	294	2	c	c	X
ajb-7	294	3	,	,	PUNCT
ajb-7	294	4	moorjani	moorjani	PROPN
ajb-7	294	5	s	s	PART
ajb-7	294	6	,	,	PUNCT
ajb-7	294	7	brun	brun	PROPN
ajb-7	294	8	d	d	PROPN
ajb-7	294	9	,	,	PUNCT
ajb-7	294	10	toussaint	toussaint	PROPN
ajb-7	294	11	m	m	PROPN
ajb-7	294	12	,	,	PUNCT
ajb-7	294	13	lupien	lupien	PROPN
ajb-7	294	14	pj	pj	PROPN
ajb-7	294	15	.	.	PUNCT
ajb-7	295	1	(	(	PUNCT
ajb-7	295	2	1979	1979	NUM
ajb-7	295	3	)	)	PUNCT
ajb-7	295	4	heterozygous	heterozygous	ADJ
ajb-7	295	5	familial	familial	ADJ
ajb-7	295	6	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	295	7	.	.	PUNCT
ajb-7	296	1	relationship	relationship	NOUN
ajb-7	296	2	between	between	ADP
ajb-7	296	3	plasma	plasma	NOUN
ajb-7	296	4	lipids	lipid	NOUN
ajb-7	296	5	,	,	PUNCT
ajb-7	296	6	lipoproteins	lipoprotein	NOUN
ajb-7	296	7	,	,	PUNCT
ajb-7	296	8	clinical	clinical	ADJ
ajb-7	296	9	manifestations	manifestation	NOUN
ajb-7	296	10	and	and	CCONJ
ajb-7	296	11	ischaemic	ischaemic	ADJ
ajb-7	296	12	heart	heart	NOUN
ajb-7	296	13	disease	disease	NOUN
ajb-7	296	14	in	in	ADP
ajb-7	296	15	men	man	NOUN
ajb-7	296	16	and	and	CCONJ
ajb-7	296	17	women	woman	NOUN
ajb-7	296	18	.	.	PUNCT
ajb-7	297	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	297	2	34:13–24	34:13–24	PROPN
ajb-7	297	3	.	.	PUNCT
ajb-7	298	1	gardner	gardner	PROPN
ajb-7	298	2	cd	cd	PROPN
ajb-7	298	3	,	,	PUNCT
ajb-7	298	4	marilyn	marilyn	PROPN
ajb-7	298	5	aw	aw	PROPN
ajb-7	298	6	,	,	PUNCT
ajb-7	298	7	stephen	stephen	PROPN
ajb-7	298	8	pf	pf	PROPN
ajb-7	298	9	(	(	PUNCT
ajb-7	298	10	2000	2000	NUM
ajb-7	298	11	)	)	PUNCT
ajb-7	298	12	population	population	NOUN
ajb-7	298	13	frequency	frequency	NOUN
ajb-7	298	14	distribution	distribution	NOUN
ajb-7	298	15	of	of	ADP
ajb-7	298	16	non	non	ADJ
ajb-7	298	17	–	–	ADJ
ajb-7	298	18	high	high	ADJ
ajb-7	298	19	-	-	PUNCT
ajb-7	298	20	density	density	NOUN
ajb-7	298	21	lipoprotein	lipoprotein	ADJ
ajb-7	298	22	cholesterol	cholesterol	NOUN
ajb-7	298	23	(	(	PUNCT
ajb-7	298	24	third	third	ADJ
ajb-7	298	25	national	national	ADJ
ajb-7	298	26	health	health	PROPN
ajb-7	298	27	and	and	CCONJ
ajb-7	298	28	nutrition	nutrition	NOUN
ajb-7	298	29	examination	examination	NOUN
ajb-7	298	30	survey	survey	NOUN
ajb-7	299	1	[	[	X
ajb-7	299	2	nhanes	nhane	VERB
ajb-7	299	3	iii	iii	NOUN
ajb-7	299	4	]	]	X
ajb-7	299	5	,	,	PUNCT
ajb-7	299	6	1988–1994	1988–1994	NUM
ajb-7	299	7	)	)	PUNCT
ajb-7	299	8	.	.	PUNCT
ajb-7	300	1	am	be	AUX
ajb-7	300	2	j	j	PROPN
ajb-7	300	3	cardiol	cardiol	NOUN
ajb-7	300	4	86	86	NUM
ajb-7	300	5	:	:	PUNCT
ajb-7	300	6	299	299	NUM
ajb-7	300	7	-	-	SYM
ajb-7	300	8	304	304	NUM
ajb-7	300	9	.	.	PUNCT
ajb-7	301	1	goldstein	goldstein	PROPN
ajb-7	301	2	jl	jl	PROPN
ajb-7	301	3	,	,	PUNCT
ajb-7	301	4	brown	brown	ADJ
ajb-7	301	5	ms	ms	NOUN
ajb-7	301	6	(	(	PUNCT
ajb-7	301	7	1974	1974	NUM
ajb-7	301	8	)	)	PUNCT
ajb-7	301	9	binding	binding	NOUN
ajb-7	301	10	and	and	CCONJ
ajb-7	301	11	degradation	degradation	NOUN
ajb-7	301	12	of	of	ADP
ajb-7	301	13	low	low	ADJ
ajb-7	301	14	density	density	NOUN
ajb-7	301	15	lipoproteins	lipoprotein	NOUN
ajb-7	301	16	by	by	ADP
ajb-7	301	17	cultured	cultured	ADJ
ajb-7	301	18	human	human	ADJ
ajb-7	301	19	fibroblasts	fibroblast	NOUN
ajb-7	301	20	.	.	PUNCT
ajb-7	302	1	comparison	comparison	NOUN
ajb-7	302	2	of	of	ADP
ajb-7	302	3	cells	cell	NOUN
ajb-7	302	4	from	from	ADP
ajb-7	302	5	a	a	DET
ajb-7	302	6	normal	normal	ADJ
ajb-7	302	7	subject	subject	NOUN
ajb-7	302	8	and	and	CCONJ
ajb-7	302	9	from	from	ADP
ajb-7	302	10	a	a	DET
ajb-7	302	11	patient	patient	NOUN
ajb-7	302	12	with	with	ADP
ajb-7	302	13	homozygous	homozygous	ADJ
ajb-7	302	14	familial	familial	ADJ
ajb-7	302	15	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	302	16	.	.	PUNCT
ajb-7	303	1	j	j	PROPN
ajb-7	303	2	biol	biol	PROPN
ajb-7	303	3	chem	chem	NOUN
ajb-7	303	4	249	249	NUM
ajb-7	303	5	:	:	PUNCT
ajb-7	303	6	5153	5153	NUM
ajb-7	303	7	-	-	SYM
ajb-7	303	8	5162	5162	NUM
ajb-7	303	9	.	.	PUNCT
ajb-7	304	1	goldstein	goldstein	PROPN
ajb-7	304	2	jl	jl	PROPN
ajb-7	304	3	,	,	PUNCT
ajb-7	304	4	hobbs	hobbs	PROPN
ajb-7	304	5	hh	hh	PROPN
ajb-7	304	6	,	,	PUNCT
ajb-7	304	7	brown	brown	ADJ
ajb-7	304	8	ms	ms	PROPN
ajb-7	304	9	(	(	PUNCT
ajb-7	304	10	2001	2001	NUM
ajb-7	304	11	)	)	PUNCT
ajb-7	304	12	familial	familial	ADJ
ajb-7	304	13	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	304	14	.	.	PUNCT
ajb-7	305	1	in	in	ADP
ajb-7	305	2	:	:	PUNCT
ajb-7	305	3	scriver	scriver	NOUN
ajb-7	305	4	cr	cr	PROPN
ajb-7	305	5	,	,	PUNCT
ajb-7	305	6	,	,	PUNCT
ajb-7	305	7	al	al	PROPN
ajb-7	305	8	beaudet	beaudet	PROPN
ajb-7	305	9	,	,	PUNCT
ajb-7	305	10	ws	ws	PROPN
ajb-7	305	11	sly	sly	ADV
ajb-7	305	12	,	,	PUNCT
ajb-7	305	13	and	and	CCONJ
ajb-7	305	14	d	d	X
ajb-7	305	15	vale	vale	NOUN
ajb-7	305	16	(	(	PUNCT
ajb-7	305	17	eds	ed	NOUN
ajb-7	305	18	.	.	PUNCT
ajb-7	305	19	)	)	PUNCT
ajb-7	306	1	the	the	DET
ajb-7	306	2	metabolic	metabolic	NOUN
ajb-7	306	3	and	and	CCONJ
ajb-7	306	4	molecular	molecular	ADJ
ajb-7	306	5	bases	basis	NOUN
ajb-7	306	6	of	of	ADP
ajb-7	306	7	inherited	inherit	VERB
ajb-7	306	8	disease	disease	NOUN
ajb-7	306	9	,	,	PUNCT
ajb-7	306	10	vol	vol	NOUN
ajb-7	306	11	.	.	PUNCT
ajb-7	306	12	120	120	NUM
ajb-7	306	13	,	,	PUNCT
ajb-7	306	14	new	new	PROPN
ajb-7	306	15	york	york	PROPN
ajb-7	306	16	,	,	PUNCT
ajb-7	306	17	ny	ny	PROPN
ajb-7	306	18	:	:	PUNCT
ajb-7	306	19	mcgraw	mcgraw	PROPN
ajb-7	306	20	-	-	PUNCT
ajb-7	306	21	hill	hill	NOUN
ajb-7	306	22	companies	company	NOUN
ajb-7	306	23	,	,	PUNCT
ajb-7	306	24	inc	inc	PROPN
ajb-7	306	25	,	,	PUNCT
ajb-7	306	26	pp	pp	X
ajb-7	306	27	.	.	PUNCT
ajb-7	306	28	2863	2863	NUM
ajb-7	306	29	-	-	SYM
ajb-7	306	30	2914	2914	NUM
ajb-7	306	31	.	.	PUNCT
ajb-7	307	1	graham	graham	PROPN
ajb-7	307	2	ca	ca	PROPN
ajb-7	307	3	,	,	PUNCT
ajb-7	307	4	mcilhatton	mcilhatton	PROPN
ajb-7	307	5	bp	bp	PROPN
ajb-7	307	6	,	,	PUNCT
ajb-7	307	7	kirk	kirk	PROPN
ajb-7	307	8	cw	cw	PROPN
ajb-7	307	9	,	,	PUNCT
ajb-7	307	10	beattie	beattie	PROPN
ajb-7	307	11	ed	ed	PROPN
ajb-7	307	12	,	,	PUNCT
ajb-7	307	13	lyttle	lyttle	PROPN
ajb-7	307	14	k	k	PROPN
ajb-7	307	15	,	,	PUNCT
ajb-7	307	16	hart	hart	PROPN
ajb-7	307	17	p	p	PROPN
ajb-7	307	18	,	,	PUNCT
ajb-7	307	19	neely	neely	PROPN
ajb-7	307	20	rd	rd	PROPN
ajb-7	307	21	,	,	PUNCT
ajb-7	307	22	young	young	PROPN
ajb-7	307	23	is	be	AUX
ajb-7	307	24	,	,	PUNCT
ajb-7	307	25	nicholls	nicholls	PROPN
ajb-7	307	26	dp	dp	PROPN
ajb-7	307	27	(	(	PUNCT
ajb-7	307	28	2005	2005	NUM
ajb-7	307	29	)	)	PUNCT
ajb-7	307	30	genetic	genetic	ADJ
ajb-7	307	31	screening	screening	NOUN
ajb-7	307	32	protocol	protocol	NOUN
ajb-7	307	33	for	for	ADP
ajb-7	307	34	familial	familial	ADJ
ajb-7	307	35	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	307	36	which	which	PRON
ajb-7	307	37	includes	include	VERB
ajb-7	307	38	splicing	splicing	NOUN
ajb-7	307	39	defects	defect	NOUN
ajb-7	307	40	gives	give	VERB
ajb-7	307	41	an	an	DET
ajb-7	307	42	improved	improve	VERB
ajb-7	307	43	mutation	mutation	NOUN
ajb-7	307	44	detection	detection	NOUN
ajb-7	307	45	rate	rate	NOUN
ajb-7	307	46	.	.	PUNCT
ajb-7	308	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	308	2	182	182	NUM
ajb-7	308	3	:	:	PUNCT
ajb-7	308	4	331–340	331–340	NUM
ajb-7	308	5	.	.	PUNCT
ajb-7	309	1	hawe	hawe	PROPN
ajb-7	310	1	e	e	PROPN
ajb-7	310	2	,	,	PUNCT
ajb-7	310	3	talmud	talmud	PROPN
ajb-7	310	4	pj	pj	PROPN
ajb-7	310	5	,	,	PUNCT
ajb-7	310	6	miller	miller	PROPN
ajb-7	310	7	gj	gj	PROPN
ajb-7	310	8	,	,	PUNCT
ajb-7	310	9	humphries	humphries	PROPN
ajb-7	310	10	se	se	PROPN
ajb-7	310	11	(	(	PUNCT
ajb-7	310	12	2003	2003	NUM
ajb-7	310	13	)	)	PUNCT
ajb-7	310	14	family	family	NOUN
ajb-7	310	15	history	history	NOUN
ajb-7	310	16	is	be	AUX
ajb-7	310	17	a	a	DET
ajb-7	310	18	coronary	coronary	ADJ
ajb-7	310	19	heart	heart	NOUN
ajb-7	310	20	disease	disease	NOUN
ajb-7	310	21	risk	risk	NOUN
ajb-7	310	22	factor	factor	NOUN
ajb-7	310	23	in	in	ADP
ajb-7	310	24	the	the	DET
ajb-7	310	25	second	second	ADJ
ajb-7	310	26	northwick	northwick	ADJ
ajb-7	310	27	park	park	NOUN
ajb-7	310	28	heart	heart	NOUN
ajb-7	310	29	study	study	PROPN
ajb-7	310	30	.	.	PUNCT
ajb-7	311	1	ann	ann	PROPN
ajb-7	311	2	hum	hum	PROPN
ajb-7	311	3	genet	genet	PROPN
ajb-7	311	4	67	67	NUM
ajb-7	311	5	:	:	PUNCT
ajb-7	311	6	97–106	97–106	NUM
ajb-7	311	7	.	.	PUNCT
ajb-7	312	1	heart	heart	NOUN
ajb-7	312	2	and	and	CCONJ
ajb-7	312	3	stroke	stroke	NOUN
ajb-7	312	4	facts	fact	NOUN
ajb-7	312	5	.	.	PUNCT
ajb-7	313	1	dallas	dallas	PROPN
ajb-7	313	2	,	,	PUNCT
ajb-7	313	3	tx	tx	PROPN
ajb-7	313	4	(	(	PUNCT
ajb-7	313	5	2001	2001	NUM
ajb-7	313	6	)	)	PUNCT
ajb-7	313	7	american	american	ADJ
ajb-7	313	8	heart	heart	PROPN
ajb-7	313	9	association	association	PROPN
ajb-7	313	10	.	.	PUNCT
ajb-7	314	1	hill	hill	PROPN
ajb-7	314	2	js	js	PROPN
ajb-7	314	3	,	,	PUNCT
ajb-7	314	4	hayden	hayden	PROPN
ajb-7	314	5	mr	mr	PROPN
ajb-7	314	6	,	,	PUNCT
ajb-7	314	7	frohlich	frohlich	PROPN
ajb-7	314	8	j	j	PROPN
ajb-7	314	9	,	,	PUNCT
ajb-7	314	10	pritchard	pritchard	PROPN
ajb-7	314	11	ph	ph	PROPN
ajb-7	314	12	(	(	PUNCT
ajb-7	314	13	1991	1991	NUM
ajb-7	314	14	)	)	PUNCT
ajb-7	314	15	genetic	genetic	ADJ
ajb-7	314	16	and	and	CCONJ
ajb-7	314	17	environmental	environmental	ADJ
ajb-7	314	18	factors	factor	NOUN
ajb-7	314	19	affecting	affect	VERB
ajb-7	314	20	the	the	DET
ajb-7	314	21	incidence	incidence	NOUN
ajb-7	314	22	of	of	ADP
ajb-7	314	23	coronary	coronary	ADJ
ajb-7	314	24	artery	artery	NOUN
ajb-7	314	25	disease	disease	NOUN
ajb-7	314	26	in	in	ADP
ajb-7	314	27	heterozygous	heterozygous	ADJ
ajb-7	314	28	familial	familial	ADJ
ajb-7	314	29	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	314	30	.	.	PUNCT
ajb-7	315	1	arterioscler	arterioscler	PROPN
ajb-7	315	2	thromb	thromb	PROPN
ajb-7	315	3	vasc	vasc	PROPN
ajb-7	315	4	biol	biol	PROPN
ajb-7	315	5	11(2	11(2	PROPN
ajb-7	315	6	):	):	PUNCT
ajb-7	315	7	290	290	NUM
ajb-7	315	8	-	-	SYM
ajb-7	315	9	297	297	NUM
ajb-7	315	10	.	.	PUNCT
ajb-7	316	1	imtiaz	imtiaz	PROPN
ajb-7	316	2	f	f	PROPN
ajb-7	316	3	(	(	PUNCT
ajb-7	316	4	2009	2009	NUM
ajb-7	316	5	)	)	PUNCT
ajb-7	316	6	estimation	estimation	NOUN
ajb-7	316	7	of	of	ADP
ajb-7	316	8	heritability	heritability	NOUN
ajb-7	316	9	of	of	ADP
ajb-7	316	10	familial	familial	ADJ
ajb-7	316	11	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	316	12	among	among	ADP
ajb-7	316	13	335	335	NUM
ajb-7	316	14	family	family	NOUN
ajb-7	316	15	members	member	NOUN
ajb-7	316	16	of	of	ADP
ajb-7	316	17	five	five	NUM
ajb-7	316	18	hypercholestrolemic	hypercholestrolemic	ADJ
ajb-7	316	19	probands	proband	NOUN
ajb-7	316	20	of	of	ADP
ajb-7	316	21	pakstani	pakstani	ADJ
ajb-7	316	22	population	population	NOUN
ajb-7	316	23	.	.	PUNCT
ajb-7	317	1	j.	j.	PROPN
ajb-7	317	2	ayub	ayub	PROPN
ajb-7	317	3	med	med	PROPN
ajb-7	317	4	coll	coll	PROPN
ajb-7	317	5	abbottabad	abbottabad	PROPN
ajb-7	317	6	21	21	NUM
ajb-7	317	7	:	:	PUNCT
ajb-7	317	8	58	58	NUM
ajb-7	317	9	-	-	SYM
ajb-7	317	10	61	61	NUM
ajb-7	317	11	.	.	PUNCT
ajb-7	318	1	jansen	jansen	PROPN
ajb-7	318	2	acm	acm	PROPN
ajb-7	318	3	,	,	PUNCT
ajb-7	318	4	van	van	PROPN
ajb-7	318	5	aalst	aalst	PROPN
ajb-7	318	6	-	-	PUNCT
ajb-7	318	7	cohen	cohen	PROPN
ajb-7	318	8	es	es	PROPN
ajb-7	318	9	,	,	PUNCT
ajb-7	318	10	tanck	tanck	ADJ
ajb-7	318	11	mw	mw	ADJ
ajb-7	318	12	,	,	PUNCT
ajb-7	318	13	trip	trip	NOUN
ajb-7	318	14	md	md	PROPN
ajb-7	318	15	,	,	PUNCT
ajb-7	318	16	lansberg	lansberg	PROPN
ajb-7	318	17	pj	pj	PROPN
ajb-7	318	18	,	,	PUNCT
ajb-7	318	19	liem	liem	PROPN
ajb-7	318	20	ah	ah	INTJ
ajb-7	318	21	,	,	PUNCT
ajb-7	318	22	roeters	roeter	NOUN
ajb-7	318	23	van	van	PROPN
ajb-7	318	24	lennep	lennep	PROPN
ajb-7	318	25	hwo	hwo	PROPN
ajb-7	318	26	,	,	PUNCT
ajb-7	318	27	sijbrands	sijbrand	VERB
ajb-7	318	28	ejg	ejg	PROPN
ajb-7	318	29	,	,	PUNCT
ajb-7	318	30	kastelein	kastelein	PROPN
ajb-7	318	31	jjp	jjp	PROPN
ajb-7	318	32	(	(	PUNCT
ajb-7	318	33	2004	2004	NUM
ajb-7	318	34	)	)	PUNCT
ajb-7	318	35	the	the	DET
ajb-7	318	36	contribution	contribution	NOUN
ajb-7	318	37	of	of	ADP
ajb-7	318	38	classical	classical	ADJ
ajb-7	318	39	risk	risk	NOUN
ajb-7	318	40	factors	factor	NOUN
ajb-7	318	41	to	to	ADP
ajb-7	318	42	cardiovascular	cardiovascular	ADJ
ajb-7	318	43	disease	disease	NOUN
ajb-7	318	44	in	in	ADP
ajb-7	318	45	familial	familial	ADJ
ajb-7	318	46	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	318	47	:	:	PUNCT
ajb-7	318	48	data	datum	NOUN
ajb-7	318	49	in	in	ADP
ajb-7	318	50	2400	2400	NUM
ajb-7	318	51	patients	patient	NOUN
ajb-7	318	52	.	.	PUNCT
ajb-7	319	1	j	j	PROPN
ajb-7	319	2	intern	intern	NOUN
ajb-7	319	3	med	me	VERB
ajb-7	319	4	256	256	NUM
ajb-7	319	5	:	:	PUNCT
ajb-7	319	6	482	482	NUM
ajb-7	319	7	-	-	SYM
ajb-7	319	8	490	490	NUM
ajb-7	319	9	.	.	PUNCT
ajb-7	320	1	junyent	junyent	PROPN
ajb-7	320	2	m	m	PROPN
ajb-7	320	3	,	,	PUNCT
ajb-7	320	4	gilabert	gilabert	PROPN
ajb-7	320	5	r	r	NOUN
ajb-7	320	6	,	,	PUNCT
ajb-7	320	7	zambón	zambón	NOUN
ajb-7	320	8	d	d	PROPN
ajb-7	320	9	(	(	PUNCT
ajb-7	320	10	2005	2005	NUM
ajb-7	320	11	)	)	PUNCT
ajb-7	320	12	the	the	DET
ajb-7	320	13	use	use	NOUN
ajb-7	320	14	of	of	ADP
ajb-7	320	15	achilles	achille	NOUN
ajb-7	320	16	tendon	tendon	VERB
ajb-7	320	17	sonography	sonography	NOUN
ajb-7	320	18	to	to	PART
ajb-7	320	19	distinguish	distinguish	VERB
ajb-7	320	20	familial	familial	ADJ
ajb-7	320	21	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	320	22	from	from	ADP
ajb-7	320	23	other	other	ADJ
ajb-7	320	24	genetic	genetic	ADJ
ajb-7	320	25	dyslipidemias	dyslipidemia	NOUN
ajb-7	320	26	.	.	PUNCT
ajb-7	321	1	arterioscler	arterioscler	PROPN
ajb-7	321	2	thromb	thromb	PROPN
ajb-7	321	3	vasc	vasc	PROPN
ajb-7	321	4	biol	biol	PROPN
ajb-7	321	5	.	.	PUNCT
ajb-7	322	1	25	25	NUM
ajb-7	322	2	:	:	SYM
ajb-7	322	3	2203	2203	NUM
ajb-7	322	4	–	–	PUNCT
ajb-7	322	5	2208	2208	NUM
ajb-7	322	6	.	.	PUNCT
ajb-7	323	1	kalina	kalina	PROPN
ajb-7	323	2	a	a	PROPN
ajb-7	323	3	,	,	PUNCT
ajb-7	323	4	csaszar	csaszar	VERB
ajb-7	323	5	a	a	DET
ajb-7	323	6	,	,	PUNCT
ajb-7	323	7	czeizel	czeizel	PROPN
ajb-7	323	8	ae	ae	PROPN
ajb-7	323	9	,	,	PUNCT
ajb-7	323	10	romics	romic	NOUN
ajb-7	323	11	l	l	NOUN
ajb-7	323	12	,	,	PUNCT
ajb-7	323	13	szaboki	szaboki	PROPN
ajb-7	323	14	f	f	PROPN
ajb-7	323	15	,	,	PUNCT
ajb-7	323	16	szalai	szalai	PROPN
ajb-7	323	17	c	c	NOUN
ajb-7	323	18	,	,	PUNCT
ajb-7	323	19	reiber	reiber	PROPN
ajb-7	323	20	i	i	PROPN
ajb-7	323	21	,	,	PUNCT
ajb-7	323	22	nemeth	nemeth	PROPN
ajb-7	323	23	a	a	PROPN
ajb-7	323	24	,	,	PUNCT
ajb-7	323	25	stephenson	stephenson	PROPN
ajb-7	323	26	s	s	PROPN
ajb-7	323	27	,	,	PUNCT
ajb-7	323	28	williams	williams	PROPN
ajb-7	323	29	rr	rr	PROPN
ajb-7	323	30	(	(	PUNCT
ajb-7	323	31	2001	2001	NUM
ajb-7	323	32	)	)	PUNCT
ajb-7	323	33	frequency	frequency	NOUN
ajb-7	323	34	of	of	ADP
ajb-7	323	35	the	the	DET
ajb-7	323	36	r3500q	r3500q	PROPN
ajb-7	323	37	mutation	mutation	NOUN
ajb-7	323	38	of	of	ADP
ajb-7	323	39	the	the	DET
ajb-7	323	40	apolipoprotein	apolipoprotein	ADJ
ajb-7	323	41	b-100	b-100	ADP
ajb-7	323	42	gene	gene	NOUN
ajb-7	323	43	in	in	ADP
ajb-7	323	44	a	a	DET
ajb-7	323	45	sample	sample	NOUN
ajb-7	323	46	screened	screen	VERB
ajb-7	323	47	clinically	clinically	ADV
ajb-7	323	48	for	for	ADP
ajb-7	323	49	familial	familial	ADJ
ajb-7	323	50	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	323	51	in	in	ADP
ajb-7	323	52	hungary	hungary	PROPN
ajb-7	323	53	.	.	PUNCT
ajb-7	324	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	324	2	154	154	NUM
ajb-7	324	3	:	:	PUNCT
ajb-7	324	4	247–251	247–251	NUM
ajb-7	324	5	.	.	PUNCT
ajb-7	324	6	kardia	kardia	PROPN
ajb-7	324	7	sl	sl	PROPN
ajb-7	324	8	,	,	PUNCT
ajb-7	324	9	sm	sm	PROPN
ajb-7	324	10	modell	modell	PROPN
ajb-7	324	11	,	,	PUNCT
ajb-7	324	12	pa	pa	PROPN
ajb-7	324	13	peyser	peyser	NOUN
ajb-7	324	14	(	(	PUNCT
ajb-7	324	15	2003	2003	NUM
ajb-7	324	16	)	)	PUNCT
ajb-7	324	17	family	family	NOUN
ajb-7	324	18	-	-	PUNCT
ajb-7	324	19	centered	center	VERB
ajb-7	324	20	approaches	approach	NOUN
ajb-7	324	21	to	to	ADP
ajb-7	324	22	understanding	understanding	NOUN
ajb-7	324	23	and	and	CCONJ
ajb-7	324	24	preventing	prevent	VERB
ajb-7	324	25	coronary	coronary	ADJ
ajb-7	324	26	heart	heart	NOUN
ajb-7	324	27	disease	disease	NOUN
ajb-7	324	28	.	.	PUNCT
ajb-7	325	1	am	be	AUX
ajb-7	325	2	j	j	PROPN
ajb-7	325	3	prev	prev	X
ajb-7	325	4	med	me	VERB
ajb-7	325	5	24	24	NUM
ajb-7	325	6	:	:	PUNCT
ajb-7	325	7	143	143	NUM
ajb-7	325	8	-	-	SYM
ajb-7	325	9	151	151	NUM
ajb-7	325	10	.	.	PUNCT
ajb-7	326	1	koivisto	koivisto	PROPN
ajb-7	326	2	um	um	INTJ
ajb-7	326	3	,	,	PUNCT
ajb-7	326	4	hamalainen	hamalainen	PROPN
ajb-7	326	5	l	l	PROPN
ajb-7	326	6	,	,	PUNCT
ajb-7	326	7	taskinen	taskinen	PROPN
ajb-7	326	8	mr	mr	PROPN
ajb-7	326	9	,	,	PUNCT
ajb-7	326	10	kettunen	kettunen	PROPN
ajb-7	326	11	k	k	PROPN
ajb-7	326	12	,	,	PUNCT
ajb-7	326	13	kontula	kontula	PROPN
ajb-7	326	14	k	k	PROPN
ajb-7	326	15	(	(	PUNCT
ajb-7	326	16	1993	1993	NUM
ajb-7	326	17	)	)	PUNCT
ajb-7	326	18	prevalence	prevalence	NOUN
ajb-7	326	19	of	of	ADP
ajb-7	326	20	familial	familial	ADJ
ajb-7	326	21	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	326	22	among	among	ADP
ajb-7	326	23	young	young	ADJ
ajb-7	326	24	north	north	ADJ
ajb-7	326	25	karelian	karelian	ADJ
ajb-7	326	26	patients	patient	NOUN
ajb-7	326	27	with	with	ADP
ajb-7	326	28	coronary	coronary	ADJ
ajb-7	326	29	heart	heart	NOUN
ajb-7	326	30	disease	disease	NOUN
ajb-7	326	31	:	:	PUNCT
ajb-7	326	32	a	a	DET
ajb-7	326	33	study	study	NOUN
ajb-7	326	34	based	base	VERB
ajb-7	326	35	on	on	ADP
ajb-7	326	36	diagnosis	diagnosis	NOUN
ajb-7	326	37	by	by	ADP
ajb-7	326	38	polymerase	polymerase	NOUN
ajb-7	326	39	chain	chain	NOUN
ajb-7	326	40	reaction	reaction	NOUN
ajb-7	326	41	.	.	PUNCT
ajb-7	327	1	j	j	PROPN
ajb-7	327	2	lipid	lipid	PROPN
ajb-7	327	3	res	re	NOUN
ajb-7	327	4	.	.	PUNCT
ajb-7	328	1	34:269–277	34:269–277	NUM
ajb-7	328	2	.	.	PUNCT
ajb-7	329	1	koivisto	koivisto	PROPN
ajb-7	329	2	um	um	INTJ
ajb-7	329	3	,	,	PUNCT
ajb-7	329	4	turtola	turtola	PROPN
ajb-7	329	5	h	h	PROPN
ajb-7	329	6	,	,	PUNCT
ajb-7	329	7	aalto	aalto	PROPN
ajb-7	329	8	-	-	PUNCT
ajb-7	329	9	setala	setala	PROPN
ajb-7	329	10	k	k	NOUN
ajb-7	329	11	,	,	PUNCT
ajb-7	329	12	top	top	ADJ
ajb-7	329	13	b	b	NOUN
ajb-7	329	14	,	,	PUNCT
ajb-7	329	15	frants	frant	VERB
ajb-7	329	16	r	r	NOUN
ajb-7	329	17	r	r	NOUN
ajb-7	329	18	,	,	PUNCT
ajb-7	329	19	kovanen	kovanen	PROPN
ajb-7	329	20	p	p	PROPN
ajb-7	329	21	t	t	PROPN
ajb-7	329	22	,	,	PUNCT
ajb-7	329	23	syvänen	syvänen	VERB
ajb-7	329	24	a	a	DET
ajb-7	329	25	c	c	NOUN
ajb-7	329	26	,	,	PUNCT
ajb-7	329	27	kontula	kontula	PROPN
ajb-7	329	28	k	k	X
ajb-7	329	29	(	(	PUNCT
ajb-7	329	30	1992	1992	NUM
ajb-7	329	31	)	)	PUNCT
ajb-7	329	32	the	the	DET
ajb-7	329	33	familial	familial	ADJ
ajb-7	329	34	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	329	35	(	(	PUNCT
ajb-7	329	36	fh)-north	fh)-north	PROPN
ajb-7	329	37	karelia	karelia	PROPN
ajb-7	329	38	mutation	mutation	NOUN
ajb-7	329	39	of	of	ADP
ajb-7	329	40	the	the	DET
ajb-7	329	41	low	low	ADJ
ajb-7	329	42	density	density	NOUN
ajb-7	329	43	lipoprotein	lipoprotein	ADJ
ajb-7	329	44	receptor	receptor	NOUN
ajb-7	329	45	gene	gene	NOUN
ajb-7	329	46	deletes	delete	VERB
ajb-7	329	47	seven	seven	NUM
ajb-7	329	48	nucleotides	nucleotide	NOUN
ajb-7	329	49	of	of	ADP
ajb-7	329	50	exon	exon	NOUN
ajb-7	329	51	6	6	NUM
ajb-7	329	52	and	and	CCONJ
ajb-7	329	53	is	be	AUX
ajb-7	329	54	a	a	DET
ajb-7	329	55	common	common	ADJ
ajb-7	329	56	cause	cause	NOUN
ajb-7	329	57	of	of	ADP
ajb-7	329	58	fh	fh	PROPN
ajb-7	329	59	in	in	ADP
ajb-7	329	60	finland	finland	PROPN
ajb-7	329	61	.	.	PUNCT
ajb-7	330	1	j	j	PROPN
ajb-7	330	2	clin	clin	PROPN
ajb-7	330	3	invest	invest	PROPN
ajb-7	330	4	.	.	PUNCT
ajb-7	331	1	90:219–228	90:219–228	NUM
ajb-7	331	2	.	.	PUNCT
ajb-7	332	1	kotze	kotze	PROPN
ajb-7	332	2	mj	mj	PROPN
ajb-7	332	3	,	,	PUNCT
ajb-7	332	4	langenhoven	langenhoven	NOUN
ajb-7	332	5	e	e	NOUN
ajb-7	332	6	,	,	PUNCT
ajb-7	332	7	warnich	warnich	PRON
ajb-7	332	8	l	l	NOUN
ajb-7	332	9	,	,	PUNCT
ajb-7	332	10	du	du	PROPN
ajb-7	332	11	plessis	plessis	PROPN
ajb-7	332	12	l	l	PROPN
ajb-7	332	13	,	,	PUNCT
ajb-7	332	14	retief	retief	PROPN
ajb-7	332	15	ae	ae	PROPN
ajb-7	332	16	(	(	PUNCT
ajb-7	332	17	1991	1991	NUM
ajb-7	332	18	)	)	PUNCT
ajb-7	332	19	the	the	DET
ajb-7	332	20	molecular	molecular	ADJ
ajb-7	332	21	basis	basis	NOUN
ajb-7	332	22	and	and	CCONJ
ajb-7	332	23	diagnosis	diagnosis	NOUN
ajb-7	332	24	of	of	ADP
ajb-7	332	25	familial	familial	ADJ
ajb-7	332	26	hypercholesterolaemia	hypercholesterolaemia	NOUN
ajb-7	332	27	in	in	ADP
ajb-7	332	28	south	south	ADJ
ajb-7	332	29	african	african	ADJ
ajb-7	332	30	afrikaners	afrikaner	NOUN
ajb-7	332	31	.	.	PUNCT
ajb-7	333	1	ann	ann	PROPN
ajb-7	333	2	hum	hum	PROPN
ajb-7	333	3	genet	genet	PROPN
ajb-7	333	4	.	.	PUNCT
ajb-7	334	1	55:115–121	55:115–121	NUM
ajb-7	334	2	.	.	PUNCT
ajb-7	335	1	kwiterovich	kwiterovich	PROPN
ajb-7	335	2	po	po	PROPN
ajb-7	335	3	(	(	PUNCT
ajb-7	335	4	2008	2008	NUM
ajb-7	335	5	)	)	PUNCT
ajb-7	335	6	primary	primary	ADJ
ajb-7	335	7	and	and	CCONJ
ajb-7	335	8	secondary	secondary	ADJ
ajb-7	335	9	disorders	disorder	NOUN
ajb-7	335	10	of	of	ADP
ajb-7	335	11	lipid	lipid	ADJ
ajb-7	335	12	metabolism	metabolism	NOUN
ajb-7	335	13	in	in	ADP
ajb-7	335	14	pediatrics	pediatric	NOUN
ajb-7	335	15	.	.	PUNCT
ajb-7	336	1	pediatr	pediatr	ADJ
ajb-7	336	2	endocrinol	endocrinol	VERB
ajb-7	336	3	rev;5(suppl	rev;5(suppl	ADJ
ajb-7	336	4	2):727	2):727	NUM
ajb-7	336	5	-	-	SYM
ajb-7	336	6	38	38	NUM
ajb-7	336	7	.	.	PUNCT
ajb-7	337	1	landsberger	landsberger	PROPN
ajb-7	337	2	d	d	PROPN
ajb-7	337	3	,	,	PUNCT
ajb-7	337	4	meiner	meiner	PROPN
ajb-7	337	5	v	v	NOUN
ajb-7	337	6	,	,	PUNCT
ajb-7	337	7	reshef	reshef	VERB
ajb-7	337	8	a	a	PRON
ajb-7	337	9	,	,	PUNCT
ajb-7	337	10	levy	levy	NOUN
ajb-7	337	11	y	y	PROPN
ajb-7	337	12	,	,	PUNCT
ajb-7	337	13	van	van	PROPN
ajb-7	337	14	der	der	PROPN
ajb-7	337	15	westhuyzen	westhuyzen	PROPN
ajb-7	337	16	dr	dr	PROPN
ajb-7	337	17	,	,	PUNCT
ajb-7	337	18	coetzee	coetzee	PROPN
ajb-7	337	19	ga	ga	PROPN
ajb-7	337	20	,	,	PUNCT
ajb-7	337	21	leitersdorf	leitersdorf	PROPN
ajb-7	337	22	e	e	PROPN
ajb-7	337	23	(	(	PUNCT
ajb-7	337	24	1992	1992	NUM
ajb-7	337	25	)	)	PUNCT
ajb-7	337	26	a	a	DET
ajb-7	337	27	nonsense	nonsense	NOUN
ajb-7	337	28	mutation	mutation	NOUN
ajb-7	337	29	in	in	ADP
ajb-7	337	30	the	the	DET
ajb-7	337	31	ldl	ldl	NOUN
ajb-7	337	32	receptor	receptor	NOUN
ajb-7	337	33	gene	gene	NOUN
ajb-7	337	34	leads	lead	VERB
ajb-7	337	35	to	to	ADP
ajb-7	337	36	familial	familial	ADJ
ajb-7	337	37	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	337	38	in	in	ADP
ajb-7	337	39	the	the	DET
ajb-7	337	40	druze	druze	ADJ
ajb-7	337	41	sect	sect	NOUN
ajb-7	337	42	.	.	PUNCT
ajb-7	338	1	am	be	AUX
ajb-7	338	2	j	j	PROPN
ajb-7	338	3	hum	hum	PROPN
ajb-7	338	4	genet	genet	PROPN
ajb-7	338	5	.	.	PUNCT
ajb-7	339	1	50:427–433	50:427–433	PROPN
ajb-7	339	2	.	.	PUNCT
ajb-7	340	1	lehrman	lehrman	PROPN
ajb-7	340	2	ma	ma	PROPN
ajb-7	340	3	,	,	PUNCT
ajb-7	340	4	russell	russell	PROPN
ajb-7	340	5	dw	dw	PROPN
ajb-7	340	6	,	,	PUNCT
ajb-7	340	7	goldstein	goldstein	PROPN
ajb-7	340	8	jl	jl	PROPN
ajb-7	340	9	,	,	PUNCT
ajb-7	340	10	brown	brown	ADJ
ajb-7	340	11	ms	ms	NOUN
ajb-7	340	12	(	(	PUNCT
ajb-7	340	13	1987	1987	NUM
ajb-7	340	14	)	)	PUNCT
ajb-7	340	15	alu	alu	NOUN
ajb-7	340	16	-	-	PUNCT
ajb-7	340	17	alu	alu	NOUN
ajb-7	340	18	recombination	recombination	NOUN
ajb-7	340	19	deletes	delete	VERB
ajb-7	340	20	splice	splice	NOUN
ajb-7	340	21	acceptor	acceptor	NOUN
ajb-7	340	22	sites	site	NOUN
ajb-7	340	23	and	and	CCONJ
ajb-7	340	24	produces	produce	VERB
ajb-7	340	25	secreted	secrete	VERB
ajb-7	340	26	low	low	ADJ
ajb-7	340	27	density	density	NOUN
ajb-7	340	28	lipoprotein	lipoprotein	ADJ
ajb-7	340	29	receptor	receptor	NOUN
ajb-7	340	30	in	in	ADP
ajb-7	340	31	a	a	DET
ajb-7	340	32	subject	subject	NOUN
ajb-7	340	33	with	with	ADP
ajb-7	340	34	familial	familial	ADJ
ajb-7	340	35	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	340	36	.	.	PUNCT
ajb-7	341	1	j	j	PROPN
ajb-7	341	2	biol	biol	PROPN
ajb-7	341	3	chem	chem	NOUN
ajb-7	341	4	.	.	PUNCT
ajb-7	342	1	262:3354–3361	262:3354–3361	NOUN
ajb-7	342	2	.	.	PUNCT
ajb-7	343	1	leitersdorf	leitersdorf	PROPN
ajb-7	343	2	e	e	PROPN
ajb-7	343	3	,	,	PUNCT
ajb-7	343	4	tobin	tobin	PROPN
ajb-7	343	5	ej	ej	PROPN
ajb-7	343	6	,	,	PUNCT
ajb-7	343	7	davignon	davignon	PROPN
ajb-7	343	8	j	j	PROPN
ajb-7	343	9	,	,	PUNCT
ajb-7	343	10	hobbs	hobbs	PROPN
ajb-7	343	11	hh	hh	PROPN
ajb-7	343	12	(	(	PUNCT
ajb-7	343	13	1990	1990	NUM
ajb-7	343	14	)	)	PUNCT
ajb-7	343	15	common	common	ADJ
ajb-7	343	16	lowdensity	lowdensity	NOUN
ajb-7	343	17	lipoprotein	lipoprotein	ADJ
ajb-7	343	18	receptor	receptor	NOUN
ajb-7	343	19	mutations	mutation	NOUN
ajb-7	343	20	in	in	ADP
ajb-7	343	21	the	the	DET
ajb-7	343	22	french	french	ADJ
ajb-7	343	23	canadian	canadian	ADJ
ajb-7	343	24	population	population	NOUN
ajb-7	343	25	.	.	PUNCT
ajb-7	344	1	j	j	PROPN
ajb-7	344	2	clin	clin	PROPN
ajb-7	344	3	invest	invest	PROPN
ajb-7	344	4	.	.	PUNCT
ajb-7	345	1	85:1014–1023	85:1014–1023	NUM
ajb-7	345	2	.	.	PUNCT
ajb-7	346	1	mabuchi	mabuchi	PROPN
ajb-7	346	2	h	h	PROPN
ajb-7	346	3	,	,	PUNCT
ajb-7	346	4	koizumi	koizumi	PROPN
ajb-7	346	5	j	j	PROPN
ajb-7	346	6	,	,	PUNCT
ajb-7	346	7	shimizu	shimizu	PROPN
ajb-7	346	8	m	m	PROPN
ajb-7	346	9	,	,	PUNCT
ajb-7	346	10	takeda	takeda	PROPN
ajb-7	346	11	r	r	X
ajb-7	346	12	(	(	PUNCT
ajb-7	346	13	1989	1989	NUM
ajb-7	346	14	)	)	PUNCT
ajb-7	346	15	development	development	NOUN
ajb-7	346	16	of	of	ADP
ajb-7	346	17	coronary	coronary	ADJ
ajb-7	346	18	heart	heart	NOUN
ajb-7	346	19	disease	disease	NOUN
ajb-7	346	20	in	in	ADP
ajb-7	346	21	familial	familial	ADJ
ajb-7	346	22	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	346	23	.	.	PUNCT
ajb-7	347	1	circulation	circulation	NOUN
ajb-7	347	2	.	.	PUNCT
ajb-7	348	1	79:225–232	79:225–232	NUM
ajb-7	348	2	.	.	PUNCT
ajb-7	349	1	meiner	meiner	PROPN
ajb-7	349	2	v	v	NOUN
ajb-7	349	3	,	,	PUNCT
ajb-7	349	4	landsberger	landsberger	PROPN
ajb-7	349	5	d	d	PROPN
ajb-7	349	6	,	,	PUNCT
ajb-7	349	7	berkman	berkman	NOUN
ajb-7	349	8	n	n	CCONJ
ajb-7	349	9	,	,	PUNCT
ajb-7	349	10	reshef	reshef	VERB
ajb-7	349	11	a	a	PRON
ajb-7	349	12	,	,	PUNCT
ajb-7	349	13	segal	segal	PROPN
ajb-7	349	14	p	p	NOUN
ajb-7	349	15	,	,	PUNCT
ajb-7	349	16	seftel	seftel	NOUN
ajb-7	349	17	hc	hc	PROPN
ajb-7	349	18	,	,	PUNCT
ajb-7	349	19	van	van	PROPN
ajb-7	349	20	der	der	PROPN
ajb-7	349	21	westhuyzen	westhuyzen	PROPN
ajb-7	349	22	dr	dr	PROPN
ajb-7	349	23	,	,	PUNCT
ajb-7	349	24	jeenah	jeenah	PROPN
ajb-7	349	25	ms	ms	PROPN
ajb-7	349	26	,	,	PUNCT
ajb-7	349	27	coetzee	coetzee	PROPN
ajb-7	349	28	ga	ga	PROPN
ajb-7	349	29	,	,	PUNCT
ajb-7	349	30	leitersdorf	leitersdorf	PROPN
ajb-7	349	31	e	e	PROPN
ajb-7	349	32	(	(	PUNCT
ajb-7	349	33	1991	1991	NUM
ajb-7	349	34	)	)	PUNCT
ajb-7	349	35	a	a	DET
ajb-7	349	36	common	common	ADJ
ajb-7	349	37	lithuanian	lithuanian	ADJ
ajb-7	349	38	mutation	mutation	NOUN
ajb-7	349	39	causing	cause	VERB
ajb-7	349	40	familial	familial	ADJ
ajb-7	349	41	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	349	42	in	in	ADP
ajb-7	349	43	ashkenazi	ashkenazi	ADJ
ajb-7	349	44	jews	jews	PROPN
ajb-7	349	45	.	.	PUNCT
ajb-7	350	1	am	be	AUX
ajb-7	350	2	j	j	PROPN
ajb-7	350	3	hum	hum	PROPN
ajb-7	350	4	genet	genet	PROPN
ajb-7	350	5	.	.	PUNCT
ajb-7	351	1	49:443–449	49:443–449	PROPN
ajb-7	351	2	.	.	PUNCT
ajb-7	352	1	miettinen	miettinen	PROPN
ajb-7	352	2	ta	ta	PROPN
ajb-7	352	3	,	,	PUNCT
ajb-7	352	4	gylling	gylle	VERB
ajb-7	352	5	h	h	NOUN
ajb-7	352	6	(	(	PUNCT
ajb-7	352	7	1988	1988	NUM
ajb-7	352	8	)	)	PUNCT
ajb-7	352	9	mortality	mortality	NOUN
ajb-7	352	10	and	and	CCONJ
ajb-7	352	11	cholesterol	cholesterol	NOUN
ajb-7	352	12	metabolism	metabolism	NOUN
ajb-7	352	13	in	in	ADP
ajb-7	352	14	familial	familial	ADJ
ajb-7	352	15	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	352	16	.	.	PUNCT
ajb-7	353	1	long	long	ADJ
ajb-7	353	2	-	-	PUNCT
ajb-7	353	3	term	term	NOUN
ajb-7	353	4	follow	follow	NOUN
ajb-7	353	5	-	-	PUNCT
ajb-7	353	6	up	up	NOUN
ajb-7	353	7	of	of	ADP
ajb-7	353	8	96	96	NUM
ajb-7	353	9	patients	patient	NOUN
ajb-7	353	10	.	.	PUNCT
ajb-7	354	1	arteriosclerosis	arteriosclerosis	NOUN
ajb-7	354	2	.	.	PUNCT
ajb-7	355	1	8:163–167	8:163–167	NUM
ajb-7	355	2	.	.	PUNCT
ajb-7	356	1	müller	müller	PROPN
ajb-7	356	2	c	c	PROPN
ajb-7	356	3	(	(	PUNCT
ajb-7	356	4	1938	1938	NUM
ajb-7	356	5	)	)	PUNCT
ajb-7	356	6	xanthomata	xanthomata	PROPN
ajb-7	356	7	,	,	PUNCT
ajb-7	356	8	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	356	9	,	,	PUNCT
ajb-7	356	10	angina	angina	PROPN
ajb-7	356	11	pectoris	pectoris	ADJ
ajb-7	356	12	:	:	PUNCT
ajb-7	356	13	acta	acta	PROPN
ajb-7	356	14	med	med	PROPN
ajb-7	356	15	scand	scand	PROPN
ajb-7	356	16	89	89	NUM
ajb-7	356	17	:	:	PUNCT
ajb-7	356	18	75–84	75–84	NOUN
ajb-7	356	19	.	.	PUNCT
ajb-7	357	1	neil	neil	PROPN
ajb-7	357	2	haw	haw	PROPN
ajb-7	357	3	,	,	PUNCT
ajb-7	357	4	v	v	NOUN
ajb-7	357	5	seagroatt	seagroatt	NOUN
ajb-7	357	6	,	,	PUNCT
ajb-7	357	7	dj	dj	NOUN
ajb-7	357	8	betteridge	betteridge	NOUN
ajb-7	357	9	,	,	PUNCT
ajb-7	357	10	m	m	VERB
ajb-7	357	11	p	p	ADJ
ajb-7	357	12	cooper	cooper	NOUN
ajb-7	357	13	,	,	PUNCT
ajb-7	357	14	p	p	NOUN
ajb-7	357	15	n	n	PRON
ajb-7	357	16	durrington	durrington	NOUN
ajb-7	357	17	,	,	PUNCT
ajb-7	357	18	j	j	PROPN
ajb-7	357	19	p	p	PROPN
ajb-7	357	20	miller	miller	PROPN
ajb-7	357	21	,	,	PUNCT
ajb-7	357	22	m	m	NOUN
ajb-7	357	23	seed	seed	NOUN
ajb-7	357	24	,	,	PUNCT
ajb-7	357	25	r	r	PROPN
ajb-7	357	26	p	p	X
ajb-7	357	27	naoumova	naoumova	PROPN
ajb-7	357	28	,	,	PUNCT
ajb-7	357	29	g	g	PROPN
ajb-7	357	30	r	r	PROPN
ajb-7	357	31	thompson	thompson	PROPN
ajb-7	357	32	,	,	PUNCT
ajb-7	357	33	r	r	NOUN
ajb-7	357	34	huxley	huxley	PROPN
ajb-7	357	35	,	,	PUNCT
ajb-7	357	36	and	and	CCONJ
ajb-7	357	37	s	s	PROPN
ajb-7	357	38	e	e	PROPN
ajb-7	357	39	humphries	humphries	PROPN
ajb-7	357	40	(	(	PUNCT
ajb-7	357	41	2004	2004	NUM
ajb-7	357	42	)	)	PUNCT
ajb-7	357	43	established	establish	VERB
ajb-7	357	44	and	and	CCONJ
ajb-7	357	45	emerging	emerge	VERB
ajb-7	357	46	coronary	coronary	ADJ
ajb-7	357	47	risk	risk	NOUN
ajb-7	357	48	factors	factor	NOUN
ajb-7	357	49	in	in	ADP
ajb-7	357	50	patients	patient	NOUN
ajb-7	357	51	with	with	ADP
ajb-7	357	52	heterozygous	heterozygous	ADJ
ajb-7	357	53	familial	familial	ADJ
ajb-7	357	54	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	357	55	.	.	PUNCT
ajb-7	358	1	heart	heart	NOUN
ajb-7	358	2	90	90	NUM
ajb-7	358	3	:	:	SYM
ajb-7	358	4	1431	1431	NUM
ajb-7	358	5	–	–	PUNCT
ajb-7	358	6	1437	1437	NUM
ajb-7	358	7	.	.	PUNCT
ajb-7	359	1	rader	rader	PROPN
ajb-7	359	2	dj	dj	PROPN
ajb-7	359	3	,	,	PUNCT
ajb-7	359	4	cohen	cohen	PROPN
ajb-7	359	5	j	j	PROPN
ajb-7	359	6	,	,	PUNCT
ajb-7	359	7	hobbs	hobbs	PROPN
ajb-7	359	8	hh	hh	PROPN
ajb-7	359	9	(	(	PUNCT
ajb-7	359	10	2003	2003	NUM
ajb-7	359	11	)	)	PUNCT
ajb-7	359	12	monogenic	monogenic	ADJ
ajb-7	359	13	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	359	14	:	:	PUNCT
ajb-7	359	15	new	new	ADJ
ajb-7	359	16	insights	insight	NOUN
ajb-7	359	17	in	in	ADP
ajb-7	359	18	pathogenesis	pathogenesis	NOUN
ajb-7	359	19	and	and	CCONJ
ajb-7	359	20	treatment	treatment	NOUN
ajb-7	359	21	.	.	PUNCT
ajb-7	360	1	j	j	PROPN
ajb-7	360	2	clin	clin	PROPN
ajb-7	360	3	invest	invest	VERB
ajb-7	360	4	.	.	PUNCT
ajb-7	361	1	111	111	NUM
ajb-7	361	2	:	:	PUNCT
ajb-7	361	3	1795–1803	1795–1803	NUM
ajb-7	361	4	.	.	PUNCT
ajb-7	362	1	rywik	rywik	PROPN
ajb-7	362	2	sl	sl	PROPN
ajb-7	362	3	,	,	PUNCT
ajb-7	362	4	am	be	AUX
ajb-7	362	5	teri	teri	NOUN
ajb-7	362	6	,	,	PUNCT
ajb-7	362	7	p	p	PROPN
ajb-7	362	8	andrzej	andrzej	PROPN
ajb-7	362	9	,	,	PUNCT
ajb-7	362	10	p	p	NOUN
ajb-7	362	11	walerian	walerian	NOUN
ajb-7	362	12	,	,	PUNCT
ajb-7	362	13	ed	ed	PROPN
ajb-7	362	14	clarence	clarence	NOUN
ajb-7	362	15	,	,	PUNCT
ajb-7	362	16	bb	bb	NOUN
ajb-7	362	17	grazyna	grazyna	NOUN
ajb-7	362	18	and	and	CCONJ
ajb-7	362	19	k	k	PROPN
ajb-7	362	20	ewa	ewa	PROPN
ajb-7	362	21	(	(	PUNCT
ajb-7	362	22	1999	1999	NUM
ajb-7	362	23	)	)	PUNCT
ajb-7	362	24	association	association	NOUN
ajb-7	362	25	of	of	ADP
ajb-7	362	26	lipids	lipid	NOUN
ajb-7	362	27	and	and	CCONJ
ajb-7	362	28	lipoprotein	lipoprotein	ADJ
ajb-7	362	29	level	level	NOUN
ajb-7	362	30	with	with	ADP
ajb-7	362	31	total	total	ADJ
ajb-7	362	32	mortality	mortality	NOUN
ajb-7	362	33	and	and	CCONJ
ajb-7	362	34	morbidity	morbidity	NOUN
ajb-7	362	35	caused	cause	VERB
ajb-7	362	36	by	by	ADP
ajb-7	362	37	cardiovascular	cardiovascular	ADJ
ajb-7	362	38	and	and	CCONJ
ajb-7	362	39	cancer	cancer	NOUN
ajb-7	362	40	disease	disease	NOUN
ajb-7	362	41	(	(	PUNCT
ajb-7	362	42	poland	poland	PROPN
ajb-7	362	43	and	and	CCONJ
ajb-7	362	44	united	united	PROPN
ajb-7	362	45	states	states	PROPN
ajb-7	362	46	collaborative	collaborative	ADJ
ajb-7	362	47	study	study	NOUN
ajb-7	362	48	on	on	ADP
ajb-7	362	49	cardiovascular	cardiovascular	ADJ
ajb-7	362	50	epidemiology	epidemiology	NOUN
ajb-7	362	51	)	)	PUNCT
ajb-7	362	52	.	.	PUNCT
ajb-7	363	1	am	be	AUX
ajb-7	363	2	j	j	PROPN
ajb-7	363	3	cardiol	cardiol	NOUN
ajb-7	363	4	84	84	NUM
ajb-7	363	5	:	:	PUNCT
ajb-7	363	6	540	540	NUM
ajb-7	363	7	-	-	SYM
ajb-7	363	8	548	548	NUM
ajb-7	363	9	.	.	PUNCT
ajb-7	364	1	schuster	schuster	PROPN
ajb-7	364	2	h	h	PROPN
ajb-7	364	3	(	(	PUNCT
ajb-7	364	4	2002	2002	NUM
ajb-7	364	5	)	)	PUNCT
ajb-7	364	6	high	high	ADJ
ajb-7	364	7	risk	risk	NOUN
ajb-7	364	8	/	/	SYM
ajb-7	364	9	high	high	ADJ
ajb-7	364	10	priority	priority	NOUN
ajb-7	364	11	:	:	PUNCT
ajb-7	364	12	familial	familial	ADJ
ajb-7	364	13	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	364	14	–	–	PUNCT
ajb-7	364	15	a	a	DET
ajb-7	364	16	paradigm	paradigm	NOUN
ajb-7	364	17	for	for	ADP
ajb-7	364	18	molecular	molecular	ADJ
ajb-7	364	19	medicine	medicine	NOUN
ajb-7	364	20	.	.	PUNCT
ajb-7	365	1	atheroscler	atheroscler	PROPN
ajb-7	365	2	suppl	suppl	PROPN
ajb-7	365	3	.	.	PUNCT
ajb-7	366	1	2:27–30	2:27–30	NUM
ajb-7	366	2	.	.	PUNCT
ajb-7	367	1	tietz	tietz	PROPN
ajb-7	367	2	nw	nw	PROPN
ajb-7	367	3	(	(	PUNCT
ajb-7	367	4	1986	1986	NUM
ajb-7	367	5	)	)	PUNCT
ajb-7	367	6	textbook	textbook	NOUN
ajb-7	367	7	of	of	ADP
ajb-7	367	8	clinical	clinical	ADJ
ajb-7	367	9	chemistry	chemistry	NOUN
ajb-7	367	10	,	,	PUNCT
ajb-7	367	11	philadelphia	philadelphia	PROPN
ajb-7	367	12	,	,	PUNCT
ajb-7	367	13	pa	pa	PROPN
ajb-7	367	14	,	,	PUNCT
ajb-7	367	15	wb	wb	PROPN
ajb-7	367	16	,	,	PUNCT
ajb-7	367	17	saunders	saunders	PROPN
ajb-7	367	18	co.	co.	PROPN
ajb-7	368	1	pp	pp	X
ajb-7	368	2	.	.	PUNCT
ajb-7	368	3	888	888	NUM
ajb-7	368	4	.	.	PUNCT
ajb-7	368	5	torres	torres	PROPN
ajb-7	368	6	al	al	PROPN
ajb-7	368	7	,	,	PUNCT
ajb-7	368	8	s	s	PART
ajb-7	368	9	moorjani	moorjani	PROPN
ajb-7	368	10	,	,	PUNCT
ajb-7	368	11	mc	mc	PROPN
ajb-7	368	12	vohl	vohl	PROPN
ajb-7	368	13	,	,	PUNCT
ajb-7	368	14	c	c	PROPN
ajb-7	368	15	gagne	gagne	X
ajb-7	368	16	,	,	PUNCT
ajb-7	368	17	b	b	PROPN
ajb-7	368	18	lamarche	lamarche	NOUN
ajb-7	368	19	,	,	PUNCT
ajb-7	368	20	ld	ld	PROPN
ajb-7	368	21	brun	brun	PROPN
ajb-7	368	22	,	,	PUNCT
ajb-7	368	23	pj	pj	PROPN
ajb-7	368	24	lupien	lupien	NOUN
ajb-7	368	25	,	,	PUNCT
ajb-7	368	26	and	and	CCONJ
ajb-7	368	27	jp	jp	NOUN
ajb-7	368	28	despres	despre	NOUN
ajb-7	368	29	(	(	PUNCT
ajb-7	368	30	1996	1996	NUM
ajb-7	368	31	)	)	PUNCT
ajb-7	368	32	heterozygous	heterozygous	ADJ
ajb-7	368	33	familial	familial	ADJ
ajb-7	368	34	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	368	35	in	in	ADP
ajb-7	368	36	children	child	NOUN
ajb-7	368	37	:	:	PUNCT
ajb-7	368	38	low	low	ADJ
ajb-7	368	39	-	-	PUNCT
ajb-7	368	40	density	density	NOUN
ajb-7	368	41	lipoprotein	lipoprotein	ADJ
ajb-7	368	42	receptor	receptor	NOUN
ajb-7	368	43	mutational	mutational	ADJ
ajb-7	368	44	analysis	analysis	NOUN
ajb-7	368	45	and	and	CCONJ
ajb-7	368	46	variation	variation	NOUN
ajb-7	368	47	in	in	ADP
ajb-7	368	48	the	the	DET
ajb-7	368	49	expression	expression	NOUN
ajb-7	368	50	of	of	ADP
ajb-7	368	51	plasma	plasma	NOUN
ajb-7	368	52	lipoprotein	lipoprotein	ADJ
ajb-7	368	53	-	-	PUNCT
ajb-7	368	54	lipid	lipid	NOUN
ajb-7	368	55	concentrations	concentration	NOUN
ajb-7	368	56	.	.	PUNCT
ajb-7	369	1	atherosclerosis	atherosclerosis	NOUN
ajb-7	369	2	126	126	NUM
ajb-7	369	3	(	(	PUNCT
ajb-7	369	4	1	1	NUM
ajb-7	369	5	):	):	PUNCT
ajb-7	369	6	163	163	NUM
ajb-7	369	7	-	-	SYM
ajb-7	369	8	71	71	NUM
ajb-7	369	9	.	.	PUNCT
ajb-7	370	1	umans	uman	NOUN
ajb-7	370	2	-	-	PUNCT
ajb-7	370	3	eckenhausen	eckenhausen	PROPN
ajb-7	370	4	ma	ma	PROPN
ajb-7	370	5	,	,	PUNCT
ajb-7	370	6	ej	ej	PROPN
ajb-7	370	7	sijbrands	sijbrand	NOUN
ajb-7	370	8	,	,	PUNCT
ajb-7	370	9	jj	jj	PROPN
ajb-7	370	10	kastelein	kastelein	PROPN
ajb-7	370	11	,	,	PUNCT
ajb-7	370	12	and	and	CCONJ
ajb-7	370	13	jc	jc	PROPN
ajb-7	370	14	defesche	defesche	NOUN
ajb-7	371	1	40	40	NUM
ajb-7	371	2	kb	kb	PROPN
ajb-7	371	3	m	m	VERB
ajb-7	371	4	j	j	PROPN
ajb-7	371	5	ou	ou	PROPN
ajb-7	371	6	rn	rn	PROPN
ajb-7	371	7	al	al	PROPN
ajb-7	371	8	o	o	PROPN
ajb-7	372	1	f	f	PROPN
ajb-7	372	2	bi	bi	NOUN
ajb-7	372	3	ol	ol	PROPN
ajb-7	372	4	og	og	PROPN
ajb-7	372	5	y	y	PROPN
ajb-7	372	6	is	be	AUX
ajb-7	372	7	sn	sn	PROPN
ajb-7	372	8	1	1	NUM
ajb-7	372	9	94	94	NUM
ajb-7	372	10	858	858	NUM
ajb-7	372	11	83	83	NUM
ajb-7	372	12	.	.	PUNCT
ajb-7	373	1	p	p	X
ajb-7	373	2	ub	ub	ADJ
ajb-7	373	3	lis	li	NOUN
ajb-7	373	4	he	he	PRON
ajb-7	373	5	d	d	NOUN
ajb-7	373	6	by	by	ADP
ajb-7	373	7	k	k	PROPN
ajb-7	373	8	bm	bm	PROPN
ajb-7	373	9	s	s	PROPN
ajb-7	373	10	ci	ci	PROPN
ajb-7	373	11	en	en	ADP
ajb-7	373	12	tifi	tifi	PROPN
ajb-7	373	13	c	c	AUX
ajb-7	373	14	pu	pu	PROPN
ajb-7	373	15	bl	bl	AUX
ajb-7	373	16	ish	ish	VERB
ajb-7	373	17	in	in	ADP
ajb-7	373	18	g	g	PROPN
ajb-7	373	19	,	,	PUNCT
ajb-7	374	1	l	l	NOUN
ajb-7	374	2	p	p	X
ajb-7	375	1	(	(	PUNCT
ajb-7	375	2	w	w	PROPN
ajb-7	375	3	w	w	PROPN
ajb-7	375	4	w	w	PROPN
ajb-7	375	5	.k	.k	PROPN
ajb-7	375	6	bm	bm	PROPN
ajb-7	376	1	-s	-s	X
ajb-7	376	2	ci	ci	PROPN
ajb-7	376	3	en	en	INTJ
ajb-7	376	4	tifi	tifi	PROPN
ajb-7	376	5	cpu	cpu	NOUN
ajb-7	376	6	bl	bl	AUX
ajb-7	376	7	ish	ish	VERB
ajb-7	376	8	in	in	ADP
ajb-7	376	9	g.	g.	PROPN
ajb-7	376	10	or	or	CCONJ
ajb-7	376	11	g	g	NOUN
ajb-7	376	12	)	)	PUNCT
ajb-7	376	13	(	(	PUNCT
ajb-7	376	14	2002	2002	NUM
ajb-7	376	15	)	)	PUNCT
ajb-7	376	16	low	low	ADJ
ajb-7	376	17	-	-	PUNCT
ajb-7	376	18	density	density	NOUN
ajb-7	376	19	lipoprotein	lipoprotein	ADJ
ajb-7	376	20	receptor	receptor	NOUN
ajb-7	376	21	gene	gene	NOUN
ajb-7	376	22	mutations	mutation	NOUN
ajb-7	376	23	and	and	CCONJ
ajb-7	376	24	cardiovascular	cardiovascular	ADJ
ajb-7	376	25	risk	risk	NOUN
ajb-7	376	26	in	in	ADP
ajb-7	376	27	a	a	DET
ajb-7	376	28	large	large	ADJ
ajb-7	376	29	genetic	genetic	ADJ
ajb-7	376	30	cascade	cascade	NOUN
ajb-7	376	31	screening	screen	VERB
ajb-7	376	32	population	population	NOUN
ajb-7	376	33	.	.	PUNCT
ajb-7	377	1	circulation	circulation	NOUN
ajb-7	377	2	106	106	NUM
ajb-7	377	3	:	:	PUNCT
ajb-7	377	4	3031–3036	3031–3036	NUM
ajb-7	377	5	.	.	PUNCT
ajb-7	377	6	vuario	vuario	PROPN
ajb-7	377	7	af	af	PROPN
ajb-7	377	8	,	,	PUNCT
ajb-7	377	9	h	h	PROPN
ajb-7	377	10	turtola	turtola	NOUN
ajb-7	377	11	,	,	PUNCT
ajb-7	377	12	and	and	CCONJ
ajb-7	377	13	km	km	NOUN
ajb-7	377	14	piilahti	piilahti	VERB
ajb-7	377	15	(	(	PUNCT
ajb-7	377	16	1997	1997	NUM
ajb-7	377	17	)	)	PUNCT
ajb-7	377	18	familial	familial	ADJ
ajb-7	377	19	hypercholesterolemia	hypercholesterolemia	NOUN
ajb-7	377	20	in	in	ADP
ajb-7	377	21	the	the	DET
ajb-7	377	22	finnish	finnish	ADJ
ajb-7	377	23	north	north	PROPN
ajb-7	377	24	karelia	karelia	PROPN
ajb-7	377	25	.	.	PUNCT
ajb-7	378	1	a	a	DET
ajb-7	378	2	molecular	molecular	ADJ
ajb-7	378	3	,	,	PUNCT
ajb-7	378	4	clinical	clinical	ADJ
ajb-7	378	5	and	and	CCONJ
ajb-7	378	6	genealogical	genealogical	ADJ
ajb-7	378	7	study	study	NOUN
ajb-7	378	8	.	.	PUNCT
ajb-7	379	1	arterioscler	arterioscler	PROPN
ajb-7	379	2	thromb	thromb	PROPN
ajb-7	379	3	vasc	vasc	PROPN
ajb-7	379	4	biol	biol	PROPN
ajb-7	379	5	17	17	NUM
ajb-7	379	6	:	:	PUNCT
ajb-7	379	7	3127	3127	NUM
ajb-7	379	8	-	-	SYM
ajb-7	379	9	3138	3138	NUM
ajb-7	379	10	.	.	PUNCT
ajb-7	380	1	weber	weber	PROPN
ajb-7	380	2	m	m	PROPN
ajb-7	380	3	,	,	PUNCT
ajb-7	380	4	s	s	VERB
ajb-7	380	5	mcnicoll	mcnicoll	PROPN
ajb-7	380	6	,	,	PUNCT
ajb-7	380	7	m	m	PROPN
ajb-7	380	8	marcil	marcil	PROPN
ajb-7	380	9	,	,	PUNCT
ajb-7	380	10	p	p	PROPN
ajb-7	380	11	connelly	connelly	PROPN
ajb-7	380	12	,	,	PUNCT
ajb-7	380	13	s	s	VERB
ajb-7	380	14	lussier	lussier	NOUN
ajb-7	380	15	-	-	PUNCT
ajb-7	380	16	cacan	cacan	NOUN
ajb-7	380	17	,	,	PUNCT
ajb-7	380	18	j	j	PROPN
ajb-7	380	19	davignon	davignon	PROPN
ajb-7	380	20	,	,	PUNCT
ajb-7	380	21	y	y	PROPN
ajb-7	380	22	latour	latour	PROPN
ajb-7	380	23	,	,	PUNCT
ajb-7	380	24	and	and	CCONJ
ajb-7	380	25	j	j	PROPN
ajb-7	380	26	genest	genest	PROPN
ajb-7	380	27	jr	jr	PROPN
ajb-7	380	28	(	(	PUNCT
ajb-7	380	29	1997	1997	NUM
ajb-7	380	30	)	)	PUNCT
ajb-7	380	31	metabolic	metabolic	NOUN
ajb-7	380	32	factors	factor	NOUN
ajb-7	380	33	clustering	cluster	VERB
ajb-7	380	34	,	,	PUNCT
ajb-7	380	35	lipoprotein	lipoprotein	ADJ
ajb-7	380	36	cholesterol	cholesterol	NOUN
ajb-7	380	37	,	,	PUNCT
ajb-7	380	38	apolipoprotein	apolipoprotein	ADJ
ajb-7	380	39	(	(	PUNCT
ajb-7	380	40	a	a	X
ajb-7	380	41	)	)	PUNCT
ajb-7	380	42	and	and	CCONJ
ajb-7	380	43	apolipoprotein	apolipoprotein	NOUN
ajb-7	380	44	e	e	PROPN
ajb-7	380	45	phenotypes	phenotype	NOUN
ajb-7	380	46	in	in	ADP
ajb-7	380	47	premature	premature	ADJ
ajb-7	380	48	coronary	coronary	ADJ
ajb-7	380	49	artery	artery	NOUN
ajb-7	380	50	disease	disease	NOUN
ajb-7	380	51	in	in	ADP
ajb-7	380	52	french	french	ADJ
ajb-7	380	53	canadians	canadian	NOUN
ajb-7	380	54	.	.	PUNCT
ajb-7	381	1	can	can	AUX
ajb-7	381	2	j	j	PROPN
ajb-7	381	3	cardiol	cardiol	VERB
ajb-7	381	4	13	13	NUM
ajb-7	381	5	(	(	PUNCT
ajb-7	381	6	3	3	NUM
ajb-7	381	7	):	):	PUNCT
ajb-7	381	8	253260	253260	NUM
ajb-7	381	9	.	.	PUNCT